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This thesis comprises of three essays on the relationships among intellectual human 
capital, strategic alliances and technological performance. Earlier research has suggested 
that intellectual human capital and strategic alliances are key inputs to a firm’s 
technological performance (Rothaermel and Hess, 2006). This dissertation investigates 
the means through which the above two factors influence a firm’s technological 
performance, explores the mechanisms required for a firm to translate the benefits from 
these factors into better technological performance and finally, examines the 
interdependence between the two factors in influencing the technological performance. 
 The first essay seeks to understand if intellectual human capital and strategic 
alliances contribute to a firm’s technological performance by assisting with the new 
knowledge search process. The second essay attempts to understand the importance of 
exploitation mechanism in converting the competencies of intellectual human capital into 
better technologies. The third essay investigates if intellectual human capital and 
alliances are substitutes or complements of each other in influencing firms’ technological 
performance.  
 I test the theoretical models in the dissertation using the patent, publication and 
alliance data of 222 biotechnology firms from around the world. The results largely 
support the arguments presented in the dissertation. My first essay illustrates that 
intellectual human capital contributes to a firm's technological performance by 
embarking on the new knowledge search process. The results also confirm that strategic 
alliances assist a firm in successfully converting the new knowledge search into better 
technological performance. My second essay shows that a firm needs to have an 
 vii
exploitation mechanism in place to ensure that the knowledge generated by its intellectual 
human capital is exploited for developing valuable technologies. My third essay suggests 
that intellectual human capital and alliances are both complementary and substitutive in 
nature, but that the relationship is contingent on the characteristics of intellectual human 
capital and the attributes of alliance partners.  
 Overall, the dissertation contributes to the managerial research on knowledge 
search, accumulation of intellectual human capital and strategic alliances in the following 
ways. Earlier studies have suggested that intellectual human capital and alliances are key 
mechanisms for knowledge search. My dissertation contributes to this stream of research 
by distinguishing the value of intellectual human capital and strategic alliances to new 
knowledge search. The findings augment the research on accumulation of intellectual 
human capital by suggesting that the kind of knowledge that can be accessed through 
different types of intellectual human capital differs depending on their characteristics. I 
contribute to the stream of research on strategic alliances by showing that a holistic 
understanding of benefits derived from alliance partners, warrants a careful examination 
of the alliance partners’ attributes and their interaction with the focal firm’s 
characteristics.  
 viii
LIST OF TABLES 
Table 1.1. Summary of the Three Essays....................................................................................... 13 
Table 2.1. U.S. Patent Classes ....................................................................................................... 39 
Table 2.2. Descriptive Statistics and Correlations ......................................................................... 49 
Table 2.3. Negative Binomial Regression in Testing the Impact of New Knowledge Search and 
Control Variables on Forward Citation.......................................................................................... 52 
Table 2.4. Regression in Testing the Impact of Intellectual Human Capital and Control Variables 
on the Technological and Geographical Search............................................................................. 55 
Table 2.5. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital and 
Control Variables on Science Search............................................................................................. 56 
Table 2.6. Negative Binomial Regression in Testing the Main and Moderating Effect of Alliance 
Portfolio Attributes ........................................................................................................................ 59 
Table 2.7. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital and 
Control Variables on Forward Citation.......................................................................................... 64 
Table 2.8. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital, 
New Knowledge Search, and Control Variables on Forward Citation .......................................... 65 
Table 2.9. Summary of Hypothesis Testing................................................................................... 66 
Table 2.10. Regression in Testing the Moderating Role of Pure Scientists................................... 73 
Table 3.1. U.S. Patent Classes ..................................................................................................... 101 
Table 3.2. Descriptive Statistics and Correlations ....................................................................... 107 
Table 3.3. Negative Binomial Regression in Testing the Impact of Bridging Scientists, 
Exploitation of Science Domain Knowledge, and Control Variables on Forward Citation ........ 108 
Table 3.4. Analysis of Correlation Differences ........................................................................... 112 
Table 3.5. Analysis of Regression Coefficient ............................................................................ 114 
Table 4.1. Summary of Interaction Hypotheses........................................................................... 132 
Table 4.2. U.S. Patent Classes ..................................................................................................... 135 
Table 4.3. Descriptive Statistics and Correlations ....................................................................... 143 
Table 4.4. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital, 
Alliances and Control Variables on the Forward Citation ........................................................... 148 
Table A.1. Summary of Dependent, Independent and Control Variables………………………167 
Table A.2. List of Sample Firms.................................................................................................. 170 
Table A.3. Descriptive Statistics of 437 Firms in the Directory.................................................. 174 
Table A.4. General Description of 222 Sample Firms between 1990-2000 ................................ 174 
 ix
Table A.5. Types of Recap Alliances .......................................................................................... 176 
Table A.6. Technology Classification of Recap Alliances .......................................................... 176 
 x
LIST OF FIGURES 
Figure 1.1. Research Model of the First Essay ................................................................................ 8 
Figure 1.2. Research Model of the Second Essay.......................................................................... 10 
Figure 1.3. Research Model of the Third Essay............................................................................. 12 
Figure 2. 1. Research Model .......................................................................................................... 19 
Figure 2.2. Interaction between Technological Search and Technological Diversity of Alliance 
Portfolio for Forward Citation ....................................................................................................... 61 
Figure 2.3. Interaction between Bridging Scientists and Pure Scientists for Technological Search
....................................................................................................................................................... 74 
Figure 2.4. Interaction between Bridging Scientists and Pure Scientists for Geographical Search
....................................................................................................................................................... 75 
Figure 4.1. Interaction between Pure Scientists and University Alliances .................................. 149 
Figure 4.2. Interaction between Bridging Scientists and University Alliances ........................... 150 
Figure 4.3. Interaction between Pure Scientists and Firm Alliances ........................................... 151 
Figure 4.4. Interaction between Bridging Scientists and Firm Alliances .................................... 152 






 This chapter introduces the research questions investigated in the three essays of 
the dissertation, then summarizes the findings and contributions of each essay.  
 
MOTIVATION AND RESEARCH QUESTIONS 
 
A firm’s ability to adapt, integrate and reconfigure its competencies in accordance with 
the dynamically changing environment is essential for its technological performance. 
Scholars studying the dynamics of technological performance believe that antecedents to 
technological performance can be found both in resources residing within a firm and in 
resources leveraged from external partners (Eisenhardt and Martin 2000). At the firm 
level, heterogeneous distribution of intellectual human capital across firms is shown to be 
a significant predictor of the variance in their technological performance (Subramaniam 
and Venkataraman, 2001). Similarly, the literature on social networks underlines that the 
resources leveraged through strategic alliance are a significant predictor of the variance in 
firms’ technological performance (Powell, Koput and Smith-Doerr, 1996). Recognizing 
the importance of intellectual human capital and strategic alliances for technological 
performance, this thesis comprises of three essays on the relationships between 
intellectual human capital, strategic alliances and technological performance.  
 The first essay of this dissertation, presented in Chapter 2, seeks to understand the 
means through which intellectual human capital and strategic alliances contribute to 
technological performance. Specifically, the essay investigates if intellectual human 
capital and strategic alliances contribute to firms’ technological performance by assisting 
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with the new knowledge search process. The background and specific research question 
of this essay are elaborated upon below.  
 In high technology industries, firms’ abilities in searching for new knowledge 
residing outside their organizational boundary are considered critical for their 
technological performance. It has been shown that through search organizations learn 
new skills (Huber, 1991) and adapt to environmental changes (Cyert and March, 1963). 
Thus, search for new knowledge is an important organizational learning mechanism for 
knowledge-creating companies. This is more so in the case of “competence destroying” 
biotech innovations (The biotechnology industry is the context in testing my research 
framework) because biotech innovations require established pharmaceutical firms to 
move away from their organic chemistry knowledge base and search for knowledge from 
immunology and molecular biology disciplines. In my dissertation, new knowledge 
search refers to a firm’s endeavors in searching external knowledge with the anticipation 
that the knowledge can be recombined into valuable technologies. 
 The first step of the new knowledge search process is to search for and identify 
external knowledge. The second step is to acquire and exploit the searched knowledge. 
The literature on absorptive capacity identifies that existing knowledge forms the base for 
identifying valuable external knowledge (Cohen and Levinthal, 1990). Following the 
literature, I believe that the knowledge residing in intellectual human capital enables 
them to engage in research activities, knowledge transformation endeavors and to act as 
gatekeepers for the flow of external knowledge. Consequently, I propose that intellectual 
human capital plays an important role in searching and identifying new knowledge 
residing outside the organization, thereby assisting with the first stage of the new 
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knowledge search process. In my dissertation intellectual human capital refers to “highly 
skilled and talented employees who hold advanced degrees”.  
 While the literature on evolutionary search acknowledges the difficulty of 
acquiring external knowledge, the literature on social networks proposes inter-
organizational collaborations as an important mechanism for the inflow of external 
knowledge (Mowery et al., 1996). Hence, I propose that strategic alliances play an 
important role at the second stage of the new knowledge search process of acquiring and 
exploiting the searched knowledge, thereby helping a firm translate its new knowledge 
search into better technologies. 
  There are also notable examples in the biotechnology industry that emphasize the 
importance of intellectual human capital and alliances for new knowledge search. The 
success of Merck in its search for the root cause of AIDS is attributed to a group of 
scientists employed by the organization. The advancement of genetic research is closely 
tied to the Nobel Prize winning scientist Kary Mullis’s search of polymerization chain 
reaction techniques. With respect to alliances, Genentech, a leading biotech firm, claims 
that their recent R&D collaboration with Abbott technologies will assist the firm in 
converting their apoptosis research into anti-cancer compounds1. A recent survey 
conducted in this industry highlights that alliances contribute to the success of biotech 
firms in translating their search for new knowledge into useful discoveries2. 
 To better understand the significance of intellectual human capital and alliance to 
new knowledge search, the first essay of this dissertation concentrates on the research 
question: 
                                                 
1 http://www.lifesciencesworld.com/news/view/37908  
2 Global pharmaceutical company partnering capabilities survey 2000    
http://www.biocouncilontario.com/media/Summary_Report.pdf 
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(1) How does (a) intellectual human capital help a firm in its search for new 
knowledge, and how does (b) alliance portfolio help a firm in translating its new 
knowledge search into better technologies? 
  In investigating the above question, I classify new knowledge search into (1) 
technological search, (2) geographical search and (3) science search, depending on the 
knowledge that is searched, and classify intellectual human capital into (1) pure 
scientists, (2) bridging scientists and (3) pure inventors, depending on their specialization. 
Similarly, I concentrate on three attributes of alliance portfolio: (1) technological 
diversity, (2) geographical diversity and (3) number of partners from a university 
background. The above classifications are used to examine how different characteristics 
of intellectual human capital and different attributes of alliance portfolio contribute to the 
three dimensions of new knowledge search in varied ways.  
 While the first essay emphasizes the importance of intellectual human capital and 
alliances, realizing the benefits of these factors is not simple and straightforward. 
Intellectual human capital is inclined to work on intellectually challenging questions, 
even if the findings are not capable of generating economic rents. Since intellectual 
human capital, like scientists, believe that their primary obligation is the advancement of 
research rather than making their skills available to the organization, it is especially 
difficult for a firm to translate their competencies into better technologies. Similarly, the 
difficulty of benefiting from alliances is demonstrated by a survey3 conducted in 2000 
which projected that about 40% of alliances failed to produce their desired effect. Though 
a number of scholars have delved into the means of leveraging alliance partners’ 
                                                 
3 Global pharmaceutical company partnering capabilities survey 2000    
http://www.biocouncilontario.com/media/Summary_Report.pdf 
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capabilities (Dyer and Singh, 1998; Lane and Lubatkin, 1996; Grant and Braden-Fuller, 
2004), the question of how firms realize the benefits of their intellectual human capital 
has not gained enough attention in the literature. Hence, the second essay of this 
dissertation, presented in Chapter 3, investigates the research question: 
(2) How can a firm benefit from the competencies of its intellectual human capital? 
 Specifically, the study looks at mechanisms for converting the competencies of 
intellectual human capital, such as scientists, into better technological performance.  
 The third essay of this dissertation, presented in Chapter 4, investigates the 
interdependency between (1) intellectual human capital and (2) alliances in explaining 
the technological performance of firms. Two different perspectives exist regarding the 
interdependency of these two factors. The first perspective argues that the two factors are 
complementary, whereas the second one perceives the factors to be substitutes of each 
other (Liebeskind et al., 1996; Rothaermel and Hess, 2007). However, neither perspective 
has paid attention to the characteristics of intellectual human capital and alliances that 
might alter the nature of their interdependencies. As the nature of information flow from 
alliance partners and the kind of knowledge that flows through intellectual human capital 
is known to depend on their characteristics (Owen-Smith and Powell, 2004), I believe 
that the attributes of intellectual human capital and alliances play an important role in 
determining their interdependency. Hence, the third essay of this dissertation, presented 
in Chapter 4, pursues the question:  
(3) How do the characteristics of intellectual human capital and alliances alter the 
nature of their interdependency (complements/substitutes)? 
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 To examine this question the essay classifies intellectual human capital into (1) 
pure scientists, (2) bridging scientists and (3) pure inventors, depending on their 
specialization, and alliances into (1) firm alliances and (2) university alliances, based on 
the institutional regime, and then investigates their interdependency.  
 The next section elaborates on the research models, findings, and contributions of 
each of the three essays that comprise this dissertation. 
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RESEARCH MODELS, FINDINGS AND CONTRIBUTIONS 
As outlined above, the first essay of this dissertation investigates the importance of 
intellectual human capital to new knowledge search and how alliances help a firm in 
translating its new knowledge search into better technologies. The research model tested 
in this essay is presented in Figure 1.1. In my study, a firm’s attempt to search for 
knowledge outside its organizational boundary is termed as new knowledge search. 
Depending on the knowledge that is searched, new knowledge search is classified into (1) 
technological search, (2) geographical search and (3) science search.  
 Intellectual human capital and alliances are categorized into three types in order to 
better understand their contributions to new knowledge search and technological 
performance. In high technology industries, intellectual human capital is known to differ 
based on whether they specialize in the science domain, technology domain or both 
(Gittelman and Kogut, 2003). Hence, I classify intellectual human capital into three 
types: (1) pure scientists (only science domain), (2) bridging scientists (both science and 
technology domains) and (3) pure inventors (only technology domain), depending on 
their domain of specialization. Similarly, the benefits from alliances are known to depend 
on their attributes, not just by their size (Stuart, 2000). Accordingly, I look at three 
attributes of alliance portfolio: (1) technological diversity, (2) geographical diversity and 
(3) number of partners from a university background. The three attributes of alliance 
portfolio are consistent with the three dimensions of new knowledge search. 
 The research question, unit of analysis and key results of the first essay are 
presented in the first column of Table 1.1. I use the patent, publication and alliance data 
of 222 biotech firms in testing the research model. The results show that bridging 
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scientists and pure inventors directly contribute to new knowledge search and 
technological performance, but pure scientists do not. The findings further demonstrate 
that the contributions of pure scientists to new knowledge search are indirect by helping 
bridging scientists in their search process. With regard to alliances, all three attributes of 
alliance portfolio have a positive influence on technological performance. A 
technologically and geographically diverse alliance portfolio is observed to enhance the 
contributions of technological and geographical searches to technological performance.  
Figure 1. 1. Research Model of the First Essay 
 
 
  The first essay of this dissertation makes the following contributions. The findings 
contribute to the research on knowledge search by distinguishing the value of intellectual 
human capital and strategic alliances to new knowledge search. The essay contributes to 
studies on intellectual human capital - technological performance link by showing that 
new knowledge search is one of the means through which intellectual human capital 
contributes to technological performance. The findings of this essay help in illustrating 
that the contributions of intellectual human capital to technological performance and new 
INTELLECTUAL 
HUMAN CAPITAL 
1. Pure Scientists 
2. Bridging Scientists 
3. Pure Inventors 
NEW KNOWLEDGE 
SEARCH 
1. Technological Search 
2. Geographical Search 





1. Technological Diversity 
2. Geographical Diversity 
3. Number of University Partners 
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knowledge search differ depending on their characteristics. Specifically, I demonstrate 
the contingent value of intellectual human capital, such as scientists, by differentiating 
between the contributions of scientists who play the bridging role (in bridging science 
and technology domains) and scientists who do pure research. The results pertaining to 
alliance portfolio are useful in proposing an alliance strategy to a firm that best fits with 
the firm’s knowledge search strategy. The findings also suggest that the strategic 
advantage derived from alliance partners depends on the partners’ attributes and their 
interaction with the focal firm’s characteristics. 
 The results from the first essay underline the importance of scientists and 
inventors for better technological performance. As inventors are solely involved in 
technology development activities, it should not be very difficult for a firm to translate 
competencies of its inventors into better technologies. This is not so in the case of 
scientists, as scientists are involved in scientific research that is not a ready-made input to 
technological development. Hence, the second essay investigates two mechanisms for 
translating competencies of a firm’s intellectual human capital into better technologies. 
  The first mechanism is an individual level mechanism of letting intellectual 
human capital, such as scientists, work on both upstream scientific research and 
downstream technology development activities. The second one is the firm’s exploitation 
mechanism of letting scientists do the upstream scientific research while also 
encouraging technology developers to exploit the knowledge produced by in-house 
scientists. The research model tested in this essay is presented in Figure 1.2. The key 
results of this essay are presented in the second column of Table 1.2.  
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 The findings of this study support the importance of bridging scientists. 
Nevertheless, exploitation mechanism turns out to be of greater significance than 
bridging scientists because the results indicate that in the absence of an exploitation 
mechanism, bridging scientists have no role to play in converting the scientific 
competency of a firm into better technologies. While existing studies view individuals as 
movers of knowledge across boundaries, my findings illustrate that bridging the science 
and technology domain within a firm is not a simple human capital story of having 
scientists do both. A firm should have an appropriate exploitation mechanism in place to 
achieve this.  
Figure 1. 2. Research Model of the Second Essay 
 
 
 The third essay of this dissertation investigates the interdependency between 
intellectual human capital and alliances. The research model tested in this essay is 
presented in Figure 1.3. Similar to the second essay, intellectual human capital is 
subdivided into (1) pure scientists, (2) bridging scientists and (3) pure inventors. 
Alliances are categorized into (1) firm alliances and (2) university alliances, depending 
INTELLECTUAL 
HUMAN CAPITAL 




FIRM LEVEL MECHANISM 
OF EXPLOITING 
SCIENTISTS’ KNOWLEDGE 
(1) Exploitation of knowledge generated 
by scientists in technological domain 
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on their institutional affiliation. The key findings of this essay are presented in the third 
column of Table 1.1.  
 In examining their interdependency, the results show that bridging scientists and 
pure scientists substitute university alliances because they are also involved in an external 
scientific network with a free flow of knowledge from academic communities adhering to 
the norm of openness. However, with respect to firm alliance partners that believe in a 
proprietary model of sharing knowledge, all three types of intellectual human capital act 
as complements to each other. While prior studies have found support for either a 
substitutive or complementary story in explaining the interdependency between 
intellectual human capital and alliances, I support both perspectives. Further, I show that 
the exact nature of interdependency (complements/substitutes) is contingent on the nature 
of intellectual human capital and attributes of alliance partners. The findings also suggest 
that benefits from a formal partnership depend on whether or not it is an extension of the 
social relationships of human capital residing within the firm. 
 This dissertation is organized as follows. Chapters 2, 3 and 4 present the three 
essays of this dissertation. Chapter 2 investigates the means through which intellectual 
human capital and strategic alliances influence a firm’s technological performance. 
Chapter 3 examines mechanisms required for a firm to translate benefits from its 
intellectual human capital into better technological performance. Chapter 4 explores the 
interdependency between intellectual human capital and strategic alliances in influencing 
the technological performance. Chapter 5 integrates the findings of the three essays and 
links these findings with the extant literature on knowledge search, human capital and 
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strategic alliances. I also discuss the limitations and future research directions of this 
dissertation in Chapter 5.  
 






1. Pure Scientists 
2. Bridging Scientists 
3. Pure Inventors 
ALLIANCES 
1. No. of University partners 
2. No. of Firm partners 
TECHNOLOGICAL 
PERFORMANCE Complements or  Substitutes X 
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Table 1.1. Summary of the Three Essays 
 




How intellectual human capital such as  
(a) pure scientists (b) bridging scientists and (c) pure inventors 
embark on   
(a) technological (b) geographical and (c) science 
search in generating valuable technologies?  
How an alliance portfolio characterized by partners from a 
(a) diverse technological background  
(b) diverse geographical background and  
(c) a greater number of partners from an academic background  
enhance the value of   
(a) technological (b) geographical and (c) science search in 
generating valuable technologies? 
How the individual-level mechanism of having  
(a) bridging scientists  
and the firm-level mechanism of  
(b) exploiting science knowledge in the 
technology domain  
help a firm in translating the competencies of its 
scientists into valuable technologies? 
Are intellectual human capital such as  
(a) pure scientists (b) bridging scientists and (c) 
pure inventors and  
alliances comprised of 
(a) firm partners and 
(b) university partners 
complements or substitutes of each other in 
explaining the technological performance of firms? 
Research 
Design 
Quantitative analysis of patent, publication and alliance data of 
222 biotech firms from Plunkett’s biotechnology directory 
Quantitative analysis of patent and publication 
data of 222 biotech firms from Plunkett’s 
biotechnology directory 
Quantitative analysis of patent, publication and 
alliance data of 222 biotech firms from Plunkett’s 
biotechnology directory 
Findings Bridging scientists and pure inventors assist the technological 
and geographical searches. Pure scientists facilitate the 
technological and geographical searches of bridging scientists.  
Technologically and geographically diverse alliance portfolio 
enhances the contribution of technological and geographical 
searches.  
Firm-level exploitation mechanism moderates 
the degree of relationship between bridging 
scientists and technological performance. In the 
absence of firm-level exploitation mechanisms, 
the mere presence of bridging scientists need not 
result in translation of scientific competency into 
better technologies 
Pure scientists and bridging scientists substitute 
university alliances 
 
Pure scientists, bridging scientists, and pure 
inventors complement firm alliances 
 
 
Contributions (1) Differentiates the value of intellectual human capital and 
strategic alliances to new knowledge search 
 
(2) Illustrates that the contribution of intellectual human capital 
to technological performance and new knowledge search differ 
depending on their characteristics.  
 
(3) Suggests that strategic advantages derived from alliance 
partners depend on the partners’ attributes and their interaction 
with the focal firm’s characteristics. 
(1) Suggests that bridging science-technology 
domains is not a simple human capital story of 
having scientists who are involved in both 
scientific research and technological activities 
 
(2) Illustrates that firms have to acknowledge 
the challenges in making the transition from 
science domain exploration to technology 
domain exploitation and attempt to have 
premeditated mechanisms to bridge the gap 
(1) Suggests that intellectual human capital and 
strategic alliances are both complements and 
substitutes of each other depending on the 
characteristics of intellectual human capital and 
attributes of alliance partners 
 
(2) Demonstrates that benefits from a formal 
partnership depend on whether or not it is an 
extension of the social relationships of human 
capital already residing within the firm 
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CHAPTER TWO 
 
NEW KNOWLEDGE SEARCH: THE ROLE OF INTELLECTUAL HUMAN 
CAPITAL AND ALLIANCE PORTFOLIO 
 
INTRODUCTION 
Organizations innovate by combining new knowledge with existing knowledge (Kogut 
and Zander, 1992). Thus, the search for new knowledge is an inevitable part of 
technological innovation. There are two types of search behaviors exhibited by firms. 
First is to look for new ideas in the neighborhood of research and development (R&D) 
activities residing within the firm. Although the process of 'local search' is cheap and this 
knowledge is easy to access, the dynamically accelerated marketplace requires firms to 
consider the second type of search which spans their organizational boundary and look 
for external knowledge. In this study, firms’ endeavors in looking for knowledge residing 
outside their organizational boundary are termed as a 'new knowledge search'. Several 
studies belonging to the evolutionary search literature have shown that the ability of 
organizations to generate high impact technologies is closely tied to their new knowledge 
search (Rosenkopf and Nerkar, 2001; Ahuja and Lampert, 2001; Rosenkopf and Almeida, 
2003; Ahuja and Katila, 2004).  
 Though new knowledge search helps a firm in generating valuable innovations, 
organizations find it difficult to reach out for distant knowledge (Jaffe, Trajtenberg and 
Henderson, 1993; Stuart and Podolny, 1996). In particular, a firm's search for new 
knowledge is shown to be geographically and technologically bounded. Recent research 
has shown that firms search for and acquire distant knowledge with the help of their 
employees and strategic alliances (Rosenkopf and Almeida, 2003). However, more 
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remains to be understood about the precise contribution of these factors to new 
knowledge search. For instance, the finer aspect of how organizations utilize intellectual 
human capital and alliances for new knowledge search remains unconnected with the 
different stages of new knowledge search.  
 A firm's search for new knowledge to generate better technologies can be 
described as consisting of two stages (Zahra and George, 2002; Tripas, 1997). The first 
stage involves searching for new knowledge. Organizations engage their intellectual 
human capital in search of new knowledge because the knowledge residing in intellectual 
human capital helps in screening and identifying valuable external knowledge. Though 
intellectual human capital engages in search of new knowledge, literature has 
acknowledged that it is not very easy to absorb and exploit knowledge residing outside a 
firm’s environment. This can be due to reasons such as relative absorptive capacity, the 
type of knowledge that is searched, etc. (Lane and Lubatkin, 1998; Gambardella, 1995; 
Phene, Fladmoe-Lindquist and Marsh, 2006). In the absence of an appropriate 
mechanism to enable the transfer and exploitation of the searched knowledge, it is 
difficult to convert new knowledge search into better technologies. Hence, the second 
stage of new knowledge search is to establish collaborative arrangements, such as 
alliances, that facilitate this process.  
 Since the search for new knowledge also incurs huge costs, it is critical to 
investigate the strategic importance of intellectual human capital and alliances for new 
knowledge search, as outlined above. This study has two objectives to demonstrate the 
differential effect of these two factors in the process of searching and acquiring new 
knowledge for creating valuable technologies.  
                                                                                                                                      16 
 The first objective is in showing that intellectual human capital endowed within a 
firm undertakes new knowledge search, thereby contributing to better technological 
performance. There are several examples in the medical industry that underline the 
significance of intellectual human capital. Their role in search of knowledge related to 
coronary artery disease, genetic research, and AIDS are exemplary examples (Mina, 
Ramlogan, Tampubolon and Metcalfe, 2007)4.   
 I explore the importance of intellectual human capital for three types of new 
knowledge search: (a) technological search (the degree to which a firm searches a wide 
array of technologies), (b) geographical search (the degree to which a firm searches 
diverse geographic locations) (c) science search (the degree to which a firm searches the 
science knowledge base). While literature on evolutionary search traditionally 
concentrates on the ‘technological’ and ‘geographical’ dimensions of search, I follow 
Ahuja and Katila (2004) in including the third dimension ‘science search’. This 
additional dimension has been shown to have a significant contribution to technological 
performance in the high-tech industries. 
 I also categorize intellectual human capital into three types. This is done in order 
to examine their differential effect on the three different dimensions of new knowledge 
search. Innovations in high-technology industries are determined by the advancement of 
both scientific and technological knowledge (Nelson, 2003) and the characteristics of 
intellectual human capital in such industries differ based on the domain in which they 
carry out research activities (science/technology/both) (Gittelman and Kogut, 2003). 
                                                 
4  http://www.lifesciencesworld.com/news/view/37908 
   http://query.nytimes.com/gst/fullpage.html?res=9903E2D61731F934A15751C0A9649C8B63  
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Hence, I classify intellectual human capital into (a) pure scientists, (b) pure inventors and 
(c) bridging scientists based on the domain in which they specialize.  
 The first objective intends to contribute to two streams of research. The first 
contribution is to the literature on evolutionary search in showing the significance of 
different types of intellectual human capital for different dimensions of new knowledge 
search. The second contribution is to the stream of research on intellectual human capital-
technological performance link in showing that intellectual human capital contributes to 
technological performance by engaging in new knowledge search. 
 Literature identifies strategic alliances, especially those on research and 
development (R&D), to be an important mechanism for acquiring and exploiting external 
knowledge (Mowery, Oxley and Silverman, 1996; Grant and Baden-Fuller, 2004). 
Hence, the second objective of this research is to show that strategic alliances help a firm 
in translating its new knowledge search into better technologies. Specifically, I show that 
strategic alliances moderate the relationship between new knowledge search and 
technological performance. One might argue that alliances can also be a direct input to 
new knowledge search. However, I support my claim that the value of strategic alliance is 
to the second stage of new knowledge search in the following way. According to the 
absorptive capacity literature, the first and foremost step in forming an alliance is 
identifying potential partners and evaluating the value of their knowledge. Therefore, a 
firm’s internal resources, such as intellectual human capital, lay the foundation for new 
knowledge search by identifying potential partners. It is with these new partners whom 
the firm then establishes formal relationships such as alliances. Thus, the role of alliances 
is in facilitating the process of acquiring and exploiting the searched knowledge.  
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 The benefits from cooperative strategy are known to depend on the characteristics 
of the alliance network (Stuart, 2000). Therefore, the second objective is to specifically 
investigate the kind of alliance portfolio that best fits the three dimensions of new 
knowledge search. I propose that an alliance portfolio characterized by partners from 
diverse technological and geographical background positively moderates the relationship 
of technological, geographical search with technological performance, respectively. 
Similarly, I argue that an alliance portfolio characterized by a higher number of partners 
from the academe enhances the value of science search.  
 The second objective also intends to contribute to two streams of research. The 
first contribution is to the evolutionary search literature. I intend to identify the kind of 
alliance portfolio that best fits with the different dimensions of new knowledge search, 
thereby enhancing the contribution of new knowledge search to technological 
performance. The next contribution is to the literature on strategic alliances. I suggest that 
a holistic understanding of the benefits derived from an alliance portfolio depends on the 
attributes of the alliance portfolio as well as their interactions with the focal firm’s 
characteristics. 
 The research framework developed in this study is tested using patent, publication 
and alliance data of biotechnology firms. This chapter is organized as follows. In the next 
section I elaborate on each of the linkages shown in Figure 2.1 and develop the 
hypotheses. This research intends to examine the correlation among the variables shown 
in Figure 2.1 and not to test their causal relationship. In the subsequent sections I present 
the research method and results. In the last section I discuss the implications of the 
findings and the limitations of the study. 
 
                                                                                                                                      19 




THEORY AND HYPOTHESES DEVELOPMENT 
New Knowledge Search 
Search is an inevitable part of the organizational learning process (Huber, 1991). 
Organizations engage in different types of searches. They are known to search for the 
best manufacturing routine (Jaikumar and Bohn, 1992), superior organizational design 
(Bruderer and Singh, 1996), the best means of implementing new technologies (von 
Hippel and Tyre, 1995), and the like. In this study, I focus on firms’ endeavors in 
searching external knowledge with the anticipation that the knowledge can be 
recombined into valuable technologies. My study refers to this type of search as 'new 
knowledge search'. 
 New knowledge search is categorized into three types: (a) technological search, 
(b) geographical search and (c) science search, depending on the knowledge that is 
searched. All three dimensions of new knowledge search are critical for technological 
performance. For instance, the importance of technological search is explained by 
INTELLECTUAL 
HUMAN CAPITAL 
1. Pure Scientists 
2. Bridging Scientists 
3. Pure Inventors 
NEW KNOWLEDGE 
SEARCH 
1. Technological Search 
2. Geographical Search 





1. Technological Diversity 
2. Geographical Diversity 
3. Number of University Partners 
  H2a, b, c H1a, b, c 
H4a, b, c H3a, b, c 
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Rosenkopf and Nerkar (2001) using the optical disk drive industry. They show that in the 
optical disk drive industry the breakthrough discovery of DVD was made possible by 
integrating ideas from laser technologies. Databases like MedTRACK that incorporate 
advanced tools in searching geographically dispersed knowledge underline the 
significance of geographical search. The importance of science search for technological 
performance can be easily appreciated from the basic definition of technology - 
“incorporating scientific knowledge into physical artifact that benefits users” (Nelson and 
Winter, 1982).  
 There are various means through which firms can search and acquire new 
knowledge. Firstly, as people are known as knowledge holders and movers of knowledge 
across boundaries, intellectual human capital assists a firm in its new knowledge search 
(Almeida and Kogut, 1999). Organizations achieve this by engaging their intellectual 
human capital in research activities, professional communities, etc. Secondly, firms 
engage in formal arrangements such as alliances to acquire and access new knowledge.  
 It should also be acknowledged that many of the organization level factors such as 
organizational design, R&D structure, firm size and technological strength also play an 
important role in directing the new knowledge search (Argyres and Silverman, 2004; 
Siggelkow and Rivkin, 2005; Rivkin and Siggelkow, 2003; Colombo, Grilli and Piva, 
2006). The above studies illustrate that decentralized organizations and organizations that 
are large and highly innovative attempt to search widely for new knowledge. As 
intellectual human capital and alliances are two mechanisms that are directly engaged in 
searching and acquiring new knowledge, my research concentrates on these two factors. 
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Nevertheless, I use some of the firm level variables such as size and technological 
strength as control variables.  
 The following sections examine the details of the three dimensions of new 
knowledge search and their contribution to technological performance.  
Technological Search and Technological Performance 
Technological search refers to the search for diverse technological areas in the 
anticipation of recombining them into novel technologies (Rosenkopf and Nerkar, 2001). 
Technological search can enhance the technological performance of firms by the 
following means. First, technological search can positively influence the technological 
performance by increasing the number of elements available for recombination. 
Innovation has been conceptualized as a process of recombination and, according to this 
perspective, important innovations arise out of combining technological components in a 
novel manner (Nelson and Winter, 1982; Henderson and Clark, 1990; Weitzman, 1996). 
When a firm attempts to move beyond existing technological landscapes and search 
broadly for technological elements, it enriches the knowledge pool available. The 
enriched knowledge pool creates opportunities for the cross-fertilization and cross-
application of ideas across technological domains for generating high-impact 
technologies. Indeed, most modern innovations are fusions of ideas searched across 
different technological landscapes. For instance, the discovery of inkjet printers by 
Hewlett Packard as well as the birth of genetic engineering5 are examples of how search 
                                                 
5 “In a conference held in 1972, Stanley Cohen of Stanford University elaborated on the technique of 
introducing DNA (the double-stranded helical molecule chain found in the nucleus of each cell that carries 
the genetic information) into Escherichia Coli, which is the main species of the lower intestine of 
mammals. In the same meeting, Herbert Boyer from the University of San Francisco shared his work on a 
revolutionary enzyme called EcoRI, which could cleave the double-stranded DNA molecule to produce 
single-stranded ends with identical termini. The two scientists saw the potential of combining the two 
discoveries into what is currently known as genetic engineering. Subsequently, the biotechnology industry 
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of new technological landscapes can increase the possibility of recombination, thereby 
resulting in valuable innovation.  
 Second, broad technological search provides a basis for breakthrough 
technologies by helping firms overcome familiarity traps. When firms experiment with 
the technological elements they are familiar with, their experience in those elements 
increases. Greater experience will foster greater usage of the same technological 
elements. This path dependency increases the risk of firms falling into the familiarity 
trap, and this can impair firms’ capability to develop valuable technologies (Ahuja and 
Lampert, 2001). A broad technological search can help to overcome this problem in the 
following ways. Technological search exposes firms to new technological elements that 
challenge the stability of the existing cognitive structure (Lei, Hitt and Bettis, 1996). In 
understanding the new and unfamiliar technological elements, firms develop additional 
insights and profundity. Exposure to diverse technological areas also helps in building a 
heterogeneous repertoire of knowledge. The broad knowledge base provides the benefit 
of heterogeneity in solving problems (Amabile, 1988) rather than solving in a 
paradigmatic way. On both these accounts, broad technological search can circumvent 
the familiarity trap, providing a basis for creating valuable technologies. The above 
arguments suggest that the search for knowledge from diverse technological domains is 
capable of generating valuable technologies.  
 Though technological search has the above-mentioned advantages, it is also 
associated with certain disadvantages. The search of wide technological areas is a costly 
and tedious task. In addition, recombining ideas from different technological domains is 
                                                                                                                                                 
has become increasingly richer, involving knowledge from different disciplines such as molecular biology, 
chemistry, computer science, and the like” (Christensen, 2003; DeCarolis and Deeds, 1999). 
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not straightforward and has inherent uncertainties (Fleming and Sorenson, 2004). 
Identifying one fruitful combination amid the potential number of technological 
recombination is time consuming. Hence, beyond a point, searching across diverse 
technological areas will result in diminishing returns. The above arguments lead to the 
following hypothesis: 
Hypothesis 1a: The breadth of a firm’s technological search is curvilinearly (inverted U) 
related to its technological performance. 
Geographical Search and Technological Performance 
Geographical search refers to the search for geographically distant knowledge in the 
prospect of locating valuable ideas (Song, Almeida and Wu, 2001). There are three 
explanations to support the argument that geographical search leads to better 
technological performance. First, geographical search can increase a firm’s awareness of 
diverse knowledge domains, thereby increasing the likelihood of generating valuable 
technologies. It has been shown that technological trajectories differ across nations 
(Freeman and Soete, 1997). Owing to the knowledge differences across boundaries, any 
attempt to span geographical boundaries can give access to diverse knowledge with the 
potential to be recombined into valuable technologies. As people from different contexts 
are capable of viewing the same thing differently, geographical search can lead to novel 
combinations of existing ideas. Geographical search can also expose firms to specialized 
local knowledge of diverse geographical boundaries that can beget valuable innovation. 
An excellent example of this is the knowledge gained by the American chemical 
company W.R. Grace in developing a commercial drug using neem, a herb traditionally 
used in India for medicinal purposes (Phene et al., 2006).  
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 Second, geographical search can positively influence technological performance 
by exposing firms to rich information and knowledge networks. In developing valuable 
technologies, firms have to constantly rely on external sources of information and 
knowledge. The globalized technological arena has increased the need for firms to stretch 
their regional boundaries in search for external knowledge. Though knowledge is an 
intangible asset, it is considered extremely difficult to transfer knowledge across 
geographical boundaries. With knowledge flow being geographically localized, firms 
have to rely on network connections in order to access knowledge. Research has 
suggested that the extent to which a recipient seeks information from a source depends on 
the extent to which the recipient is aware of the source (Borgotti and Cross, 2003). 
Therefore, searching or scanning for new knowledge is the first step involved in exposing 
firms to valuable sources of knowledge. Thus, a firm’s geographical search will promote 
awareness of different regional networks, thereby providing an opportunity to tap into 
knowledge embedded in these networks for generating valuable technologies. The above 
arguments suggest that the search for knowledge from diverse geographical regions is 
capable of generating valuable technologies.  
 However, scanning wide geographic locations can also be dysfunctional (Ahuja 
and Katila, 2004). Acquiring and integrating knowledge obtained from different 
geography is a difficult job. Distance and cultural differences further exasperate the 
problem of utilizing the searched knowledge to develop technologies. Hence, beyond an 
extent, scanning diverse geographic locations can result in decreased technological 
performance. The above arguments lead to the following hypothesis: 
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Hypothesis 1b: The breadth of a firm’s geographical search is curvilinearly (inverted U) 
related to its technological performance.  
Science Search and Technological Performance 
Science search refers to the intensity of scientific knowledge search with the expectation 
that the knowledge will assist in finding novel technologies (Ahuja and Katila, 2004). 
Unlike technological and geographical search, science search refers to intensity but not 
breadth. This is because the purpose of using scientific knowledge is to achieve a deeper 
understanding of why some phenomena occur during the technology development 
process (Fleming and Sorenson, 2004).  
  Science search can positively influence the technological performance of firms 
through the following means. First, science search has a positive influence on 
technological performance by acting as a direct source of new ideas. Though important 
innovations are seen as a combination of technological ideas, the set of elements 
available for recombination is finite. As a result, the recombination search space will 
decrease over time, ultimately resulting in technological exhaustion (Hargadan and 
Sutton, 1997). In the event of the exhaustion of ideas firms must embark on alternative 
search trajectories, and science is a natural choice. Science search helps in generating 
new theories which, consequently, increases the availability of new ideas. The new ideas 
generated by science subsequently become key ingredients for technology activities.  
 Second, science search can reduce the combinatorial search pace, thereby 
positively influencing technological performance. For instance, scanning scientific 
knowledge can improve the understanding of the cause-effect relationship between 
technological elements. Scientific knowledge also helps in assessing technology and in 
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foreseeing technological risk (Brooks, 1973). Consequently, science search can assist 
firms in exploring productive research avenues and inventing technologies with greater 
reliability.  
 Apart from being a direct input to technological innovation, science search is 
observed to provide some indirect benefits in generating valuable technologies. These 
benefits include enhancing the skills and capabilities of human resources, fine-tuning the 
engineering design and tool and the like. For example, scientific knowledge exploration 
is shown to impart the necessary research skills required for carrying out technology 
development activities. Much of the technical knowledge used in designing and in 
evaluating engineering designs is also shown to be developed from the scientific 
knowledge base (Brooks, 1994). The above arguments suggest that the search for 
knowledge from science base is capable of generating valuable technologies.  
 Though searching the science knowledge base is helpful, excessive amounts of 
science search can be detrimental to technological performance for the following reasons. 
Engaging in scientific exploration can lead to random drift and frequent alterations of a 
firm’s knowledge base. The difficulty associated with adjusting to such random drift can 
obstruct a firm from concentrating on technology development. Time spent on scientific 
exploration can also reduce the availability of time for actively integrating and exploiting 
knowledge, thereby reducing the technological performance. Hence, I hypothesize that: 
Hypothesis 1c: The intensity of a firm’s science search is curvilinearly (inverted U) 
related to its technological performance.  
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Intellectual Human Capital and New Knowledge Search 
 
Knowledge is considered to be the core of a firm, and much of an organization’s 
knowledge resides in its human capital. Consequently, human capital is one of the 
important resources that contribute to knowledge-intensive activities such as new 
knowledge search. This is one reason why highly-skilled and talented employees are 
considered to be valuable resources for successfully adapting to technological changes 
(Siegel, 1999; Siegel, Waldman and Youngdahl, 1997). There are three explanations to 
support the positive association between intellectual human capital and new knowledge 
search.  
 First, the absorptive capacity literature identifies pre-existing knowledge to be an 
important factor in screening and identifying valuable external knowledge (Cohen and 
Levinthal, 1990). The knowledge and skills residing in intellectual human capital enables 
them to actively engage in research activities, thereby playing a key role in new 
knowledge search. Especially in biotechnology industries requiring specialized skill sets, 
intellectual human capital has a significant role in the pursuit of searching knowledge 
(Zuker, Darby and Brewer, 1998). The genetic engineering, AIDS, and polymerization 
chain reaction examples illustrated earlier also underline the contribution of intellectual 
human capital to new knowledge search.  
 Second, propensity to transform knowledge is an essential step for embarking on 
new knowledge search. Rather than relying on preserved knowledge, engaging in 
knowledge transformation activities requires questioning of prevailing norms. Intellectual 
human capital plays a vital role in questioning prevailing norms within the organization 
and in imparting new ways of thinking (Tushman and Anderson, 1986). Thus, by acting 
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as a predominant source for knowledge transformation, intellectual human capital has a 
positive influence on search for new knowledge. 
 Third, engaging in new knowledge search requires awareness of valuable sources 
of knowledge. By actively plugging itself in external professional communities, 
intellectual human capital acts as a channel for the flow of information about valuable 
sources of knowledge. Thus, intellectual human capital plays the vital role of carrying 
meta-knowledge, thereby having a positive influence on new knowledge search. Meta-
knowledge is defined as knowledge about sources of knowledge (Majchrzak, Cooper and 
Neece, 2004). While the above arguments suggest a positive influence of intellectual 
human capital on new knowledge search, the following section categorizes intellectual 
human capital into three types and exemplifies their individual contribution to search.  
 Traditionally, studies on professional careers concentrated on two tracks. The first 
track focused on academic researchers and their scientific activities (Keith and Babchuk, 
1998), and the second track on industrial engineers and their technological activities 
(Allen and Katz, 1992). But, with the birth of science intensive industries such as 
biotechnology and the introduction of the Bayh-Dole Act, we observe an increasing 
number of scientists from academe actively contributing to technological activities in the 
industry. Firms are also known to attract scientists into their organizations and encourage 
them to publish their findings (Stern, 2004). Consequently, we notice three different 
types of intellectual human capital within an organization. The first one, pure scientists, 
are exclusively involved in scientific research. The second type, pure inventors, 
predominantly focus on technological activities. The third type of intellectual human 
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capital, called bridging scientists, are involved in both scientific and technological 
activities. 
  The three classifications of intellectual human capital contribute to new 
knowledge search in varied ways. For instance, involvement of pure scientists in 
scientific research and scientific community enable them to contribute to science search. 
The open scientific community comprised of scientists from different geographic 
locations allows pure scientists to search geographically wide knowledge (Furukawa and 
Goto, 2006). Since basic scientific knowledge can also help in technology assessment, 
pure scientists have a significant role in technological search. The nature of scientific 
research is to question basic assumptions. This means pure scientists play a vital role in 
knowledge transformation activities of a firm, thereby contributing to new knowledge 
search.  
 In parallel, the pure inventors who are engaged in technological activities and 
connected to technical communities facilitate the technological and geographical search 
of a firm. They can also direct the attention of search to useful scientific knowledge that 
has applications in technology development, thereby helping the science search.  
 Bridging scientists have a role in both scientific research and technological 
activities, and therefore contribute to new knowledge search in all the above-mentioned 
ways. In addition, their bridging role aids the flow of information about valuable sources 
of knowledge across these two groups. Hence, I hypothesize that: 
 
Hypothesis 2a: The number of intellectual human capital (Pure Scientists, Bridging 
Scientists, Pure Inventors) within a firm is positively related to its technological search. 
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Hypothesis 2b: The number of intellectual human capital (Pure Scientists, Bridging 
Scientists, Pure Inventors) within a firm is positively related to its geographical search. 
Hypothesis 2c: The number of intellectual human capital (Pure Scientists, Bridging 
Scientists, Pure Inventors) within a firm is positively related to its science search. 
 New knowledge search is just one of several avenues through which intellectual 
human capital can affect technological performance. They can also influence the 
technological performance by increasing the reputation of the firm. For example, 
technology emerging from a firm endowed with important intellectual human capital can 
gain the attention of industry better than technology from a firm lacking in rich 
intellectual human capital. This effect can also be compared to Merton’s Mathew effect 
in sociology of science literature. A firm’s valuable intellectual human capital can also 
attract investments from corporate venture capitalists, thereby contributing to 
technological performance. Hence, I do not expect new knowledge search to fully 
mediate the relationship between intellectual human capital and technological 
performance. Though mediation is not a part of the research model, the methodology 
section encompasses the test for mediation.  
Alliance Portfolio Attributes and Technological Performance 
Strategic alliances are “voluntary arrangements between firms to exchange and share 
knowledge and resources with the intent of developing processes, products or services” 
(Gulati, 1998). A number of studies have shown that alliances influence the technological 
performance of firms. In particular, strategic alliances are shown to be beneficial for 
patent and new product development rates (Deeds and Hill, 1996; Shan, Walker, and 
Kogut, 1994). There are various means through which firms benefit from the alliances in 
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developing better technologies. For instance, alliance is considered to be an important 
means for sourcing external knowledge and leveraging external resources that are crucial 
for better technological performance (Dyer and Singh, 1998). Firms especially rely on 
alliance partners for gaining the technical, social and commercial capital that are valuable 
to their innovation performance (Ahuja, 2000). Alliances also influence the technological 
performance of firms by granting access to complementary assets (Pisano, 1990). Other 
benefits of alliances for better technological performance include: (1) imparting social 
status and recognition (Stuart, 2000), (2) defraying cost and sharing risk (Hagedoorn, 
1993) and the like. These benefits have an effect on the technological performance of 
firms in the following ways. Social status and recognition might enhance the 
opportunities available to a firm for engaging in more R&D alliances, thereby having a 
spiraling effect on technological performance. The advantage of sharing risk and 
investment with its partners can encourage a firm to embark on pioneering research 
avenues that are capable of rendering breakthrough innovations. The above arguments 
suggest that a firm’s alliance network is positively associated with its technological 
performance. 
 Though alliances are generally known to be beneficial, the structural holes 
perspective demonstrates that not all alliance partners are equally beneficial (Burt, 1992). 
Similarly, an increase in the number of alliances is not necessarily considered to bring in 
additional benefits. There is a high chance that the attributes of a new partner overlap 
with existing alliance partners, providing access to redundant information and 
competency. As engaging in an alliance and managing the relationship entails a huge 
investment from the focal firm, such redundancies can be very costly. Hence, it is 
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essential to consider the attributes of alliance partners in assessing their contributions 
(Stuart, 2000). It is also vital to understand the synergetic effect of the whole alliance 
portfolio rather than viewing them as independent events (George, Zahra, Wheatley and 
Khan, 2001; Baum et al., 2000). An efficient alliance portfolio comprising of partners 
with diverse attributes is known to help firms in overcoming redundancy issues and 
gaining enhanced benefits from the alliance. An efficient alliance network characterized 
by diverse partners is also recognized to help firms in lowering their failure rate (Baum 
and Silverman, 1998) and in improving their performance (Baum et al., 2000).  
 Diversity can be attributed to different sources. The importance of concentrating 
on the diverse technological and geographical attributes of an alliance network has been 
recently demonstrated by a study that explored the different dimensions of social capital 
(Koka and Precott, 2002). Similarly, the significance of relationships with public research 
organizations, such as universities, has been underlined in a study by Powell and Smith-
Doerr (1996) in which they highlight that the development of an animal model for 
Alzheimer’s disease is affiliated with a diverse range of knowledge sources including 
universities and nonprofit research institutes. Hence, in this study I concentrate on 
diversity pertaining to the three attributes of an alliance portfolio: (1) technological, (2) 
geographical and (3) number of partners with a university background. The three alliance 
attributes under study also correspond to the three types of new knowledge search. Based 
on the above arguments, I hypothesize that:  
Hypothesis 3a: The alliance portfolio of a firm characterized by partners with diverse 
technological attributes is positively related to its technological performance. 
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Hypothesis 3b: The alliance portfolio of a firm characterized by partners with diverse 
geographical attributes is positively related to its technological performance. 
Hypothesis 3c: The alliance portfolio of a firm characterized by a greater number of 
partners with a university background is positively related to its technological 
performance. 
Alliance Portfolio Attributes Moderating the Effect of New Knowledge Search 
Although internal resources such as intellectual human capital engage in search of new 
knowledge, acquiring external knowledge is not simple. The knowledge and experience 
residing in the intellectual human capital can help them, to an extent, in absorbing 
external knowledge. However, in the absence of a facilitating mechanism, certain 
knowledge, especially knowledge characterized as tacit and complex is difficult to absorb 
from the external environment. Prior studies have also recognized the difficulty in 
absorbing knowledge from the three types of new knowledge search. For instance, 
technology related capabilities are often based on tacit knowledge and are subject to 
considerable uncertainty concerning their quality and performance. Transferring such 
knowledge and exploiting them are subject to high risk failures (Mowery, 1983). Studies 
on national innovation systems suggest that countries have distinct patterns of 
specialization, and that the difference has increased over time (Archibugi and Pianta, 
1992). The geographical distance of the knowledge that makes it valuable also creates 
difficulty in acquiring and absorbing the knowledge (Phene et al., 2006). Similarly, the 
difficulty in absorbing science knowledge that is easily available in the form of public 
good has also been recognized in the past (Gambardella, 1995). 
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 Inter-firm collaborative mechanisms such as alliances are widely recognized as 
devices for overcoming the above-mentioned difficulties in acquiring and accessing 
knowledge (Kogut, 1988; Hamel, 1991). Frequent interactions between alliance partners 
act as a platform for inter-firm knowledge flows. Consequently, by enhancing the degree 
to which knowledge is absorbed, alliance helps a firm in translating new knowledge 
search into better technologies. In particular, an alliance portfolio that best fits with the 
different dimensions of the new knowledge search will be rendering the above-mentioned 
benefits of enhancing the value of search.  
Even if a firm is capable of absorbing the widely searched knowledge, it is very 
difficult for the firm to have in-depth expertise in all the knowledge areas it searches. 
Alliance is a prevalent mechanism used by firms in maintaining a broader and deeper 
knowledge base for translating knowledge into valuable innovations. Many of the 
alliances in knowledge-based industries are knowledge accessing alliances. These allow 
the focal firm to concentrate on a few core knowledge areas while collaborating with 
other firms in order to access their stronger capabilities in additional areas (Grant and 
Braden-Fuller, 2004). Alliances between biotech firms and IT firms, alliances between 
firms and universities and alliances that span national borders are some of the prevalent 
examples in the biotechnology industry falling under this category. Thus, an efficient 
alliance portfolio that best fits with the different dimensions of the new knowledge search 
helps a firm in maintaining knowledge diversity as well as richness, thereby moderating 
the relationship between new knowledge search and technological performance.  
Alliances can also enhance the contribution of new knowledge search to 
technological performance in the following ways. Firms search for new knowledge in the 
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anticipation of combining them into useful technologies. Though widely searched 
knowledge has the potential of being recombined into breakthrough innovations, the 
process of achieving this is a risky task. It is highly likely that a firm will invest money 
and time on a certain combination for several years, yet it might turn out to be 
unsuccessful. There are several drug failure cases (Pfizer, Merck) in the biotechnology 
industry that are exemplary examples of this. As biotech innovations are costly in nature, 
with a new drug consuming about USD 800 million of R&D, firms in this industry are 
known to distribute the risk by forming collaborations. With an additional firm to share 
the cost and risk, firms embark on risky journeys in the pursuit of translating the searched 
knowledge into breakthrough technologies.  
Though the last argument suggests that, in general, alliances moderate the 
relationship between new knowledge search and technological performance, the former 
two arguments suggest an efficient alliance portfolio that corresponds to different 
dimensions of new knowledge search to render the moderating effect. Since an alliance 
portfolio with technologically and geographically diverse alliance partners and partners 
from a university background is also comparable with the different dimensions of search, 
I have the following hypotheses: 
Hypothesis 4a: An alliance portfolio characterized by partners with diverse technological 
attributes positively moderates the relationship between a firm’s technological search 
and its technological performance. 
Hypothesis 4b: An alliance portfolio characterized by partners with diverse geographical 
attributes positively moderates the relationship between a firm’s geographical search 
and its technological performance. 
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Hypothesis 4c: An alliance portfolio characterized by a high proportion of partners with 
a university background positively moderates the relationship between a firm’s science 
search and its technological performance. 
 It should be acknowledged that the tacit knowledge of intellectual human capital 
also helps a firm in the process of converting new knowledge search into valuable 
technologies. As the focus of the paper is only on those factors that assist a firm in 
identifying and absorbing knowledge from its external environment, I did not investigate 
this relationship. Intellectual human capital also helps a firm in absorbing knowledge 




To test the hypotheses I collected data from biotechnology firms. This industry is 
recognized to be one of the most innovation-intensive industries (Sorenson and Stuart, 
2000). The biotechnology industry was an ideal context for testing the framework 
because the industry is characterized by technological transformation, a growing number 
of inter-organizational relationships and the widely recognized importance of intellectual 
human capital.  
 The data was drawn from Plunkett's6 directory that comprises of 437 public-listed 
biotechnology firms. Biotechnology directories are one of the sources that prior studies 
have consulted in drawing their sample (Gulati and Singh, 1998; Stuart, Huang and 
Hybels, 1999). Generally, firms in the directory are based in the United States of 
                                                 
6 Plunkett's Biotech and Genetics Industry Almanac 2005: the only comprehensive guide to biotechnology 
and genetic companies and trends/editor and publisher: Jack W. Plunkett. 
                                                                                                                                      37 
America. However, the headquarters of 70 firms are located in other nations such as 
Canada, Japan, UK, India, Switzerland, etc. The directory has 3 firms from agriculture, 
13 from infotech, 100 from chemical manufacturing and 321 from the health care areas of 
biotechnology. The directory comprises of firms such as EISAI Co. Ltd., DOW 
Agrosciences, BASF AG and TRIPOS Inc. that have attained the highest sales revenue in 
the year 2000 for the health care, agriculture, chemical manufacturing and infotech areas 
respectively. The directory includes very small firms (with respect to R&D, number of 
employees and sales) such as VIRAGEN and SPECTRAL DIAGNOSTICS, as well as 
large firms such as BAYER and NOVARTIS. With respect to age, there are old firms 
such as PFIZER, as well as new firms formed in the late 90’s such as ATHEROGENICS 
and ARENA PHARMACEUTICAL. 
 I used the publication, patenting and alliance data of these firms in testing the 
hypotheses. The patents issued to these firms between 1990-2000 were obtained from the 
NUS patent database7. The database comprises of patents issued to firms by the United 
States Patent and Trademark Office (USPTO). Publication information of firms between 
1980-2000 was obtained from Web of Science, ISI Science Citation Index (SCI). The SCI 
is an excellent source because it covers a broad range of basic and applied scientific 
journals (Lim, 2004). As the birth of the biotechnology industry is dated back to the late 
70’s and my patent data is restricted to 2000, I focused on publication during the period 
1980-2000.The Recombinant Capital (Recap) database that provides a comprehensive list 
of biotechnology companies worldwide along with their alliances, valuations and clinical 
trials information is used to cross-validate the list of biotechnology firms chosen from the 
                                                 
7 http://patents.nus.edu.sg/ 
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directory and to obtain alliance-related information between 1990-2000. Compustat 
Global is used in collecting the financial data of these firms. 
 The US patent classification system comprises of over 100,000 patent subclasses 
aggregated to about 400 three-digit patent classes. I used the three-digit patent classes and 
only included those patents that fall within the U.S. patent classes listed in Table 2.1, 
which belong to the biotechnology industry. The classes were chosen with reference from 
the USPTO Technology Profile Reports and from prior research (Lim, 2004). Filtering 
those firms that did not have patent data in the specified classes between 1990-2000, the 
final sample size was 222 firms. The list of 222 firms is provided in Table A.2 of the 
Appendix. Of the listed firms, 215 (437-222) firms were dropped from the directory 
because they had zero patents. To ensure that the results were still generalizable, I carried 
out a preliminary assessment of firm level variables. As shown in Table A.3, the average 
of firm R&D and firm size for 437 firms was not significantly different from the average 
of these variables in my final sample. However, I found that the average age of my final 
sample firms was higher than that of the average age for 437 firms. This is possibly 
because younger firms in the directory might not have patents issued between 1990-2000. 
Nevertheless, I do believe that the results of my study hold true even for younger firms, 
because my sample does indeed include younger firms such as Atherogenics and Arena.  
 The total number of patents and publications under consideration was 10,646 and 
100,375. There is huge heterogeneity with respect to patent and publication data. Firms 
like Anika Therapeutics and Viragen received one patent each, while Abbott and Bayer 
had about 1000 patents. Patents issued to firms increased from 424 in 1990 to 1722 in 
2000. There were 19 firms in my sample with 0 publications, but also about 10 firms with 
                                                                                                                                      39 
at least a few thousand publications. The publications made by firms increased from 1826 
in 1980 to 8181 in 2000. The number of publications, patents and alliances of my sample 
firms between 1990-2000 is provided in Table A.4 of the Appendix.  
Table 2.1. U.S. Patent Classes 
 
 Class Description 
424 Drug, bio-affecting and body treating compositions 
435 Chemistry: molecular biology and microbiology 
436 Chemistry: analytical and immunological testing 
514 Drug, bio-affecting and body treating compositions 
530 Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction 
products thereof 
536 Organic compounds 
800 Multicellular living organisms and unmodified parts thereof and related processes 
 
Measures 
Technological Performance (Forward Citation): The dependent variable is the 
cumulative forward citation frequencies accrued to an individual patent. I count all 
forward citations received by each patent at of the end of 2004. By law, each patent must 
cite prior patents that relate to its technology. Research demonstrates that the number of 
forward citations received by a patent correlates highly with its technological importance 
(Trajtenberg, 1990; Albert, Avery, Narin and McAllister, 1991). Prior studies have 
observed that the self-citation of a firm to its patents represents the extent to which the 
firm appropriates the returns from the patents. As a consequence, they find self-citation to 
reduce the probability of other firms citing the patent (Zhuang, Wong and Lim, 2006). 
However, in my sample I found the self-citations to be positively related to the overall 
forward citations, which indicates that overall citations represent the value of knowledge 
underlying the technology. Hence, instead of removing self-citations, I restricted my 
attention to overall citations accrued by a patent.  
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 One way to measure technological performance would be to use the number of 
products introduced by a firm. However, I restricted my focus to a patent-based 
performance measure because of the following three reasons. First, obtaining data on the 
number of products introduced by my sample firms was difficult.  
 Second, the number of products introduced by a firm not only depends on the 
technological competency of the firm but also other factors such as U.S. Food and Drug 
Administration (FDA) authorization etc. In order to prevent the results from being 
confounded by factors that are not of interest to my research, I relied on patent-based 
performance measure.  
 Third, the biotechnology industry is characterized by open innovation in which 
the activities pertaining to the higher end of the value chain are performed by the firms 
competent in it, while FDA approval and commercialization are taken care of by other 
firms. Hence, a firm introducing a product into the market may not necessarily be the one 
responsible for its basic technological development. As the focus of my study is to relate 
technological competency of a firm with its performance, I believe that a patent would be 
a more appropriate measure of a firm’s capability to generate valuable technologies.  
 Since patent to product conversion process in the biotechnology industry is time 
consuming, many of the results that hold true for a patent-based technological 
performance measure might not hold for a product-based measure. Hence, an interesting 
future research can be to test my research model with both patent-based and product- 
based performance measures and compare their results.  
Independent Variables 
Technological Search (Breadth of Technological Search): Technological search refers 
to the breadth of technological search conducted by firms. This measure is based on the 
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technology class of patents cited by the focal patent issued to a firm (after removing self-









−∑  (One minus the Herfindahl concentration index of the technology classes) 
where ijS refers to the proportion of citations made by patent i to the patents in 
technology class j (after removing self-citations). ni varies for each patent depending on 
the number of different technology classes that the focal patent cites. The three-digit 
technology class is considered in measuring the above. This measure would range 
between 0 and 1, with a greater value suggesting that the patent has searched for a broad 
set of technologies. This measure corresponds to the “originality” measure in the work of 
Jaffe and Trajtenberg (2002). 
Geographical Search (Breadth of Geographical Search): One way to measure the 
geographical search for knowledge would be to use the firm’s R&D laboratories and 
R&D budgets in different locations. Since obtaining data at that level was difficult, I 
relied on patent data to measure the geographic dispersion of a firm’s search for 
knowledge.  
 This measure is based on the geographic location of patents cited by the focal 
patent issued to a firm (after removing self-citations). Specifically, the breadth of 









−∑  (One minus the Herfindahl concentration index of the geographical locations) 
where ijS refers to the proportion of citations made by patent i to the patents in geography 
j (after removing self-citations). ni varies for each patent depending on the number of 
                                                                                                                                      42 
different geographic locations that the focal patent cites. Patent data contains information 
regarding the geographic location of its inventors. The first inventor’s address (as he/she 
is considered to be a significant contributor for the patent) is taken into consideration in 
measuring the geographic search (Singh, 2005). The geographical unit is defined at the 
country level, in which I use the country of the first inventor as the geographic unit for all 
the patents. In my sample, the majority of the citations are made to patents originating 
from USA, Japan and Europe. Similar to technological search, this measure would range 
between 0 and 1, with a greater value suggesting that the patent has searched a broad set 
of geographic locations. 
Science Search: Science search is the number of times a patent issued to a firm 
references non-patented literature. Every patent is required to cite the prior art that it 
builds upon. This includes both the patent and non-patent references. Sorenson and 
Fleming (2004) have observed that 69% of non-patent references are from peer-reviewed 
scientific journals. The non-patent references cited by a patent are often used as an 
indicator of the science intensity of the invention, which is in turn found to influence the 
forward citation of patents (Gittelman and Kogut, 2003; Noyons, van Raan, Grupp and 
Schmoch, 1994). But the measure does not exclude self-citations to non-patent literature. 
In this way it is different from the technological and geographical search measures. 
However, I did examine the extent to which a firm’s publications are being cited in its 
patents. To observe this, I first identified all the publications produced by the focal firm 
and all the patents citing those publications. For each publication, I checked the first 
assignee name of the citing patents to see if the patent belongs to the firm that generated 
the publication or others. I noticed that just 2% of the firms’ scientific publications are 
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being cited in their patents. This statistic mitigates the limitation of not removing self-
citations.  
Intellectual Human Capital (Pure Scientists, Bridging Scientists, and Pure Inventors):  
The greater the presence of the three types of intellectual human capital, the higher the 
availability of knowledge, experience and skill for new knowledge search. Traditionally, 
studies captures the quality of human capital by measuring their qualifications, affiliation, 
etc. (Hitt, Bierman, Uhlenbruck, and Shimizu, 2001; Hitt, Bierman, Shimizu, and 
Kochhar, 2006). My study implicitly captures this by looking only at intellectual human 
capital that possesses high qualifications in order to engage in R&D activities.  
 I operationalize the three variables in the following manner. The pure scientist 
measure represents the percentage of scientists within firms whose names are exclusively 
listed in publications and not in patents. Next, the bridging scientist measure represents 
the percentage of patent inventors within a firm whose names are listed in both patents 
and in scientific papers published by the firm. Finally, the pure inventor measure 
represents the proportion of inventors of each patent who are exclusively involved in 
patenting but not publishing. In order to obtain these measures, I identified two 
overlapping sets of individuals for each firm. The first comprises of scientists whose 
names are listed on at least one publication made by the focal firm, and the second 
comprises of inventors whose names are listed on at least one patent issued to the focal 
firm. Based on these two lists, I found the percentage of individuals listed as inventors 
who are also listed as scientists for each firm. This percentage is termed as bridging 
scientists. The measure is borrowed from the work of Gittelman and Kogut (2003). Then, 
I identified the percentage of those scientists whose name appeared only in the 
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publications and not in the patents. These scientists who are exclusively involved in 
scientific publishing are termed as pure scientists. Then, for each patent, I identified the 
number of inventors whose names do not appear in the list of scientists. These inventors 
who are exclusively involved in patenting are termed as pure inventors. On average, my 
sample firms had about 900 pure scientists, 34 bridging scientists and 47 pure inventors. 
Firms such as Bayer and Merck had the highest number of pure scientists, bridging 
scientists, and pure inventors. This shows that the measures are not a complement of each 
other, with the pure inventors measures being calculated at the patent level while scientist 
measures are at the firm level.  
 Apart from qualifications, there are other aspects of quality of intellectual human 
capital as measured by the extent to which they are active in producing high quality work. 
This aspect of quality, as measured by the volume and citations of firms’ publications and 
stocks of patents, are captured and controlled in this study. This helps in exploring if 
firms endowed with a greater proportion of each of the intellectual human capital 
dimensions (after controlling for quality) are better in their new knowledge search. 
Technological Diversity of the Alliance Portfolio: Similar to the work of Baum et al. 
(2000), I used the Herfindahl index to measure the diversity of the alliance portfolio. By 
the alliance portfolio, I mean the list of all alliances made by a firm in a year. 









−∑   
where ijS refers to the proportion of alliances of firm i that falls under the technology 
category j (which is nothing but the technology concentration of alliances that is 
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described below). ni varies depending on the number of different technology category 
alliances that the focal firm engages in a year.   
 The Recap database is used in measuring the technological diversity of the 
alliance portfolio. The Recap database comprises of a list of alliances made by firms in a 
particular year, along with other information such as the type of alliance (R&D, 
acquisition, manufacturing, joint venture, licensing, etc.) and technology concentration of 
the alliance (bioinformatics, DNA probes, combinatorial, gene sequencing, gene 
expression, microassays, potenomics, etc.). There are 26 types of alliances and 53 types 
of technology classifications available in the Recap database. The list of alliance types 
and technology classifications is provided in Table A.5 and A.6 of the Appendix. Since 
the study pertains to the R&D activities of the value chain, I concentrated on the alliances 
pertaining to research and development. I then used the classification of partnered 
technology of all alliance partners in a year in order to arrive at the technological 
diversity of the alliance portfolio for that year.  
Geographical Diversity of the Alliance Portfolio: Similar to the technological diversity 
of the alliance portfolio, the Herfindahl index was used to measure geographical 
diversity. I used the nationality of the alliance partners in calculating the Herfindahl 
index. In my sample, alliance partners are from USA, Europe, Japan and Asia, but the 
majority of partners are from the USA.  
Number of Alliance Partners with a University Background: This measure captures the 
extent to which the alliance portfolio of a firm in a year is composed of partners from the 
academe. Hence, I calculated this variable for the focal firm in each year by obtaining the 
number of alliance partners that are classified as academic institutions. On an average, 
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my sample engaged in 40 alliances during the period of observation, of which 7 are 
academic institutions.  
Control Variables 
Publication Volume: This measure is the number of publications produced by the focal 
firm in the year of observation in which the firm filed a patent. I used the number of 
publications made by a firm as a proxy for its scientific capability. A number of scholars 
have used publication count to measure the scientific capability of firms (Lim, 2004; 
Gittelman and Kogut, 2003; Arora and Gambardella, 1994). A firm with strong scientific 
capability is able to identify new applications in the technology domain that might give 
rise to more valuable patents. Prior studies have also shown the significant relationship 
between publication count and patent performance. It is therefore imperative that I 
control for it.  
Firm’s Average Cites to Publications: I use the citations received by the focal firm’s 
publications to represent the relative quality of the firm’s stock of scientific knowledge. 
To compute this measure I first identified all the publications produced by the focal firm 
between the years 1980-2000 and then obtained the number of citations received by these 
publications. Based on the citations, I calculated the mean and standard deviation of the 
citations received by all articles of the sample firms in a publication year. Next, the raw 
citation counts for each publication of firms are normalized by the mean and standard 
deviation of the citations received by all articles in its publication year. Normalizing the 
raw citations by year allows the citations to be summed across years for each firm 
(Gittelman and Kogut, 2003). I then aggregated the normalized citation count of 
publications in a year and divided it by the total number of publications made by the firm. 
The normalized citation count is then aggregated up to the year the observed patent was 
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filed in order to obtain a cumulated amount of publication quality. Because a firm’s 
competency in generating high-quality scientific papers has been observed to impact its 
capability to produce high-impact innovation, I controlled for it (Gittelman and Kogut, 
2003).  
Firm’s Technological Strength: Since a technologically strong firm is likely to receive 
more citations, there is a need to control for it. I used the number of patents granted to a 
firm to measure its technological strength. I take into account the year of the focal patent 
in calculating the count of patents granted to a firm. For example, if the patent under 
observation is a patent filed by a firm in year t, I count the number of patents issued to the 
firm in the year t to account for its technological strength.  
Other Control Variables (Technology Class Dummy Variable, Patent Age, Year Fixed 
Effects, R&D Expenditure, Firm Size and Firm Age): Forward citations may accrue to 
patents for other reasons such as technology field characteristics, patent characteristics 
and firm characteristics. Therefore, I included the patent-level and firm-level control 
variables to account for the heterogeneity among firms and for age and field effects. 
Patents belonging to a certain technology class may inherently be more cited than others. 
Similarly, patents with a higher number of years that elapsed since the patent was filed 
are capable of attaining higher citations. I used technology-class dummy variables and 
patent age as patent-level control variables to control for these effects. I also used year-
fixed effects to capture the differences in citation probability across different years.  
 Firms may be highly innovative for different reasons. Larger firms have this 
capability due to economies of scale and scope, younger firms because they represent the 
knowledge of the younger vintage and some firms devote significantly more resources to 
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R&D. Hence, I included firm-level control variables such as R&D expenditure, size of 
the firm as measured by the number of employees and age of the firm as measured by the 
number of years since the firm was founded. I included the logarithmic value of the 
above variables as the control variables.  
  The summary of the dependent, independent and control variables is presented in 
Table A.1 of the Appendix. The summary data for the dependent and independent 
variables and the correlation between the variables at the patent level are reported in 
Table 2.2.  
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N Variables Mean Std. 
Dev 
Min Max 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 Forward Citation 6.34 11.87 0 233 1                
2 Technological 
Search 
0.35 0.29 0 0.98 0.11* 1               
3 Geographical 
Search 
0.23 0.26 0 0.85 0.05* 0.46* 1              
4 Science Search 18.36 35.14 0 492 0.05* 0.16* 0.10* 1             
5 Pure Scientists 0.77 0.32 0 0.99 0.02 -0.08* -0.03* 0.12* 1            
6 Bridging 
Scientists 
0.25 0.15 0 0.83 -0.02 0.09* 0.08* -0.19* -0.69* 1           
7 Pure Inventors 0.65 1.11 0 17 -0.01 0.11* 0.08* -0.06* -0.34* 0.45* 1          
8 Tech.Diversity of 
Alliance Portfolio 
0.30 0.27 0 1 0.19* 0.06* 0.01 0.07* 0.06* -0.10* -0.05* 1         
9 Geog. Diversity of 
Alliance Portfolio 
0.10 0.22 0 1 0.04* 0.27* 0.45* 0.02 -0.21* 0.28* 0.49* 0.03* 1        
10 No. of Univ. 
Partners in 
Alliance Portfolio 
1.61 2.25 0 18 0.27* -0.03* 0.03* -0.05* 0.02 0.09* 0.03* -0.03* 0.04* 1       
11 Publication 
Volume 
136.39 222.74 0 1272 -0.06* -0.06* 0.01 -0.01 0.31* -0.18* -0.10* -0.15* -0.05* -0.01 1      
12 Publication 
Citation 
0.04 0.91 -6.73 9.65 -0.04* 0.03* 0.05* -0.15* -0.28* 0.25* 0.08* -0.10* 0.07* 0.08* -0.08* 1     
13 Patent Age 10.12 2.80 7 17 0.28* 0.03* -0.01 -0.15* -0.09* 0.10* -0.02 0.17* -0.02 0.08* 0.11* 0.00 1    
14 R&D 3.04 2.15 -0.55 12 0.17* 0.06* -0.00 0.05* 0.34* -0.37* -0.21* 0.29* -0.12* -0.02 -0.30* 0.09* 0.06* 1   
15 Firm Size 6.82 2.32 0 11.69 -0.10* -0.03* 0.01 -0.06* -0.63* 0.55* 0.30* -0.20* 0.18* 0.03* 0.00 -0.04* 0.01 -0.69* 1  
16 Firm Age 3.37 1.21 0 5.01 -0.18* -0.01* 0.07 -0.23* -0.47* 0.61* 0.28* -0.31* 0.18* 0.18* 0.14* 0.29* 0.07* -0.57* 0.53*  
17 Tech. Strength 62.86 61.33 1 240 -0.16*  0.00 0.01 0.02 -0.37* 0.32* 0.17* -0.30* 0.09* -0.02 0.18* -0.12* -0.09* -0.65* 0.62* 0.46* 
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Analysis 
Since the dependent variable is forward citation count, a count model was more 
appropriate for this research. The Poisson model is a frequently used count model. As 
patent citations exhibited over-dispersion, I used a negative binomial model that is best 
suited for estimating an over-dispersed parameter (Cameron and Trivedi, 1998). The 
results of negative binomial regression are presented in Table 2.3. All specifications 
include fixed effects for both technology class and application year of the patents. I used 
robust standard errors adjusted for clustering of the firm to control for random firm 
effects. Though my sample had 222 firms and 10,606 patents, due to missing 
observations, the final regression results are based on 157 firms and 7,648 patents. 
Effect of Control Variables 
Model 1 of Table 2.3 presents the regression coefficients for the control variables. The 
publication volume has a significant negative effect (p<0.01) on the forward citation of 
patents. The result pertaining to the negative role of publications on patent citation rate is 
contrary to the findings of Cockburn and Henderson (1998), Gambardella (1995) and 
Gittelman and Kogut (2003). These scholars observed publication volume to have either 
an insignificant or positive influence on patent citations. One possible explanation of my 
result is that when firms concentrate more on producing scientific publications, their 
attention towards developing important technologies might deteriorate and result in fewer 
forward citations for their patents. This explanation is also consistent with the result 
pertaining to publication citation. The quality of firms’ publications as reflected by the 
average cites to these publications has a negative relationship with the forward citation of 
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patents (p<0.05). This shows that when firms engage in the generation of cutting-edge 
scientific research, their technological performance suffers.  
 As expected, firm age has a negative impact on the forward citation of patents 
(p<0.01). Firm size and R&D expenditure do not have a significant relationship with the 
forward citation of patents. A plausible explanation for R&D and firm size being 
insignificant is that increased R&D spending and economies of scale need not necessarily 
increase the quality of technologies, as measured by the forward citations. The 
technological strength of a firm, as measured by the number of patents it generates, is 
negatively associated with the forward citation of patents (p<0.01). This shows that the 
quality of patents is inversely proportional to the quantity generated. A plausible 
explanation for the above negative association is that when firms generate more patents, 
only a small number of these patents are likely to have applications elsewhere, while 
majority of them remain unexploited. The significant (p<0.01) positive effect of patent 
age shows that older patents receive more citations.  
Main Effect of New Knowledge Search 
The regression coefficients in testing the main effect of new knowledge search and 
intellectual human capital are provided in Table 2.3. Models 2, 3, and 4 provide the 
curvilinear test results for technological search, geographical search, and science search 
independently. The linear term of technological search is significantly positive (p<0.01) 
and its squared term is insignificant. The linear terms of geographical and science 
searches are positively significant (p<0.01) and their squared terms are negatively 
significant (p<0.01). Model 5 presents the results of curvilinear test for all three search 
variables. The results of the combined model are consistent with earlier models. Taken 
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together, the results show that technological search has a linear positive effect on 
technological performance, while geographical and science searches have curvilinear 
effects. The results reject H1a and support H1b and H1c.   
Table 2.3. Negative Binomial Regression in Testing the Impact of New Knowledge Search and 
Control Variables on Forward Citation 
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-20551.68 -20480.89 -20501.23 -20517.27 -20449.79 
No of 7648 7648 7648 7648 7648 
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Observations 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses 
Technology class dummy variables and year fixed effect were included but not reported 
  
 The regression results in testing the main effects of intellectual human capital 
variables on new knowledge search are presented in Table 2.4 and Table 2.5. Since the 
technological and geographical search variables are continuous with values restricted 
between 0 and 1, a Tobit regression model is employed. Models 1, 2 and 3 in Table 2.4 
present the Tobit regression with technological search as the dependent variable and the 
three intellectual human capital variables as independent variables, included one at a 
time. Model 4 presents the results when all of the three intellectual human capital 
variables are included together. The results show that both bridging scientists and pure 
inventors have a significant positive influence on technological search (p<0.01). 
However, the relationship between pure scientists and technological search is negatively 
significant (p<0.01). Hence, H2a is supported for bridging scientists and pure inventors, 
but not for pure scientists. Models 5, 6, 7 and 8 in Table 2.4 present the Tobit regression 
with geographical search as the dependent variable and the three intellectual human 
capital variables as the independent variables. Similar to the previous result, I observe 
both bridging scientists and pure inventors to have a positive impact on geographical 
search (p<0.01), while pure scientists have a negative influence (p<0.05) on geographical 
search. Therefore, H2b is also supported for bridging scientists and pure inventors, but 
not for pure scientists. As science search is a count variable, I ran a negative binomial 
regression to test the relationship between science search and intellectual human capital. 
Table 2.5 presents the path coefficients with science search as the dependent variable and 
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the three intellectual human capital variables as the independent variables. The 
coefficients of all the three intellectual human capital variables are insignificant, thereby 
rejecting H2c. 
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Table 2.4. Regression in Testing the Impact of Intellectual Human Capital and Control Variables on the Technological and Geographical Search 
 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
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Firm-Level Control Variables 


































































































Patent-Level Control Variables 
















Log Likelihood -4854.14 -4834.94 -4857.24 -4810.36 -5102.80 -5090.97 -5088.70 -5081.77 
No. of Observations 7648 7648 7648 7648 7648 7648 7648 7648 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported. 
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Table 2.5. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital and 
Control Variables on Science Search 
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-27870.01 -27867.20 -27871.50 -27859.14 
No. of 
Observations 
7648 7648 7648 7648 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported. 
 
 
Main and Moderating Effect of Alliance Portfolio Attributes 
The regression coefficients for testing the main effects of alliance portfolio attributes are 
provided in Table 2.6. Models 1, 2 and 3 present the main effects of the three attributes of 
alliance portfolio. Model 4 presents the results when all three alliance portfolio attributes 
are included together. The results show that the technological and geographical diversity 
of the alliance portfolio and the number of university partners in the alliance portfolio 
57 
have significant positive effects on the forward citation of patents (p<0.01). Hence, H3a, 
H3b and H3c are accepted.  
 In order to test if alliance portfolio moderates the relationship between new 
knowledge search and technological performance, I included the interaction terms. The 
results of these are presented in Models 5, 6 and 7 in which each of the interaction terms 
is introduced one by one. Model 8 presents the results when all the interaction terms are 
included together. As technological search had a linear positive effect on forward citation 
(from Table 2.3), I included just the linear interaction term for technological search. 
Since geographical and science search are curvilinearly related to forward citation, I 
included both the linear and squared interaction terms.  
 The significant interaction term of technological diversity of the alliance portfolio 
and technological search in Models 5 and 8 (p<0.01) supports H4a. Figure 2.2 is a 3D 
representation of this interaction effect. The coordinate (L, L) represents low in 
technological search and low in technological diversity of alliance portfolio, while (L, H) 
represents low in technological search and high in technological diversity of alliance 
portfolio. Since technological diversity of alliance portfolio has a positive influence on 
technological performance, the coordinate (L, H) has a higher technological performance 
than (L, L). Similarly, the coordinate (H, L) represents high in technological search and 
low in technological diversity of alliance portfolio, while (H, H) represents high in 
technological search and high in technological diversity of alliance portfolio. The positive 
slope from (L, L) to (H, L) and (L, H) to (H, H), clearly shows that there is positive 
interaction between technological search and technological diversity of alliance portfolio. 
In testing the interaction effect of geographical diversity of alliance portfolio with 
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geographical search, I looked at the squared term of interaction because it provides a 
more complete explanation by preventing any misinterpretation of effects due to linearity 
and additivity in correlated variables (Cortina, 1993). The significant interaction term of 
geographical diversity of alliance portfolio with geographical search squared (p<0.01) 
supports H4b.  However, the interaction between number of universities and science 
search squared is negatively significant, thereby rejecting H4c.  
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*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported.























































































Patent-Level Control Variables 


















-20527.82 -20510.30 -20114.23 -20056.08 -20452.59 -20478.22 -20027.68 -19935.71 
No. of 
Observations 
7648 7648 7648 7648 7648 7648 7648 7648 
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Figure 2.2. Interaction between Technological Search and Technological Diversity of Alliance 
Portfolio for Forward Citation 
 




Mediating Role of New Knowledge Search in Explaining the Relationship between 
Intellectual Human Capital and Technological Performance 
Though mediation is not a part of the research model, I performed this test in order to 
have a better understanding of the intellectual human capital-new knowledge search- 
technological performance link. I followed the three-step procedure suggested by Baron 
and Kenny (1986) to test the mediating effect of new knowledge search. In the first step, I 
tested if intellectual human capital demonstrates significant association with 
technological performance. Models 1, 2 and 3 of Table 2.7 present the main effects of the 






bridging scientists and pure inventors have a significant positive influence on the forward 
citation of patents (p<0.10, p<0.01). On the contrary, pure scientists have a significant 
negative effect on the forward citation of patents (p<0.01). A detailed discussion of these 
results is provided in the next section.  
  The second step in testing the meditating effect of new knowledge search is to 
test the relationship between intellectual human capital and new knowledge search. The 
results of regressions in Tables 2.4 and 2.5, which investigate this relationship, have been 
discussed earlier. The regression results suggest the possibility of technological and 
geographical searches mediating the relationship of bridging scientists and pure inventors 
with that of technological performance. The results rule out the need for testing the 
mediation for pure scientists as well as for testing science search as a mediating variable.  
 Therefore, in testing the last step of Baron and Kenny (1986), I concentrated 
solely on the mediating roles of technological and geographical searches for bridging 
scientists and pure inventors. In testing this, I regressed the technological performance 
variable on bridging scientists, pure inventors and new knowledge search, the results of 
which are presented in Table 2.8. To establish complete mediation, the effects of 
intellectual human capital variables on forward citation should become insignificant in 
the presence of new knowledge search variables. However, in comparing Models 1 and 2 
of Table 2.8, I observed that, in the presence of technological search, the effect of 
bridging scientists decreased from (1.2057, p<0.01) to (0.9554, p<0.05). Similarly, 
comparing Models 1 and 3 shows that, in the presence of geographical search, the effect 
of bridging scientists decreased to (1.1403, p<0.05). This shows that geographical search 
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and technological search partially mediate the relationship between bridging scientists 
and technological performance.  
 From Models 4, 5 and 6 of Table 2.8, I observed that technological search and 
geographical search partially mediate the relationship between pure inventors and 
technological performance. Thus, the results show that technological and geographical 
search variables partially mediate the relationship of bridging scientists and pure 
inventors with that of technological performance. Table 2.9 presents the summary of 
hypotheses and results as to whether the hypotheses are supported or not. 
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Table 2.7. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital and 
Control Variables on Forward Citation 
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[0.0206] 













































Patent-Level Control Variables 








-20525.79 -20514.69 -20506.12 
No. of 
Observations 
7648 7648 7648 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported.
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Table 2.8. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital, New 
Knowledge Search, and Control Variables on Forward Citation 
 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported. 
 














Technological Search  0.5797*** 
[0.1462] 
   0.5923*** 
[0.1560] 
 
Geographical Search   0.5139*** 
[0.1230] 
   0.5196*** 
[0.1253] 
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Log Likelihood -20525.50 -20464.26 -20489.02 -20533.70 -20469.60 -20496.6 
No. of Observations 7648 7648 7648 7648 7648 7648 
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Table 2.9. Summary of Hypothesis Testing 
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DISCUSSION AND CONCLUSION 
Organizations search for new knowledge in the anticipation of developing valuable 
technologies. The first initiative towards “new knowledge search” is to search and 
identify new knowledge existing outside an organization. Since knowledge residing in 
intellectual human capital helps a firm in scanning and identifying new knowledge, my 
research hypothesizes that intellectual human capital contributes to searching new 
knowledge residing outside the firm boundary. Having identified the knowledge, the next 
important step is to acquire and exploit the searched knowledge in creating valuable 
technologies. Though the internal resources of a firm, including intellectual human 
capital, play an important role in converting new knowledge search into better 
technologies, my study emphasizes that collaboration with other firms is essential for a 
firm to acquire and exploit the new knowledge search. Hence, I hypothesize alliances to 
play an important role in enhancing the capability of a firm to translate its new 
knowledge search into better technologies. Consequently, my study has two objectives.  
 The first objective of this study is to understand how internal resources, such as 
intellectual human capital, contribute to technological performance by engaging in new 
knowledge search. Specifically, my study explores how the three different types of 
intellectual human capital (1) pure scientists, (2) bridging scientists and (3) pure 
inventors, assist the three dimensions of new knowledge search (1) technological, (2) 
geographical and (3) science, thereby contributing to technological performance. The 
second objective is to investigate the role of alliances in enhancing the contribution of 
new knowledge search to technological performance. In particular, the study investigates 
how an alliance portfolio characterized by (1) technologically diverse partners, (2) 
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geographically diverse partners and (3) partners from academic institutions, moderates 
the relationship between the three dimensions of new knowledge search and 
technological performance. When combined, the two objectives help in understanding 
how intellectual human capital and alliances help a firm in the process of searching new 
knowledge and translating it into better technologies. The following sections discuss the 
four hypotheses of my research that encompass the above two objectives. 
 The first hypothesis tests the curvilinear relationship of the three dimensions of 
new knowledge search with technological performance. The results show that 
technological search has a linear positive effect on forward citations, and that the 
relationship is not curvilinear as hypothesized. This suggests that even though searching a 
broad array of technologies is time-consuming and associated with high uncertainty, it is 
helpful in creating valuable technologies. The reason for the results not supporting the 
curvilinear effect of technological search can also be due to the biotech context that is 
under study. Biotech innovations are considered to be interdisciplinary in nature. Hence, 
in creating important innovations, firms inevitably have to search for technologically 
wide knowledge.  
 However, I find geographical and science search to have curvilinear relationships 
with forward citations. This suggests that searching knowledge across a wide geography 
and from the science base is good but, beyond a point, it is detrimental to technological 
performance. My results limit me in further discussion about the possible reasons for 
diminishing returns of geographical search. Nevertheless, some of the results of control 
variables combined with the curvilinear effect of science search help in better 
understanding the role of science for technological performance. Two of my control 
69 
variables, publication volume and publication citation, had significant negative influences 
on forward citation of patents. The publication volume and publication citation variables, 
as measured in this study, can be interpreted as the capability of firms to generate high 
quality scientific knowledge. The science search reflects a firm’s effort in searching 
scientific knowledge to apply it to technology development. The results corresponding to 
these variables show that the capability of firms to generate scientific knowledge is not 
helpful for technological performance. However, a firm's ability to optimally search for 
knowledge and then apply it to technological development is beneficial to technological 
performance.  
  While prior studies have extensively examined the benefits and drawbacks of 
local search (Karim and Mitchell, 2000; Ahuja and Lampert, 2001), the results from the 
first hypothesis attempt to follow the recent stream of research in explaining the benefits 
and drawbacks of search that spans different boundaries (Ahuja and Katila, 2004). The 
findings highlight the benefits and drawbacks of geographical search and science search. 
Earlier studies have suggested the importance of scientific findings to technological 
search and that technological search conducted beyond national boundaries is detrimental 
to innovation (Fleming and Sorenson, 2004; Phene et al., 2006). My findings suggest that 
searching a wide array of technologies (after controlling for the geographical and science 
searches) is always beneficial for innovations, which are characterized to be inter-
disciplinary in nature.  
 The second hypothesis studies the relationship between the three intellectual 
human capital variables and new knowledge search. Both bridging scientists and pure 
inventors have a significant role to play in assisting with the technological and 
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geographical search process of a firm. However, pure scientists, who are exclusively 
involved in scientific research, have a negative impact on technological and geographical 
searches. It is surprising to find that none of the three intellectual human capital variables 
are related to science search. Two limitations pertaining to science search can be 
plausible explanations for the insignificant results. First, count of all non-patent 
references is taken into consideration in measuring science search. A more appropriate 
measure would have been to consider only citations to scientific publications. But this 
limitation is, to some extent, mitigated by the observation of Sorenson and Fleming 
(2004) that 70% of non-patent references are citations to scientific publications. The 
second limitation is related to the observation by Noyons et al. (1994). They showed that 
reference to scientific literature in patents is not an appropriate measure for identifying 
the science intensity associated with the innovation.  
 A plausible explanation for the negative influence of pure scientists on new 
knowledge search is the same as that of negative influences of publication volume and 
publication citation on technological activities. Pure scientists of an organization 
represent human capital that engages in pure scientific research. The results pertaining to 
publication volume and publication citation and evidences from prior research suggests 
that a firm’s scientific research endeavors are not direct inputs to its technological 
activities (Gittelman and Kogut, 2003). Indeed firms’ technological activities are shown 
to suffer when they concentrate on scientific research. This can be one of the reasons why 
pure scientists have a negative influence on new knowledge search that is targeted toward 
developing technologies. It is only through the skillful application of scientific research 
and resources to technological activities that a firm can benefit from its scientific research 
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endeavors (Gittelman and Kogut, 2003). The following section elaborates on how pure 
scientists can indirectly contribute to technological activities by assisting bridging 
scientists and pure inventors.  
 Fleming and Sorenson (2004) observed that scientific knowledge alters 
technology inventors' search process. According to my conceptualization, bridging 
scientists and pure inventors are those who are directly involved in developing 
technologies. Therefore, the above observation by Fleming and Sorenson (2004) guides 
me to explore if pure scientists’ contributions to new knowledge search are through 
bridging scientists and pure inventors, by providing them with a stylized representation of 
search. If the role of pure scientists is indirect as speculated above, then the relationship 
between bridging scientists, pure inventors and new knowledge search would be 
moderated by pure scientists. In order to test this effect I performed interaction tests, the 
results of which are presented in Table 2.10.  
 Model 1 presents the interaction between pure scientists and bridging scientists in 
explaining the technological search. The interaction term is significant (p<0.01), 
confirming that the contribution of bridging scientists to technological search increased in 
the presence of pure scientists. Figure 2.3 is a 3D representation of this interaction effect. 
The coordinate (L, L) represents low in bridging scientists and low in pure scientists, 
while (L, H) represents low in bridging scientists and high in pure scientists. Since pure 
scientists have a negative influence on technological performance, the coordinate (L, L) 
has a higher technological performance than (L, H). Similarly, the coordinate (H, L) 
represents high in bridging scientists and low in pure scientists, while (H, H) represents 
high in bridging scientists and high in pure scientists. The positive slope from (L, L) to 
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(H, L) and (L, H) to (H, H), clearly shows that there is positive interaction between 
bridging scientists and pure scientists. On the contrary, Model 2 in Table 2.10 shows that 
pure scientists do not help pure inventors in their technological search. Models 3 and 4 
present the interaction results for geographical search and are similar to that for 
technological search. The moderating effect of pure scientists in explaining the 
relationship between bridging scientists and geographical search is further illustrated 
using a 3D graph in Figure 2.4. The interpretation of Figure 2.4 is similar to that of 
Figure 2.3.  
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Table 2.10. Regression in Testing the Moderating Role of Pure Scientists 
 
Variables Model 1 Model 2 Model 3 Model 4 
Regression Model Tobit Tobit Tobit Tobit 
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[0.0128] 
Firm-Level Control Variables 
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Log Likelihood -5291.4 -5285.23 -5085.35 -5088.04 
No. of Observations 7648 7648 7648 7648 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported.
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Figure 2.3. Interaction between Bridging Scientists and Pure Scientists for Technological Search 
 
 




























Figure 2.4. Interaction between Bridging Scientists and Pure Scientists for Geographical Search 
 










Taken together, the results illustrate that pure scientists facilitate the technological and 
geographical search processes of bridging scientists, but not of pure inventors. A 
potential explanation is that bridging scientists, who are involved in both science and 
technology domains are in a better position to benefit from pure scientists. Because of 
their dual role, bridging scientists tend to collaborate with pure scientists, thereby 
benefiting from the pure scientists' scientific understanding (Furukawa and Goto, 2006). 
This is also evident from my data, as I observed a number of collaborations between pure 
scientists and bridging scientists in publishing papers. On the other hand, pure inventors 
have been observed to exhibit different communication behavior from that of pure 
scientists (Allen, 1977), and can find it difficult to bridge the gap and take advantage of 
the scientific knowledge possessed by pure scientists. Thus, I follow Gittelman and 
Kogut’s (2003) assertion that scientists who can play a dual role and successfully bridge 
the science and technology domains have a positive influence on technological 
performance. I go one step further in saying that the dual role of bridging scientists can 
also help in translating the ideas of pure scientists into a language that can be easily 
interpreted by pure inventors.  
 Before discussing the results pertaining to alliances, it is worth explaining a few 
other results related to intellectual human capital that are not part of the research model. 
First is the findings related to the influence of intellectual human capital on technological 
performance. The results demonstrate that pure inventors and bridging scientists have 
positive impacts on the technological performance of firms. On the contrary, pure 
scientists have a negative impact on the technological performance. The positive effect of 
pure inventors is trivial because they are solely dedicated to applied research and to 
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developing important innovations. However, it is interesting to note the contingent value 
of scientists, whose involvement in scientific research detracts them from technology 
development. Scientists have a positive influence on technological performance only if 
they are bridging scientists, viz. they are capable of also engaging themselves in 
technology development. This finding further underlines the importance of bridging 
scientists to firms (Gittelman and Kogut, 2003)  
 The next result is corresponding to the mediating role of new knowledge search in 
explaining the intellectual human capital and technological performance link. As 
speculated, the results support only partial mediation, suggesting that new knowledge 
search is one of the means through which intellectual human capital contribute to 
technological performance. Specifically, the findings reveal that technological and 
geographical searches partially mediate the path connecting pure inventors and 
technological performance. Similarly, technological and geographical searches are found 
to partially mediate the relationship between bridging scientists and technological 
performance. The mediating role of new knowledge search is not supported for pure 
scientists. Thus, both pure inventors and bridging scientists, who are directly involved in 
technology development activities, have a positive impact on technological performance 
by assisting in the technological and geographical searches. Since pure scientists are not 
directly involved in the technology development, it is not surprising to notice that the 
results do not support the role of new knowledge search in mediating the relationship 
between pure scientists and technological performance. However, I discussed the indirect 
contribution of pure scientists to new knowledge search in a previous section.  
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 The above findings that pertain to the influence of intellectual human capital on 
new knowledge search have important theoretical and practical implications. The 
theoretical implication is to the stream of research that emphasizes the importance of 
intellectual human capital to technological performance (Subramaniam and Youndt, 
2005). Although the basic link between intellectual human capital and the technological 
performance of firms is persuasive, the finer aspect of how organizations utilize 
intellectual human capital for new knowledge search, which is capable of explaining the 
heterogeneity across firms’ technological performance, is unexplored. This research gap 
is surprising given that organizations invest a significant amount of resources in their 
intellectual human capital, often with the strategic need to develop expertise along new 
trajectories (Zucker, Darby, and Brewer, 1998). My study addresses this issue by 
showing that intellectual human capital engages in new knowledge search, thereby 
contributing to technological performance. Further, it contributes to the literature on 
evolutionary search by illustrating the importance of intellectual human capital to new 
knowledge search and how the contribution of human capital differs depending on their 
domain of expertise. The differences exhibited by the three intellectual human capital 
variables in influencing the new knowledge search as well as technological performance 
(elaborated in the following sections) help managers decide how to utilize their varied 
intellectual human capital in different knowledge-related activities.  
 Hypothesis 3 pertains to the main effect of alliance portfolio. The results 
demonstrate that an alliance portfolio characterized by technologically and 
geographically diverse partners and partners with academic background are beneficial for 
the technological performance of firms. This finding draws the attention of scholars to 
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concentrate on the alliance portfolio attributes rather than merely look at the size of the 
portfolio (Stuart, 2000). Further to the main effect of an alliance portfolio, Hypothesis 4 
tests the moderating effect of an alliance portfolio in enhancing the contribution of new 
knowledge search for better technological performance. The results show that a 
technologically and geographically diverse alliance portfolio enhances the value of a 
firm’s technological and geographical searches, respectively. However, the number of 
university partners does not enhance the value of science search. There are two possible 
reasons for this result. The first reason is due to the limitations of the science search 
measure as described earlier. The second reason is that the difference in institutional 
affiliation (profit firms/non-profit academic institutions) can prevent firms from fully 
benefiting from their university partnership. But the latter reasoning cannot be true, at 
least with respect to my results, because the main effect of the number of university 
partners on technological performance was positive. While prior studies have shown that 
alliance helps firms in going beyond local search (Rosenkopf and Almedia, 2003), the 
above results pertaining to the alliance-knowledge search strategy fit have important 
implications in framing an effective alliance strategy that best fits the search strategy of a 
firm. The findings also suggest that a holistic understanding of strategic advantage of 
alliance partners warrants careful examination of the alliance partners’ attributes and their 
interaction with the focal firm’s knowledge requirements. In addition, I contribute to the 
literature on strategic alliances by illustrating one of the second-order benefits of 
alliances, viz. enhancing the value of new knowledge search.  
 This research is subject to a number of limitations, the first pertaining to patent 
data. Restricting the scope to patent data can be limiting because not all companies have 
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the same propensity to patent and organizations can limit their patents only to most 
successful innovations. In spite of the above limitations, patent data has been widely used 
in testing the factors contributing to innovation (Sorenson and Fleming, 2004; Gittelman 
and Kogut, 2003).  
 The second limitation is related to the operationalization of new knowledge 
search. Currently search is restricted to inference from patent documents, which 
represents successful searches that eventually transformed into patentable innovations. 
However, an enormous amount of search conducted by firms is unsuccessful or at least 
not converted into patents. A measure that incorporates all search efforts made by firms 
will improve my findings and implications.  
 The third limitation is pertaining to the forward and backward citations of patents. 
It is noted that 40% of the citations in patents are added by patent examiners (Alacer and 
Gittelman, 2006). I take into account all the forward and backward citations of patents in 
calculating my measure, which is a limitation of the study. However, this limitation is 
mitigated by the way citations are used in my study. With respect to forward citations, 
whether the citation is made by firms or included by examiners, it represents in general 
the value of the patent. With respect to search measures, even if some of the citations are 
included by examiners, it signifies that the focal firm has implicitly made use of the 
knowledge. 
 The fourth limitation is pertaining to publications. Not all firms involved in 
scientific research have the inclination to disclose their findings by publishing. Even 
among publications, there are articles that can be classified as basic journals and applied 
journals (Lim, 2004). A fine-grained approach in categorizing publications can strengthen 
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my implications. There are also publications made by firms through collaboration with 
other firms and universities. My study includes all publications that are affiliated with the 
sample firms, irrespective of whether the publication is associated with more than one 
organization or not. However, not considering the information on collaboration is not a 
major limitation of my study because the publication is still a strong predictor of the 
knowledge captured by the firm and that the firm has acquired the tacit knowledge of 
individuals engaged in the research (Zucker, Darby and Armstrong, 2002).  
  A fifth limitation is related to the intellectual human capital measure. Currently it 
is operationalized as the proportion of intellectual human capital in 
science/technology/both domains. In reality there exists huge heterogeneity, even among 
individuals belonging to each of these categories. Hence, one of the fruitful research 
extensions can be to develop an intellectual human capital measure that is capable of 
capturing individuals' breadth and depth of knowledge.  
 Sixth, it would be helpful if my study could capture the benefits derived from an 
alliance partner using patents emerging from that specific collaboration, rather than 
looking at the performance of the whole patent portfolio of a firm. Though this is an 
important agenda for my future work, I intend to acknowledge this limitation in 
interpreting the findings of this study.  
 A seventh and final limitation is that, because my study explores the importance 
of intellectual human capital, it can only be generalized to other high-technology 
industries where intellectual human capital is considered a key input for technological 
innovation.  
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 Despite these limitations, this research explaining the means through which 
intellectual human capital and alliance influence the technological performance of firms 
has made several theoretical and practical contributions. In conclusion, this study 
identifies three types of intellectual human capital and illustrates their contributions to 
new knowledge search. The study also demonstrates the characteristics of an alliance 
portfolio that best fits with the different dimensions of new knowledge search, thereby 
enhancing the value of new knowledge search to technological performance.  
 Although the current study explains the importance of intellectual human capital, 
examples in the first chapter reveal that converting their competencies into important 
discoveries, especially the contributions of scientists, is not straightforward. The next 
chapter addresses this issue by determining some of the mechanisms through which a 
firm can benefit from its scientists. Since the results of this chapter identified bridging 
scientists as a valuable human capital, the focus of the next chapter is restricted to 




UNDERSTANDING THE MECHANISM OF BRIDGING SCIENCE AND 




Scholars have long believed that scientific input and R&D effort improve a firm’s 
technological innovation and performance (Henderson and Cockburn, 1994). A study of 
66 firms from seven major manufacturing industries estimates that about 11% of new 
products and 9% of new processes could not have been developed in the absence of 
scientific research from the academe (Mansfield, 1991). Several explanations have been 
offered to illustrate the benefits of science for better technological innovation. Scholars 
have shown that scientific research enhances a firm’s absorptive capacity (Cohen and 
Levinthal, 1990; Gambardella, 1992; Lim, 2004) and serves as guideposts for the process 
of technological investigation (Dasgupta and David, 1994), management of research 
activities (Owen-Smith, 2001), technological search (Fleming and Sorenson, 2004) and 
firm entry into new technologies (Zucker, Darby and Brewer, 1998).  
 While these studies illustrate the benefits of scientific knowledge for technology 
innovation, the process of converting competencies of scientists into better technological 
performance is actually not simple or straightforward (Gittelman and Kogut, 2003). In 
spite of the difficulty in benefiting from scientific competency, firms in high technology 
industries continue to spend heavily on scientific research through research programs 
organized internally and externally (Rosenberg, 1990). Firms also provide lucrative 
research funds and opportunities in order to attract star scientists into their organizations. 
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With these huge investments emerges an important question: How do firms make use of 
the competencies of scientists and translate them into better technology innovations?  
 The difficulty of converting the competencies of scientists into better 
technological performance has not been well investigated with a few exceptions such as 
Gittelman and Kogut (2003). Their study demonstrates that innovation builds on 
knowledge made in science, but science that is good for innovation is propelled by a logic 
different from that employed by the scientific community in determining valuable 
science. Using the patenting and publishing data in the biotechnology industry, they 
generated evidence to show that the logic of scientific discovery does not adhere to the 
same logic that governs the development of new technologies. Their findings suggest that 
by possessing the so-called bridging scientists, who are engaged in both scientific and 
technology domains, firms are in a better position to exploit the competencies of their 
scientists. Thus, their study suggests the importance of the individual-level mechanism of 
possessing bridging scientists in managing the two evolutionary logics.   
 While Gittelman and Kogut (2003) suggest the importance of bridging scientists, 
it is not feasible to expect all scientists in a firm to be bridging scientists. According to 
the learning style inventory model proposed by Kolb, Osland and Rubin (1995), different 
individuals are inclined to different styles of learning and knowledge generation. The two 
learning styles pertaining to knowledge residing in science and technology domains are 
1) conceptualization and 2) experimentation. Conceptualization means designing an 
abstract concept— a theory —in order to explain events, which is similar to producing 
scientific publications. The process of trying out theories in practice is called 
experimentation, and this is equivalent to applying scientific knowledge in practice to the 
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technology innovation process. Every person is inclined to either one learning style or, at 
maximum, two learning styles (Kolb et al. 1995; Raelin, 1997). Hence, it is not 
reasonable to expect every scientist who conducts fundamental research within an 
organization to also focus on downstream innovation activities requiring scientific 
knowledge.  
 While the learning style inventory model questions the viability of expecting all 
scientists to be involved in scientific research and technological innovation, March’s 
(1991) explorative/exploitative learning framework provides a remedial solution. 
Scientists' attempts to investigate new phenomena so as to provide a basic understanding 
of why phenomena occur can be termed as exploration. In contrast, inventors' attempts to 
test and apply the scientific knowledge for developing new technologies can be termed as 
exploitation. A recent study that builds on March’s (1991) framework has emphasized the 
importance of delineating the different domains of experiential learning and advancing 
the notion of maintaining exploration/exploitation balance within and across the domains 
(Lavie and Rosenkopf, 2006). Extending the lessons from this branch of study, I 
distinguish between the science and technology domains within organizations and 
advance the argument that, apart from relying on bridging scientists, firms have to 
encourage inventors involved in technology development to exploit the knowledge 
produced by their scientists. Organizations should have the necessary mechanisms in 
place to ensure that the scientific knowledge discovered by scientists is independently 
exploited by the inventors.  
 The importance of such firm-level mechanism in benefiting from scientists has 
also been established in the past. A study by Furukawa and Goto (2006) has shown that 
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heavily-publishing scientists are not known to directly contribute to the technology 
development process. However, these scientists are known to help the firm indirectly by 
increasing the patenting activities of other inventors who collaborate with them. This 
emphasizes that firm-level knowledge sharing and integration are necessary mechanisms 
for translating scientists’ competencies into better technological performance.  
 To further underscore the importance of firm-level mechanism over individual-
level mechanism in bridging science-technology domains, I study the interaction effect 
between the two mechanisms. Specifically, I use the absorptive capacity literature to 
propose that, in the presence of firm-level exploitation mechanism, the contribution of 
bridging scientists to technological performance increases. Thus, the major tenet of this 
paper is to show how March’s exploration/exploitation framework complements the 
lessons drawn by Gittelman and Kogut (2003) from the sociology and economics of 
science literature in explaining the mechanisms through which science-technology 
domains can be bridged within a firm. I use the publication and patenting behavior of 
biotechnology firms to test my hypotheses.  
 This chapter is organized as follows. The next section provides an overview of 
prior studies pertaining to science-technology relationship and discusses the need for 
bridging the science and technology domains within the firm. In the subsequent sections I 
develop hypotheses pertaining to the two mechanisms through which the science-
technology domains can be bridged, present the research method and results. The last 
section discusses the implications of my findings and the limitations of the study. 
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THE NEED FOR BRIDGING SCIENCE AND TECHNOLOGY DOMAINS 
WITHIN FIRMS 
The notion that scientific research stimulates technological performance and economic 
growth has long been established (Mansfield, 1972; Adams, 1990; Henderson and 
Cockburn, 1994; Jaffe and Trajtenberg, 1996). Both scientific research and scientists are 
known to have a significant positive effect on firms’ performances, especially that of 
firms in high-tech industries (Zucker and Darby, 2001; Zucker, Darby and Armstrong, 
1998).  
 Although research has reiterated the benefits of science and scientists for 
technology innovation, there is difficulty associated with the process of converting 
competencies of scientists into tangible benefits that a corporate firm demands. The 
reason8 is driven by the open norm of the scientific community and the general conflict 
involved in the adaptation of professionals, such as scientists, to organizational goals. 
Scientific endeavors were cloaked in secrecy until sixteenth century, but today scientific 
investigation receives a substantial amount of attention for its norm of openness. The 
institutionalization of science has encouraged the validation and diffusion of scientific 
ideas as open to public scrutiny (David, 1998; Gittelman and Kogut, 2003; Merton, 
1973). The nature of the scientific community reinforces norms of rapid disclosure and 
wider dissemination of new discoveries to account for rapid validation of findings, 
reducing excess duplication of efforts, and enlarging the domain of complementarities. 
                                                 
8 While certain areas of scientific research cannot be translated into practical applications (an example 
pertaining to the biotech context includes gene-sequencing. Identifying a gene-sequence potentially has no 
direct application. But the gene-sequencing research aids the process of relating a disease with a distortion 
in a gene-structure, which can subsequently be corrected by a chemical compound), in discussing the 
above, I focus on that scientific research that has practical applications. 
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Consequently, the success of scientists and their professional reputation is tied to priority 
based publication in prestigious journals.   
 While firms have a lower incentive to let potentially valuable information 
spillover to the public domain, in order to attract and retain very good scientists, firms 
realign the incentive structure and allow scientists to publish their research findings 
(Stern, 1999; Zucker and Darby, 2001). In addition to giving scientists autonomy and 
letting them operate in a community that values communism, firms must also become 
more adept at utilizing their scientific skills for better technological performance. The 
difficulty in achieving the above has been highlighted by Merton (1949) wherein he 
mentions that professional scientists differ from ‘technicians’ (or technical inventors) 
who believe that their primary obligation is to make their technical skills available to the 
organization. Kornhauser (1962, p:9) has termed this phenomenon as ‘professions limit 
organizations’, whereby professionals are constrained to act according to the 
requirements set by their profession rather than their corporate firms.  
 Thus, utilizing the competencies of scientists and translating them into better 
technological performance is not simple or straightforward. However, the question of 
how firms bridge science and technology domains has not attained enough attention in 
the literature. Such an understanding is essential because, in the absence of mechanisms 
to translate the competencies of scientists into better technological performance, firms 
might not be able to directly benefit from their scientific investments. In the following 
section, I develop hypotheses pertaining to two important mechanisms in bridging the 
science and technology domains within firms.  
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THEORY AND HYPOTHESES DEVELOPMENT 
Bridging Science-Technology Domains: Individual Level 
The work of Arrow (1962) exhibits science to be associated with features of public good 
and hence the need for academia and non-profit research to be involved in the production 
and dissemination of basic research findings. In subsequent research on the science and 
technology relationship, scholars started recognizing the importance of in-house scientific 
research for firms to even absorb scientific knowledge from the public domain (Allen, 
1991; Gambardella, 1995). The development of pharmaceutical and biotechnology 
industries has also singled out the scientific competency of firms and the presence of star 
scientists as critical factors for successful and productive firms (Zucker, Darby and 
Brewer, 1998; Cockburn and Henderson, 1998; Zucker, Darby and Armstrong, 2002).  
 Although scientists represent a vital resource for firms in high-tech industries, 
managing scientists who conduct fundamental research in industrial organizations creates 
friction. The friction is due to the conflicting nature of organizational demands and the 
identity of scientists being embedded in a collegiate reputation-based reward system of 
open science. Scientists are more inclined to utilize their competency in producing 
scientific publications so as to gain a reputation in the community of scientists, whereas 
the competitive advantage of science-based organizations depends on the ability of the 
scientists to exploit their scientific competency in innovation.  
 Though scientific research programs can be tailored to be useful inputs for 
furthering scientific investigation as well as technological innovation, one major 
challenge for firms with industrial R&D function is to define the roles of scientists, 
identify and evaluate the competencies of individual scientists, and provide appropriate 
incentive schemes to align their interests accordingly. The ability of the firm to find a 
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way to manage the two contradictory logics of science and innovation will be crucial for 
innovation performance (Cockburn, Henderson and Stern, 1999). However, ineffective 
human resource policy may also result in some scientists being trapped between the two 
evolutionary logics. 
As implied in the study by Gittelman and Kogut (2003), when scientists are 
properly motivated, they can be involved in generating both scientific findings as well as 
developing technologies. This will enable them to establish links between the science and 
technology domains, thereby creating valuable innovations. A feasible incentive structure 
is to induce scientists to play a dual role as both scientists and inventors, encouraging 
them to contribute to both knowledge domains, while inhabiting a single epistemic 
community. Their primary role as scientists in the community will facilitate firms to 
benefit from their networks and social interactions (Salter and Martin, 2001), generating a 
perpetual flow of external knowledge into the firm (Allen, 1991; Furukawa and Goto, 
2006). Meanwhile, by making the scientists indulge in technology innovation, a firm can 
utilize their tacit knowledge specific to internal scientific research to create technological 
innovation that no other firms can duplicate (Nonaka, 1994; Leonard-Barton, 1995). 
Thus, their secondary role as inventors aids in utilizing their scientific competencies in 
the technology innovation process, the consequence of which is found to have positive 
influence on the innovation performance of the firm (Gittelman and Kogut, 2003). The 
dual role of scientists also enables them to be gatekeepers of knowledge to bring in new, 
related and complementary knowledge that is beneficial for technological innovation 
(Allen, 1991; Gittelman and Kogut, 2003; Tushman, 1977).  
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 The importance of pushing scientists into marketable innovations has also been 
explained in a study on the Japanese and German biotechnology industries (Lehrer and 
Asakawa, 2004). The study found that the biotech firms in these countries, unlike the 
American and British counterparts, had failed to capitalize on the competencies of their 
scientists for better technological performance because of the lack of science 
entrepreneurship in the broader industrial context. The inability of these countries to 
excel in the biotechnology field was said to be a consequence of their scientists’ over-
inclination toward scientific publishing instead of patenting through commercially driven 
innovation (Lehrer and Asakawa, 2004).  
Following the above arguments and research findings, I posit that by defining the 
dual role of scientists in both scientific and technology innovation activities, firms can 
effectively bridge the science-technology domains. With the growing importance of 
individuals as movers of knowledge between organizational boundaries (Almeida and 
Kogut, 1999), using scientists as the level of analysis facilitates an ‘inside the box’ view 
of how firms bridge the two domains. In this paper, “dual role” means the extent to which 
scientists are engaged in both publishing and patenting activities organized within the 
firm. The above arguments suggest that: 
Hypothesis 1: The number of scientists within a firm who are directly involved in both 
scientific publications and technology patenting is positively associated with the 
technological performance of the firm 
Bridging Science-Technology Domains: Firm Level  
Building on March’s (1991) exploration/exploitation framework, a recent study that 
delineates distinct domains of exploration and exploitation provides some useful insights 
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through which a firm can benefit from the competencies of its scientists (Lavie and 
Rosenkopf, 2006).Exploitation is defined as 'refinement and extension of existing 
competencies', and exploration as 'embarking on new alternatives'. Exploration and 
exploitation differ on the type and amount of learning rather than presence and absence of 
learning. Recent studies on exploration/exploitation have shown that the delineation of 
exploration and exploitation in different domains enable firms to simultaneously embark 
on both, thereby maintaining the balance (Gupta, Smith and Shalley, 2006; Lavie and 
Rosenkopf, 2006). The capability of maintaining the exploration/exploitation balance by 
concurrently engaging in both types of knowledge searches is termed as ambidexterity.  
 Scientific efforts in producing abstract theories for understanding basic 
phenomena and causal relationships between technological components can be termed as 
exploration. The effort in applying the knowledge gained from scientific theories to the 
technology development process can be termed as exploitation. Though Gittelman and 
Kogut’s (2003) suggestion that having bridging scientists enables the generation and 
application of scientific knowledge in technology, there are practical limitations 
associated with this approach. Exploration and exploitation require radically different 
mindsets and routines, and it is not reasonable to expect every scientist within firm to also 
be competent in technology development. Consequently, though engaging scientists in 
both exploration and exploitation can lead to bridging of science and technology 
domains, a firm cannot solely rely on this mechanism to exploit the knowledge possessed 
by its scientists.  
 The organization learning literature that emphasizes the need for carrying out 
exploration/exploitation in different domains and maintaining a balance both within and 
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between them provides useful insights in overcoming the above-mentioned limitation 
(Lavie and Rosenkopf, 2006). Extending lessons from this branch of study, I distinguish 
the science and technology domains within an organization and advance the notion of 
letting scientists explore scientific areas and facilitating inventors in the technology 
domain to actively exploit the knowledge generated by the science domain. The main role 
of scientists in the science domain will be to specialize in their expertise areas and 
generate important findings that are valuable to technology development. In addition to 
the scientific role, scientists who are competent in technology development should be 
permitted to play a dual role by engaging themselves in technological innovation.  
 But in bridging the science and technology domains, firms should not wholly rely 
on the scientists playing the dual role. Instead, the capability of firms in bridging science 
and technology domains relies on how well the firm has organizing principles to exploit 
the knowledge produced by the science domain in its technology domain. The organizing 
principles underlying firm level exploitation mechanism encompasses (a) the extent to 
which a firm has lateral communication across functional domains (Demsetz, 1991) (b) 
how work is coordinated within the organization and information disseminated across 
groups (Grant, 1996) (c) the collective experiences of members of firms that enable even 
tacit knowledge of scientists to be transformed into comprehensible code that can be 
exploited by technology inventors (Teeni, 2001) (d) the introduction of an appropriate 
incentive structure to encourage employees to exploit the knowledge produced by 
colleagues (Subramanian and Soh, 2009) etc. The mechanisms stated above will facilitate 
the inventors in the technology domain to actively test and apply the internally-generated 
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scientific findings in developing technologies, thereby bridging the science and 
technology domains. 
 The firm-level mechanism of exploiting scientific knowledge in the technology 
domain results in better technological performance in the following ways. Firstly, firm-
level exploitation mechanism provides inventors with quick and easy access to internally-
generated scientific findings before being published, thereby enabling the inventors to 
introduce better products earlier than other firms. Secondly, the firm level exploitation 
mechanisms help firms readily apply scientific knowledge to resolve many technical 
problems related to technological breakthrough development. Thirdly, firm-level 
exploitation mechanism increases a firm’s capability in realizing the benefits of its 
investment in internal basic research.  
 Following the above arguments, I posit that firms that are capable of exploiting 
internally-generated scientific knowledge in their technology domain are in a better 
position to bridge the science and technology domains. The above arguments lead to my 
second hypothesis: 
Hypothesis 2: The degree to which a firm exploits the knowledge produced by its 
scientists in the technology domain is positively associated with the technological 
performance of the firm. 
 It is to be noted that Hypotheses 1 and 2 are not mutually exclusive. The first 
hypothesis explains the importance of nurturing bridging scientists, whose competence is 
invaluable to producing better technological innovation. The second hypothesis puts 
emphasis on a broader firm-level exploitation mechanism. In other words, enabling 
inventors to access and apply the internally generated scientific knowledge as well as 
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developing absorptive capacity for external sources of innovation would be the routines 
to establish inside a firm. Therefore, it is feasible for a firm to have both bridging 
scientists and the exploitation mechanism which utilizes the internally-generated 
scientific knowledge in the firm’s technology domain. For example, consider a firm with 
two scientists (A&B) in the science domain. Scientist A may be competent in both the 
science and technology domains, and hence becomes a bridging scientist, whereas 
scientist B may be a pure scientist exclusively involved in generating scientific 
knowledge. In order to fully translate the competencies of both scientists into better 
innovation performance, the firm has to facilitate the process of exploiting both the 
scientists’ knowledge in the technology domain, rather than just relying on scientist A to 
do the job.  
 The following section develops my third hypothesis which underscores the 
importance of firm-level exploitation mechanism. I argue that, in the presence of 
exploitation mechanism, the contribution of bridging scientists to technological 
performance increases. 
Bridging Science-Technology Domains: Firm Level Moderating Individual Level 
According to the absorptive capacity literature (Cohen and Levinthal, 1990), a strong 
positive interaction exists between individual-level and firm-level mechanisms of 
capability building. It has been observed that the benefits derived from individual-level 
capabilities are significantly influenced by firm-level mechanisms such as knowledge 
transfer, integration, and exploitation across units. For example, more conducive 
organizational mechanisms are found to increase the effectiveness of intellectual human 
capital (Hitt, Hoskisson, Ireland and Harrison, 1991). In particular, a study by 
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Grosysberg, Nanda and Nohria (2004) showed that when star financial analysts switched 
firms their short-term variations in performance were determined by organizational 
aspects of the new firm. Following this perspective, I hypothesize that the firm-level 
exploitation mechanism moderates the positive influence of bridging scientists on the 
technological performance. In order words, the degree of influence of bridging scientists 
on technological performance is higher for firms that are good at exploiting the scientific 
knowledge in their technology innovation. Two explanations support the moderating 
effect.    
 First, scientific knowledge exploitation in the technology domain widens the 
scope of application of bridging scientists’ knowledge, thereby enhancing their 
contribution to technological performance. As emphasized by Brooks (1994), scientific 
knowledge can help technology development in sundry ways. Science generates new 
knowledge that can function as inputs to technology development across wide areas. For 
example, advancement in basic physics led to the discovery of the transistor, which was 
subsequently found to be useful in developing medical equipment such as hearing aids. 
Scientific knowledge can be used in designing engineering tool and techniques. In 
addition, science helps in evaluating technological areas.  
 Though the presence of bridging scientists can help in exploiting scientific 
knowledge, it is undue to expect bridging scientists to be involved in every application 
area to exploit the knowledge. Bridging scientists can help firms in translating abstract 
scientific theories into working ideas for technology development. Despite the surface 
level similarities, scientists and engineers are observed to exhibit different 
communication behavior (Allen, 1991). Bridging scientists can act as a channel to 
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translate the ideas of other core scientist within the firm into a language that can be easily 
interpreted by inventors. In the presence of such bridging scientists, when a firm 
encourages its inventors in the technology domain to exploit the knowledge, the 
translated ideas of bridging scientists can span a broader set of technology domains. 
Thus, by widening the application of bridging scientists’ knowledge, firm-level 
exploitation mechanism can positively moderate the relationship between bridging 
scientists and the technological performance of firms.  
 Second, firm-level exploitation mechanisms enhance the value of bridging 
scientists by providing them with novel scientific challenges. The application of science 
knowledge to the technology innovation process is a rich source of novel scientific 
challenges. Exploration of these scientifically challenging questions would bring forth 
important findings that are in turn valuable to technological innovation. For example, the 
use of basic physics to understand some of the material processes and properties in 
semiconductor devices has led to the birth of a new scientific discipline called Materials 
Sciences (Brooks, 1994). This discipline now has an extensive use in the technology 
innovation process, including innovations related to nutrition and dietetics. Firm-level 
mechanisms that encourage the exploitation of scientific knowledge in technology 
domain would make inventors from diverse background experiment with the knowledge 
generated by scientists. Since bridging scientists are involved in science and technology 
domains, the firm-level exploitation mechanism would expose these scientists to new 
application areas. Novel questions arising from these diverse areas can be easily picked 
up by bridging scientists for further exploration, thereby enhancing the value of bridging 
scientists for technology development. The above arguments lead to my third hypothesis:  
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Hypothesis 3: The degree of relationship between the dual role of scientists and the 
technological performance of a firm is moderated by the extent to which the firm exploits 
its scientists’ knowledge in the technology domain.   
 Even in the presence of bridging scientists, certain circumstances might prevent 
firms from translating the competencies of scientists into better technologies. For 
instance, since scientific ideas serve as inputs for scientific research as well as technology 
development, it is vital that bridging scientists make use of the important scientific 
knowledge to generate valuable technologies rather than merely investing their time and 
effort in furthering the scientific understanding. But, as the professional reputation of 
scientists is tied to their important discoveries in the scientific discipline, even bridging 
scientists might intend to use the knowledge for scientific advancement. Besides, as 
publishing scientists in firms receive lower wages than other scientists and inventors who 
are not allowed to publish, they have less incentive to exploit the important scientific 
findings for the benefit of the firm. Therefore, the professional orientation of bridging 
scientists can prevent a firm from translating their scientific competency into better 
technological innovation. Active collaboration between inventors and scientists can 
facilitate inventors to exploit important scientific findings in the technology development 
process. This can enable firms to overcome the incentive issues and to fully benefit from 
the competencies of bridging scientists. Further to the moderation effect of exploitation 
mechanism in enhancing the value of bridging scientists, the above argument emphasizes 
that, in the absence of firm-level exploitation mechanisms, the presence of bridging 





To test the hypotheses I collected data from the biotechnology industry. Biotechnology is 
recognized to be one of the most innovation-intensive industries (Sorenson and Stuart, 
2000). The biotechnology industry was an ideal context in testing the framework because 
the industry is characterized by technological transformation and the widely-recognized 
importance of scientific research and intellectual human capital.  
 The data was drawn from Plunkett's9 directory that comprises of 437 public-listed 
biotechnology firms. Biotechnology directories are one of the sources that prior studies 
have consulted in drawing their samples (Gulati and Singh, 1998; Stuart, Hoang and 
Hybels, 1999). Generally, firms in the directory are based in the United States of 
America. However, the headquarters of 70 firms are located in other nations such as 
Canada, Japan, UK, India, Switzerland, etc. The directory has 3 firms from agriculture, 
13 from infotech, 100 from chemical manufacturing and 321 from the health care areas of 
biotechnology. The directory comprises of firms such as EISAI Co. Ltd., DOW 
Agrosciences, BASF AG and TRIPOS Inc. that have attained the highest sales revenue in 
the year 2000 for the health care, agriculture, chemical, and infotech areas respectively. 
The directory includes very small firms (with respect to R&D, number of employees, and 
sales) such as VIRAGEN and SPECTRAL DIAGNOSTICS, as well as large firms such 
as BAYER and NOVARTIS. With respect to age, there are old firms such as PFIZER as 
well as new firms formed in late 90’s such as ATHEROGENICS and ARENA 
PHARMACEUTICAL. 
                                                 
9 Plunkett's Biotech and Genetics Industry Almanac 2005: the only comprehensive guide to biotechnology 
and genetic companies and trends/editor and publisher: Jack W. Plunkett. 
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 I used the publication and patenting activities of these firms in testing the 
hypotheses. The patents issued to these firms between 1990-2000 were obtained from the 
NUS patent database10.The database comprises of patents issued to firms by the United 
States Patent and Trademark Office (USPTO). Publication information of firms between 
1980-2000 was obtained from Web of Science, ISI Science Citation Index (SCI). The SCI 
is an excellent source because it covers a broad range of basic and applied scientific 
journals (Lim, 2004). As the birth of the biotechnology industry is dated back to the late 
70’s and my patent data is restricted to 2000, I focused on publication during the period 
1980-2000.Compustat Global is used in collecting the financial data of these firms. 
 The US patent classification system comprises of over 100,000 patent subclasses 
aggregated to about 400 three-digit patent classes. I used the three-digit patent classes and 
only included those patents that fall within the U.S. patent classes listed in Table 3.1, 
which belong to the biotechnology industry. The classes were chosen with reference from 
the USPTO Technology Profile Reports and from prior research (Lim, 2004). Filtering 
those firms that did not have patent data in the specified classes between 1990-2000, the 
final sample size was 222 firms. The list of 222 firms is provided in Table A.2 of the 
Appendix. Of the listed firms, 215 (437-222) firms were dropped from the directory 
because they had zero patents. To ensure that the results were still generalizable, I carried 
out a preliminary assessment of firm level variables. As shown in Table A.3, the average 
of firm R&D and firm size for 437 firms was not significantly different from the average 
of these variables in my final sample. However, I found that the average age of my final 
sample firms was higher than that of average age for 437 firms. This is possibly because 
younger firms in the directory might not have patents issued between 1990-2000. 
                                                 
10http://patents.nus.edu.sg/ 
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Nevertheless, I do believe that the results of my study hold true even for younger firms, 
because my sample does indeed include younger firms such as Atherogenics and Arena.  
 The total number of patents and publications under consideration was 10,646 and 
100,375. There is huge heterogeneity with respect to patent and publication data. Firms 
like Anika Therapeutics and Viragen received one patent each, while Abbott and Bayer 
had about 1000 patents. Patents issued to firms increased from 424 in 1990 to 1722 in 
2000. There were 19 firms in my sample with 0 publications, but also about 10 firms with 
at least a few thousand publications. The publications made by firms increased from 1826 
in 1980 to 8181 in 2000. The number of publications and number of patents of my 
sample firms between 1990-2000 is provided in Table A.4 of the Appendix. 
 
Table 3.1. U.S. Patent Classes 
 
Class Description 
424 Drug, bio-affecting and body treating compositions 
435 Chemistry: molecular biology and microbiology 
436 Chemistry: analytical and immunological testing 
514 Drug, bio-affecting and body treating compositions 
530 Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof 
536 Organic compounds 




Technological Performance (Forward Citation) : The dependent variable is the 
cumulative forward citation frequencies accrued to an individual patent. I count all 
forward citations received by each patent at of the end of 2004. By law, each patent must 
cite prior patents that relate to its technology. Research demonstrates that the number of 
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forward citations received by a patent correlates highly with the technological importance 
(Trajtenberg, 1990; Albert, Avery, Narin and McAllister, 1991). On average, each patent 
in my sample received about 6 forward citations. Prior studies have observed that the 
self-citation of a firm to its patents represents the extent to which the firm appropriates 
the returns from the patents. As a consequence, they find self-citation to reduce the 
probability of other firms citing the patent (Zhuang, Wong and Lim, 2006). However, in 
my sample I found the self-citations to be positively related to the overall forward 
citations, which indicates that overall citations represent the value of knowledge 
underlying the technology. Hence, instead of removing self-citations, I restricted my 
attention to overall citations accrued by a patent. 
 
Independent Variables 
Bridging scientists or Joint Patent-Publishers: This measure represents the percentage 
of patent inventors within a firm whose names are also listed on scientific papers 
published by the firm. In order to obtain this measure I identified two overlapping sets of 
individuals for each firm. The first comprises of those scientists listed on at least one 
publication made by the focal firm, and the second list comprises of inventors involved in 
at least one patent issued to the focal firm. Based on these two lists, I calculated the 
percentage of individuals listed as inventors who are also listed as scientists for each 
firm. The measure is borrowed from Gittelman and Kogut (2003).  
Exploitation of science domain knowledge in technology domain or Relative use of a 
firm’s publications in patents: Since measuring the exploitation mechanisms through 
secondary data was difficult, I take into account the outcome of exploitation mechanism 
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in my measure, which the extent to which a firm uses internally-generated scientific 
knowledge in technology. For this, I measured the proportion of the focal firm’s patents 
over all patents citing the focal firm’s scientific publications. To compute this measure, I 
first identified all the publications produced by the focal firm and then all the patents 
citing those publications. For each publication, I checked the first assignee name of the 
citing patents to obtain a count of patents by focal firm and by other firms. Next, I 
computed the proportion of publication citations by focal firm over the total citations 
received by each publication. I then averaged this out for all the publications made by the 
focal firm. For each firm the value of this measure ranges from 0 to 1. The value 0 is 
assigned when focal firm’s publications are cited only by other firms and 1 when the 
publications are cited only by the focal firm.  
 
Control Variables 
Publication Volume: This measure is the number of publications produced by the focal 
firm in the year of observation in which the firm filed a patent. I used the number of 
publications made by a firm as a proxy for its scientific capability. A number of scholars 
have used publication count to measure the scientific capability of firms (Lim, 2004; 
Gittelman and Kogut, 2003; Arora and Gambardella, 1994). A firm with strong scientific 
capability is able to identify new applications in the technology domain that might give 
rise to more valuable patents. Prior studies have also shown the significant relationship 
between publication count and patent performance. It is therefore imperative that I 
control for it. 
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Non-patent Reference: Non-patent reference is the count of the number of times a patent 
issued to a firm references non-patented literature. Every patent is required to cite the 
prior art that it builds upon, and this includes both the patent and non-patent references. It 
has been observed by Fleming and Sorenson (2004) that 69% of the non-patent 
references are from peer-reviewed scientific journals. Non-patent references cited by a 
patent are often used as an indicator of the science intensity of the invention that is found 
to be influencing the forward citation of patents (Gittelman and Kogut, 2003; Noyons, 
van Raan, Grupp and Schmoch, 1994). Hence, I controlled for it. The average number of 
non-patent references cited by the patents under study is about 18.  
Firm’s Average Cites to Publications: I use the citations received by the focal firm’s 
publications to represent the relative quality of the firm’s stock of scientific knowledge. 
To compute this measure, I first identified all the publications produced by the focal firm 
between the years 1980-2000, and then obtained the number of citations received by 
these publications. Based on the citations, I calculated the mean and standard deviation of 
the citations received by all articles of the sample firms in a publication year. Next, the 
raw citation counts for each publication of firms are normalized by the mean and standard 
deviation of the citations received by all articles in its publication year. Normalizing the 
raw citations by year allows the citations to be summed across years for each firm 
(Gittelman and Kogut, 2003). I then aggregated the normalized citation count of 
publications in a year and divided it by the total number of publications made by the firm. 
The normalized citation count is then aggregated up to the year the observed patent was 
filed in order to obtain a cumulated amount of publication quality. Because a firm’s 
competency in generating high-quality scientific papers has been observed to impact its 
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capability to produce high-impact innovation, I controlled for it (Gittelman and Kogut, 
2003).  
Number of Pure Inventors: This measure is the number of inventors listed in a patent 
who are exclusively involved in patenting. Since the number of inventors listed in a 
patent represents the research effort and resources invested in coming up with the patent, 
I controlled for it.  
Other Control Variables (Technology class dummy variable, Patent age, Year fixed 
effects, R&D expenditure, Firm size, and Firm age): Forward citations may accrue to 
patents for other reasons such as technology field characteristics, patent characteristics 
and firm characteristics. Therefore, I included the patent-level and firm-level control 
variables to account for the heterogeneity among firms and for age and field effects. 
Patents belonging to a certain technology class may inherently be more cited than others. 
Similarly, patents with a higher number of years that elapsed since the patent was filed 
are capable of attaining higher citations. I used technology-class dummy variables and 
patent age as patent-level control variables to control for these effects. I also used year-
fixed effects to capture the differences in citation probability across different years. 
 Firms may be highly innovative for different reasons. Larger firms have this 
capability due to economies of scale and scope, younger firms because they represent the 
knowledge of the younger vintage, and some firms devote more resources to R&D. 
Hence, I included firm-level control variables such as R&D expenditure, size of the firm 
as measured by the number of employees, and age of the firm as measured by the number 
of years since the firm was founded.  
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  The summary of the dependent, independent and control variables is presented in 
Table A.1 of the Appendix. The summary data for the dependent and independent 
variables and the correlation between the variables at the patent level are reported in 
Table 3.2. As the numbers show, the patents and publications exhibit a lot of variance. 
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Table 3.2. Descriptive Statistics and Correlations 
 
S.No Variables Mean Std. 
Dev 
Min Max 1 2 3 4 5 6 7 8 9 10 11 
1 Forward Citation 6.34 11.87 0 233 1           
2 Bridging Scientists 0.25 0.15 0 0.83 -0.02 1          
2 Exploitation of 
Science Knowledge 
0.29 0.28 0 1 0.05* -0.38* 1         
3 Publication Volume 136.39 222.74 0 1272 -0.06* -0.18* 0.04* 1        
4 Publication Citation 0.04 0.91 -6.73 9.65 -0.04* 0.25* 0.23* -0.08* 1       
5 Patent Age 10.12 2.80 7 17 0.28* 0.10* -0.15* 0.11* -0.01 1      
6 R&D 3.04 2.15 -0.55 12 0.17* -0.37* 0.28* -0.30* 0.09* 0.06* 1     
7 Firm Size 6.82 2.32 0 11.69 -0.10* 0.55* -0.45* 0.00 -0.04* 0.01 -0.69* 1    
8 Firm Age 3.37 1.21 0 5.01 -0.18* 0.61* -0.29* 0.14* 0.29* 0.07* -0.57* 0.53* 1   
9 Tech. Strength 53.22 56.29 1 240 0.31* 0.32* -0.34* 0.18* -0.12* -0.09* -0.65* 0.62* 0.46* 1  
10 Non-patent 
reference 
18.36 35.14 0 492 0.05* -0.19* 0.07* -0.01 -0.15* -0.15* 0.05* -0.06* -0.23* 0.02  
11 No of Pure 
Inventors 




Since the dependent variable is forward citation count, the count model was more 
appropriate for my study. The Poisson model is a frequently used count model. As patent 
citations exhibited over-dispersion, I used the negative binomial model that is best suited 
for estimating an over-dispersed parameter (Cameron and Trivedi, 1998). The results of 
negative binomial regression are presented in Table 3.3. 
 
Table 3.3. Negative Binomial Regression in Testing the Impact of Bridging Scientists, Exploitation of 
Science Domain Knowledge, and Control Variables on Forward Citation 
 












Bridging scientists  1.1610*** 
[0.5504] 
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Exploitation of science domain 
knowledge 
    -0.6558 
[1.0979] 
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Patent-Level Control Variables 




















Log Likelihood -20506.10 -20483.69 -20488.22 -20459.97 -20458.76 
No. of Observations 7648 7648 7648 7648 7648 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported. 
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All specifications include fixed effects for both technology class and application year 
from 1985-2000. I used robust standard errors adjusted for clustering of firm to control 
for random firm effects.   
Results pertaining to Control Variables: Model 1 in Table 3.3 presents the results for 
all the control variables. The publication volume has a negative influence on the forward 
citation of patents (p<0.01). On the contrary, the non-patent reference has a significant 
positive influence (p<0.01) on the forward citation of patents. One possible explanation 
of my result is that when firms concentrate more on producing scientific publications, 
their attention towards developing important technologies might deteriorate and result in 
fewer forward citations for their patents. This explanation is also consistent with the 
result pertaining to the publication citation. The quality of firms’ publications, as 
reflected by the average cites to publications, has a negative relationship with the forward 
citation of patents (p<0.10). This shows that when firms engage in the generation of 
cutting-edge scientific research, their technological performance suffers. As expected, the 
firm age and number of pure inventors have, respectively, a negative and positive impact 
on the forward citation of patents (p<0.01, p<0.01). Firm size and R&D expenditure do 
not have a significant relationship with the forward citation of patents. A plausible 
explanation for R&D and firm size being insignificant is that increased R&D spending 
and economies of scale need not necessarily increase the quality of innovation, as 
measured by the forward citations. The technological strength of a firm, as measured by 
the number of patents generated by the firm, is negatively associated with forward 
citation of patents (p<0.01). This shows that quality of patents is inversely proportional to 
the quantity generated. A plausible explanation is that for a given amount of R&D 
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investment and firm size, firms producing more number of patents receive fewer citations 
for their patents. The significant (p<0.01) positive effect of patent age shows that older 
patents receive more citations.   
Results pertaining to the independent variables: Model 2 presents the results after 
including the first independent variable, bridging scientists. The coefficient of bridging 
scientists is positively significant (p<0.01) suggesting that the presence of bridging 
scientists confirms the translation of scientific competency into valuable patents for 
firms. Thus, hypothesis 1 is accepted.  
 Model 3 includes the second independent variable, which is the extent to which 
organizations exploit their scientific publications in their technology domain. The 
positive significant coefficient (p<0.10) supports hypothesis 2 that firms’ endeavors 
toward the exploitation of their scientific knowledge in technology innovation will 
increase the forward citation rates of their patents. Model 4 includes both the independent 
variables. The significant coefficients of both ‘bridging scientists’ and ‘exploitation of 
science domain knowledge’ confirm the acceptance of hypotheses 1 and 2.Model 5 
introduces the interaction term of the two independent variables under study. Since 
hypothesis 3 pertains to degree moderation, an insignificant interaction term need not 
mean that the hypothesis is rejected. The following section elaborates on the 
methodology in testing the degree moderation.  
Results pertaining to the moderation effect: The moderation effect is usually tested by 
observing the interaction term of regression analysis. However, such a test will only 
verify the moderating effect of the form of relationship, not the degree of relationship. 
The degree of relationship between a dependent variable Y and an independent variable 
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X indicates the percentage of Y variance accounted for by X. The form of relationship 
denotes the amount of score difference in Y associated with a unit change in X. As 
argued by Arnold (1982), the form of relationship between two variables is indicated by 
the coefficients of the regression equation, whereas the degree of relationship is measured 
by the magnitude of the correlation coefficient. Since my third hypothesis is regarding the 
moderation of degree, I observed the correlation coefficient to test the effect.   
 In testing the moderating effect of the degree of relationship between bridging 
scientists and technology performance, I performed a mean split on the variable 
‘exploitation of science domain knowledge’, resulting in two groups. In other words, I 
broke the sample into two groups based on the extent to which the firms exploited their 
scientific knowledge in the technology domain. With the mean of scientific knowledge 
exploitation in technology being 0.29, I had the high exploitation group comprising of 
47% of the sample firms. The low exploitation group had about 53% of the sample firms. 
The technique of splitting the sample is also consistent with Baron and Kenny’s (1986) 
third case of moderation, wherein it is suggested that, at some value of ‘exploitation of 
science domain knowledge’, the ‘bridging scientists’ become more effective in increasing 
the technological performance of firms. Their study also suggests the approach of 
dichotomizing the moderating variable to evaluate a variable’s moderating effect. Thus, 
in testing the degree of moderation using the above technique, I observe the correlation 
between bridging scientists and forward citation for both the groups. According to Arnold 
(1982), the following formulae are used in testing the difference in correlation between 
the two groups to confirm the significance of moderation effect: 
Fisher Z= (Z1 - Z2)/SQRT [1/ (n1-k-2) + (1/n2-k-2)] 
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where k is the number of independent variables and n is the size of the group.  
Z1 and Z2 are obtained by the Fisher Z transformation of the partial correlations between 
bridging scientists and forward citation obtained for the two subgroups, given by   
Zi=0.5 * LN [(1+ri)/ (1-ri)] 
where LN is the natural log and ri is the partial correlation coefficient.  
 Table 3.4 reports the result of correlation analysis for testing the moderating 
effect of bridging scientists. The significance of the Z value shows that, in the presence of 
exploitation of scientists’ knowledge in the technology domain, bridging scientists 
account for much higher variance in the forward citation of patents. This confirms that 
exploitation of science domain knowledge moderates the degree of relationship between 
bridging scientists and technology innovation performance, thus supporting hypothesis 3. 
 
Table 3.4. Analysis of Correlation Differences 
 
Variables Group 1: 
High Exploitation of 
science domain knowledge 
(Z1) 
Group 2: 
Low Exploitation of 
science domain knowledge 
(Z2) 


















Apart from testing the correlation differences, I also estimated the regression coefficients 
of bridging scientists for the two subgroups. This was done to understand the extent to 
which the relationship between bridging scientists and forward citation of patents is 
moderated by the exploitation mechanism. It is evident from Table 3.5 that the regression 
coefficient of bridging scientists in explaining the forward citation of patents for high 
exploitation group is significant at the 5% level of significance. On the contrary, the 
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coefficient is insignificant for the low exploitation group. Taken together, the results 
show that, when the exploitation of science domain knowledge in technology domain is 
low, the mere presence of bridging scientists is not capable of generating valuable 
technological innovation. Thus, the results strongly confirm the moderating effect of 
‘exploitation of science domain knowledge in technology domain’ in explaining the 
relationship between ‘bridging scientists’ and ‘forward citation of patents’.  
 One might suspect that the story behind such a relationship is that the firm-level 
mechanism of exploitation is actually capturing the bridging scientists’ efforts in 
exploiting science knowledge in the technology domain. Nevertheless, this reason 
appears to be unlikely because, in my data, very few inventors (2.5% of the inventors) 
referenced their own publication materials. While Sorenson and Fleming (2004) observed 
about 3% of the inventors in their sample to reference their own publications, in my data 
I found the percentage to be much smaller. Hence, it is highly unlikely that the result 
pertaining to firm-level bridging mechanism is confounded because of bridging scientists. 
In addition, it is important to note that, in the presence of firm-level exploitation 
mechanisms, the main effect of bridging scientists on forward citation rate of patents is 
positively significant (Table 3.3). If the firm-level mechanism is capturing the effect of 
exploitation of knowledge by bridging scientists, then the main effect of bridging 
scientists should have become insignificant in Table 3.3.  
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Table 3.5. Analysis of Regression Coefficient 
 
Variables Group 1: 












Firm-Level Control Variables 






























Patent-Level Control Variables  








No. of Observations 3595 4053 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 




DISCUSSION AND CONCLUSION 
While many studies explore the benefits of science to technology development, this study 
focuses on the means through which firms are able to make use of the competencies of 
scientists and translate them into better technological innovations. My study investigates 
two important mechanisms of bridging science-technology domains, one at the individual 
level and the other at the firm level, and has several important findings to enrich this 
branch of literature.  
 The first mechanism explored in my study is the extent to which a firm has 
bridging scientists, who are involved in both scientific research and technological 
innovation. In other words, these scientists publish as well as patent. My results are 
consistent with Gittelman and Kogut’s (2003) assertion that bridging scientists improve 
the technological performance of firms. Further to bridging scientists, in my second 
mechanism I show that it is also important for firms to have an exploitation mechanism in 
place so as to ensure that the knowledge generated by their scientists is exploited by the 
inventors in technology domain. One of the main contributions of my study is to show 
that the degree to which bridging scientists enhance the technological performance is 
much higher in the presence of a firm-level exploitation mechanism. In the absence of 
calculated exploitation of scientific knowledge in the technology domain, bridging 
scientists do not play a significant role in explaining the technological performance. 
Therefore, the mere presence of bridging scientists in an organization does not ensure a 
smooth transfer of knowledge between science and technology domains.  
 Consequently, my research demonstrates that March’s exploration/exploitation 
framework complements the sociology and economics of science literature in 
understanding the mechanisms of transforming competencies of scientists into better 
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technological innovation. Science and technology are two distinct domains within a firm. 
Apart from maintaining exploration/exploitation balance within each domain, it is also 
important that knowledge exploration of the science domain is complemented by the 
exploitation of such knowledge in the technology domain. This underlines Lavie and 
Rosenkopf’s (2006) suggestion that firms ought to be ambidextrous in maintaining an 
exploration/exploitation balance, both within and across domains. Bridging science-
technology domains is not a simple human capital story of having scientists who are 
involved in both patenting and publishing. Firms have to acknowledge the challenges in 
making the transition from science domain exploration to technology domain 
exploitation, and attempt to have premeditated mechanisms to bridge the gap. Inventors 
involved in developing technologies should be encouraged to actively experiment and 
make use of the knowledge generated by the scientists. Similarly, scientists should be 
encouraged to coordinate with inventors in solving basic problems encountered in the 
technology development process. This underscores active communication, coordination 
and knowledge sharing within an organization to let individuals specialize in their 
expertise area, yet not to let them work solo. 
 There are a few other results worth explaining to understand the science-
technology relationship. First, the non-patent reference also termed as the science 
intensity of patents was found to be a significant predictor of patents’ values. This result, 
together with the negative relationship of publication volume with patent performance, 
suggests that a firm’s ability to generate scientific knowledge does not result in the firm 
generating better technological innovation. On the contrary, a firm’s capability to apply 
scientific knowledge in technology development guarantees generation of valuable 
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technological innovation. This result is consistent with the findings of Gittelman and 
Kogut (2003). I follow their contention in saying that it is only through the skillful 
application of science to the innovation process that firms can transform their scientific 
capability into valuable innovation. This has important implications for firms with low 
R&D budgets. These firms can encourage their inventors to effectively utilize scientific 
findings in their technology innovation process, so as to benefit from the scientific 
community’s knowledge spillover.  
 Second, the publication citation has a negative influence on the forward citation 
of patents. This shows that a firm’s capability to generate cutting-edge science is not 
helpful for its technological innovation. Rather, the extra attention paid in creating 
cutting-edge science diverts the firm’s attention from working on valuable technologies. 
As explained above, another plausible reason could be that the cutting-edge science 
represents an embryonic stage of research which the firms’ are unable to translate into 
patentable innovations within a short span. Thus, indulging in breakthrough science is 
detrimental to firms’ technological performance if they fail to exploit the breakthrough 
results in developing valuable patents. 
 This research is subject to a number of limitations. The first one is pertaining to 
patent data. Restricting the scope to patent data has several limitations because not all 
companies have the same propensity to patent and firms can limit their patents only to 
their most successful innovations. In spite of the above limitations, patent data has been 
widely used in testing the factors contributing to innovation (Sorenson and Fleming, 
2004; Gittelman and Kogut, 2003). Secondly, a count of all non-patent references is 
considered when measuring a firm's capability to apply science to technology 
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development. A more appropriate measure would have been to consider only citations to 
scientific publications. However, this limitation is to some extent mitigated by the 
observation of Fleming and Sorenson (2004) that the majority of the non-patent 
references are citations to scientific publications. My research interprets the citations of 
publications in patents as the usage of scientific knowledge in technology. However, 
practitioners such as Narin, Hamilton, and Olivastro (1997) have acknowledged that such 
linear science-push perspective is simplistic and inaccurate. 
 Third is a limitation is pertaining to publications. Not all firms involved in 
scientific research have the inclination to disclose their findings by publishing. Even 
among publications, there are articles that can be classified as basic journals and applied 
journals (Lim, 2004). A fine-grained approach in categorizing publications can strengthen 
my implications. There are also publications made by firms through collaboration with 
other firms and universities. My study includes all publications that are affiliated with the 
sample firms, irrespective of whether the publication is associated with more than one 
organization or not. However, not considering the information on collaboration is not a 
major limitation of my study because the publication is still a strong predictor of the 
knowledge captured by the firm and that the firm has acquired the tacit knowledge of 
individuals engaged in the research (Zucker, Darby and Armstrong, 2002). 
 Fourth, my study exploring the relationship between science and technology can 
be generalized to only those industries where scientific findings are important inputs for 
technological innovation.  
 Despite the above limitations, the study has enhanced the understanding of 
bridging the science and technology domains. In summary, the research has made an 
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important theoretical contribution by showing that the degree to which bridging scientists 
enhance the technological performance of a firm depends on the extent to which the firm 
exploits its scientific findings in technology development. 
 While the first two essays emphasize the importance of intellectual human capital 
and alliances, it is important to analyze the interdependency across these two factors to 
better understand their contribution to technological performance. The next essay 
attempts to investigate this issue. Specifically, the next essay explores if intellectual 
human capital and alliances are substitutes or complements of each other in explaining 




INTELLECTUAL HUMAN CAPITAL AND STRATEGIC ALLIANCES: ARE 
THEY SUBSTITUTES OR COMPLEMENTS 
INTRODUCTION 
 
Organizations are perceived as biological organisms that struggle and compete in a 
hostile environment (Nelson and Winter, 1982). Since the survival of firms in such an 
environment depends on their innovativeness, a number of scholars investigate factors 
related to firms’ capability to generate high-impact technologies. Studies exploring this 
issue can be classified into two levels: firm level and network level.  
 Scholars exploring the firm level determinants of innovation attribute 
technological performance differences across firms to the variance in firms’ resources. 
Resources are defined as those attributes of physical and knowledge-based assets that 
enable firms to conceive and implement strategies that lead to a variance in performance 
(Wernerfelt, 1984). Among the organizational resources, the human element has gained 
greater importance because the knowledge they hold is considered a critical ingredient for 
a competitive advantage (Grant, 1996). It is especially true that an organization’s 
capability to produce valuable technologies is closely tied to its intellectual human capital 
(Subramaniam and Venkataraman, 2001). In this study, intellectual human capital refers 
to “highly skilled and talented employees who hold advanced degrees”. 
 Scholars investigating the network level determinants of innovation attribute 
performance differences across firms to the variance in the extent to which firms leverage 
external resources. Among the various means of leveraging external resources, resources 
leveraged through strategic alliance are known to significantly alter a firm’s competitive 
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position (Kogut, 1988). Specifically, a number of studies have conceived of alliances as 
instruments used by firms to acquire know-how and to learn new skills vital for 
developing technologies (Hamel, 1991; Powell and Smith-Doerr, 1996; Hagedoorn, 
1993).  
 Recently, scholars have begun to explore the interdependency between 
determinants of technological performance that lie across multiple levels (Rothaermel 
and Hess, 2007; Cassiman and Veugelers, 2006). Two different perspectives exist 
regarding the interdependency of the firm level determinant: Intellectual human capital, 
and the network level determinant: Strategic alliances. The first perspective argues that 
intellectual human capital and strategic alliances are complements (i.e. marginal return to 
one factor increases in the presence of another) (Liebeskind, Oliver, Zucker and Brewer, 
1996). On the contrary, the second perspective argues that intellectual human capital and 
alliances are substitutes (i.e. marginal return to one factor decreases in the presence of 
another) (Rothaermel and Hess, 2007). Nevertheless, neither perspective has paid 
attention to the characteristics of these two factors that might alter the nature of their 
interdependency. Considering that scholars have established that the kind of information 
and knowledge flowing through intellectual human capital and alliances differs 
depending on their attributes, this research gap is especially surprising (Owen-Smith and 
Powell, 2004; Corolleur, Carrere and Mangematin, 2004). Since the contribution of 
intellectual human capital and alliances to technological performance depends on the 
nature of the information and knowledge that flows through them, their characteristics are 
vital in studying the interdependency. 
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 The objective of this study is to use the economics and sociology of science 
literature in showing that the nature of interdependency (whether substitutes or 
complements) between intellectual human capital and strategic alliance is contingent on 
their characteristics. I synthesize insights from prior studies and classify intellectual 
human capital into three types. Innovations in high-technology industry are determined 
by the advancement of both scientific and technological knowledge (Nelson, 2003). The 
characteristics of intellectual human capital in such industries differ based on the domain 
in which they carry out research activities (science/technology/both) (Gittelman and 
Kogut, 2003). Hence, I classify intellectual human capital into (a) pure scientists, (b) pure 
inventors or (c) bridging scientists, based on the domain in which they specialize. 
Similarly, I categorize alliance partners into two types. As information flow from 
network partners is known to depend on their institutional regimes (Owen-Smith and 
Powell, 2004), I classify them into (1) firm partners and (2) university partners.  
 I begin with the consideration that intellectual human capital and strategic 
alliances are both substitutive and complementary in nature, depending on their 
respective attributes. For instance, I argue that pure scientists and bridging scientists 
substitute university partners. The institutional underpinning of university partners 
encourages them to be transparent in sharing their knowledge. Through their 
publications, the pure scientists and bridging scientists of a firm are potentially connected 
to a scientific network rich in spillover of knowledge from the academe (Furukawa and 
Goto, 2006). Therefore, I posit that pure scientists and bridging scientists act as boundary 
spanners in facilitating free flow of knowledge from universities, thereby substituting 
them. On the contrary, firm partners are committed to proprietary uses of knowledge and 
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require formal arrangement such as alliances in sharing knowledge. The knowledge 
residing in a firm’s intellectual human capital helps the firm in identifying potential firm 
partners, evaluating their knowledge quality, and in absorbing knowledge from the 
partnership (Murray, 2004). Hence, I propose that intellectual human capital 
complements firm partners. The hypotheses concerning the substitutive and 
complementary nature of determinants of technological performance across different 
levels are tested using patent, publication, and alliance data drawn from biotech firms. 
 This chapter is organized as follows. The next section develops hypotheses 
regarding the interdependency between the firm-level and network-level determinants of 
technological performance. In the subsequent sections I present the research method and 
results. In the last section I discuss the implications of my findings and the limitations of 
the study. 
THEORY AND HYPOTHSES DEVELOPMENT 
Intellectual Human Capital and Technological Performance 
Knowledge is considered as the core of the theory of firms, and much of the 
organization’s knowledge resides in its human capital. Consequently, human capital is 
considered to be one of a firm's most important resources (Pfeffer, 1994). Although 
human capital is considered a valuable resource, firms in high-technology industries 
consider highly-skilled and talented employees to be critical determinants of 
technological performance (Subramaniam and Venkataraman, 2001). Several studies 
have provided evidence that intellectual human capital is a key input for technological 
performance (Zucker, Darby and Brewer, 1998; Zucker and Darby, 2001).  
 Intellectual human capital has a positive influence on the technological 
performance through the following means. First, intellectual human capital renders a 
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positive impact on the technological performance by actively engaging in technology 
development. The rigorous training acquired by intellectual human capital during the 
course of education and tacit knowledge resulting from their research activities help firms 
to embark on important application areas, consequently having a positive influence on the 
technological performance.  
 Second, external resource is an indispensable element of a firm’s technology 
development process. By actively engaging themselves in external professional 
communities, intellectual human capital acts as a channel for continuous flow of external 
knowledge, thereby having a positive influence on the technological performance 
(Corolleur, Carrere and Mangematin, 2004).  
 Third, intellectual human capital positively influences the technological 
performance by enhancing the absorptive capacity of firms (Cohen and Levinthal, 1990). 
By participating in external communities, intellectual human capital facilitates acquiring 
and assimilating external knowledge and information, thereby improving the potential 
absorptive capacity of firms. The tacit knowledge and experience of intellectual human 
capital helps in combining existing knowledge with newly acquired knowledge and in 
exploiting the knowledge for competitive advantage, thereby enhancing the realized 
absorptive capacity of firms. The above arguments suggest that firms endowed with 
intellectual human capital have a greater capability for engaging in knowledge intensive 
activities, and this is helpful in generating valuable technologies.  
 Numerous studies have pointed out that not all intellectual human capital is 
equally competent, creating the notion that there exists heterogeneity even within 
specialized human capital (Rothaermel and Hess, 2007). Traditionally, studies on 
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professional careers concentrated on two tracks. The first track focused on academic 
researchers and their scientific activities (Keith and Babchuk, 1998), and the second on 
industrial engineers and their technological activities (Allen and Katz, 1992). But with 
the birth of science intensive industries such as biotechnology and the introduction of the 
Bayh-Dole act, we observe increasing number of scientists from academe actively 
contributing to technological activities in the industry. Firms are also known to attract 
scientists into their organization and encourage them to publish their findings (Stern, 
2004). Consequently, we notice three different types of intellectual human capital within 
an organization depending on their domain of specialization: (1) pure scientists, (2) pure 
inventors and (3) bridging scientists. The first type called 'pure scientists' are exclusively 
involved in scientific research. The second type called 'pure inventors' predominantly 
focus on technological activities. The third type of intellectual human capital is called 
'bridging scientists', and they are involved in both scientific and technological activities.  
 All the three types of intellectual human capital are known to fetch the above-
mentioned benefits of engaging in R&D activities and acting as gatekeepers of 
knowledge. Pure scientists contribute to technological performance by engaging in basic 
research and helping the inflow of scientific knowledge from external environments. On 
the other hand, pure inventors contribute to technological performance by getting 
involved in applied research and the inflow of technological knowledge from external 
environments. Bridging scientists contribute in both these ways as well as helping to 
bridge pure scientists and pure inventors, thereby enhancing technological performance. 
Based on the above arguments, I hypothesize: 
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Hypothesis 1a: The proportion of pure scientists within a firm is positively related to the 
firm’s technological performance. 
Hypothesis 1b: The proportion of bridging scientists within a firm is positively related to 
the firm’s technological performance. 
Hypothesis 1c: The proportion of pure inventors within a firm is positively related to the 
firm’s technological performance. 
Alliance Portfolio Attributes and Technological Performance 
Strategic alliances are voluntary arrangements between firms to exchange and share 
knowledge and resources with the intent of developing processes, products, or services 
(Gulati, 1998). A number of studies have shown that alliances influence the technological 
performance of firms. In particular, strategic alliances are shown to be beneficial for 
patent and new product development rates (Deeds and Hill, 1996; Shan, Walker and 
Kogut, 1994). There are various means through which firms benefit from alliances in 
developing better technologies. For instance, alliance is considered to be an important 
means for sourcing external knowledge and leveraging external resources that are crucial 
for better technological performance (Dyer and Singh, 1998). Firms especially rely on 
alliance partners in gaining technical, social and commercial capital that are valuable to 
their innovation performance (Ahuja, 2000). Alliances also influence the technological 
performance of firms by giving access to complementary assets (Pisano, 1990). Other 
benefits of alliances for better technological performance include: (1) imparting social 
status and recognition (Stuart, 2000), (2) defraying cost and sharing risk (Hagedoorn, 
1993), etc. These benefits have an effect on the technological performance of firms in the 
following ways. Social status and recognition might enhance the opportunities available 
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to a firm to engage in a greater number of R&D alliances, thereby having a spiraling 
effect on the technological performance. The advantage of sharing risk and investment 
with its partners can encourage a firm to embark on pioneering research avenues that are 
capable of rendering breakthrough innovations. The above arguments suggest that a 
firm’s alliance network is positively associated with its technological performance. 
 Though alliances are generally known to be beneficial, the advantages which a 
focal firm derives from its alliance partners have been shown to depend on the attributes 
of the partners (Stuart, 2000). With respect to biotechnology, it is shown that the strength 
and robustness of the industry depend on contributions from both public and private 
research entities (Owen-Smith, Riccaboni, Pammoli, and Powell, 2002). Prior studies 
have also shown that profit and non-profit organizations differ in their flow of 
information (Owen-Smith and Powell, 2004). Hence, I classify alliances partners into two 
types: (1) university alliances and (2) firm alliances, depending on their institutional 
demography. The classification of alliance into the above two types depending on their 
institutional regime is also consistent with the different types of external professional 
communities to which the three types of intellectual human capital are connected. 
Scientists are connected to scientific communities that comprise of other scientists from 
universities, while inventors are connected to technological communities that comprise of 
inventors from other firms.  
 Both university and firm partners are recognized to bring the above benefits to 
technological performance. University partners are capable of bringing in knowledge and 
social capital as outlined in the previous section. Apart from knowledge and social 
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capital, firm partners can also bring in commercial capital, thereby contributing to the 
focal firm’s technological performance. Based on the above arguments, I hypothesize: 
Hypothesis 2a: The number of university alliances of a firm is positively related to its 
technological performance.  
Hypothesis 2b: The number of firm alliances of a firm is positively related to its 
technological performance.  
Intellectual Human Capital and Alliances: Complements or Substitutes? 
Two different perspectives exist regarding the interdependency of intellectual human 
capital and strategic alliances. According to the first perspective, intellectual human 
capital complements strategic alliance. Two activities are said to be complements of each 
other if the marginal effect of an activity increases in the presence of the other activity. 
Intellectual human capital and strategic alliances are proposed to be complements due to 
the following reasons. The presence of intellectual human capital is known to help 
organizations in identifying and incorporating pertinent research from external networks 
(Liebeskind et al., 1996). Intellectual human capital can act as a gatekeeper, thereby 
facilitating knowledge flow from alliance partners (Tushman and Katz, 1980). The 
knowledge residing in intellectual human capital also helps in absorbing knowledge from 
alliance partners (Cohen and Levinthal, 1990).  
 On the contrary, the second perspective argues that intellectual human capital and 
strategic alliance are substitutes of each other. Two activities are said to be substitutes if 
the marginal benefit of each activity decreases in the presence of the other. According to 
this perspective, different technology strategies of a firm compete for a finite resource. 
Hence, a firm’s attempt to simultaneously venture in pursuit of innovation across 
multiple levels (firm and network) would result in decreased innovation output at the 
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margin. It is also recognized that firms use one innovation mechanism repeatedly, learn 
by experience, and build competency in that specific mechanism, rather than switching 
across different innovation mechanisms (Levitt and March, 1988). For example, the 
pharmaceutical firm Merck is known to develop its research capability by developing its 
intellectual human capital, whereas Eli Lily is known to engage in alliances for 
innovation (Rothaermel and Hess, 2007).  
 While both perspectives offer important insights about the interdependency of 
intellectual human capital and alliances, neither approach has paid attention to the 
characteristics of intellectual human capital and attributes of alliances that are vital to 
understanding their interrelationship. For instance, the interdependency of intellectual 
human capital and alliances can be both complementary and substitutive, depending on 
the characteristics of intellectual human capital and attributes of alliances that are under 
consideration. The following section elaborates on how such contingent factors might 
alter the nature of interdependency. As outlined in previous sections, my study 
concentrates on three different types of intellectual human capital: (1) pure scientists, (2) 
bridging scientists and (3) pure inventors, and two attributes of alliance: (1) university 
alliances and (2) firm alliances. 
 The institutional differences between university and firm stem from: (1) the kind 
of research being conducted and (2) the nature of information flow and knowledge 
diffusion. Universities engage in early stages of research activities that are scientifically 
advanced and valuable for technology development. Scientific research has received a 
substantial amount of attention for its norm of openness (David, 1998; Gittelman and 
Kogut, 2003; Merton, 1973). Consequently, public research organizations such as 
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universities differ from research intensive firms in diffusing their knowledge. New 
knowledge is known to flow out of universities more readily than it does from 
commercial entities such as firms (Jaffe, Trajtenberg and Henderson, 1993). Universities 
are also open to sharing knowledge through informal networks (Dasgupta and David, 
1994).  
 With universities following the open norm of knowledge disclosure, I believe 
corporate scientists to fetch the information and knowledge benefits that university 
alliance partners can bring forth. Though the primary task of corporate scientists is to 
conduct R&D to invent new technologies, many of these scientists also publish papers in 
order to be connected with the academic community. By building a relationship of give-
and-take with the scientific community, corporate scientists also establish trust with 
university scientists (Furukawa and Goto, 2006). This provides opportunities for them to 
have significant technological discussions and exchanges of ideas with university 
scientists in academic meetings. As a result of plugging themselves with the scientific 
community, corporate scientists help in the inflow of knowledge from universities that 
adhere to the norm of open information disclosure. Corporate scientists also help firms 
absorb knowledge from articles published by university scholars in the open domain. The 
above arguments suggest that, through their informal networks, scientists working for 
firms can assist in the free flow of information and knowledge from the academic 
community without necessarily having partnership with them. This can also be 
appreciated from the fact that the leading biotech firm Genetech, founded by a group of 
scientists, engaged in only 2 university alliances between the years 1980-200711. Hence, I 
suppose pure scientists and bridging scientists within firms to act as substitutes for 
                                                 
11 Source: Recap database 
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university alliances. However, the likelihood of pure inventors being associated with the 
academic community is much less because they are not involved in scientific research 
and in publishing. Therefore, I do not expect pure inventors to substitute university 
alliances. The above arguments suggest that bridging scientists and pure scientists 
substitute university alliances. 
 In a similar vein, we also observe that, in the biotechnology industry, firms 
lacking internal scientific expertise offset this disadvantage by forming partnerships with 
universities (George, Zahra, Wheatley and Khan, 2001). This suggests that university 
alliances can substitute scientific capital of a firm, leading to my third hypotheses: 
Hypothesis 3a: Pure scientists and university alliances substitute one another in 
explaining a firm’s technological performance. 
Hypothesis 3b: Bridging scientists and university alliances substitute one another in 
explaining a firm’s technological performance. 
 
 Unlike universities, firms are committed to proprietary uses of knowledge and 
require formal ties in transferring knowledge. Though corporate scientists and inventors 
are connected to professional communities that involve other firms, such linkages 
represent closed conduits (Owen-Smith and Powell, 2004). The possibility of knowledge 
spillover from other firms through informal relationship is negligible and requires 
contractual arrangements, such as alliances, in transferring knowledge. Hence, I believe 
that intellectual human capital within a firm cannot substitute firm partners. Nevertheless, 
I suppose the informal connections of intellectual human capital to transmit information 
about potential alliance partners and opportunities for technical collaboration (Rosenkopf, 
Metiu and George, 2001). Pure inventors, who are connected to professional technical 
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communities, especially help a firm in identifying potential firm partners. Intellectual 
human capital can also help in evaluating the knowledge of potential firm partners. 
Particularly, scientific knowledge that is used in assessing technological activities enables 
pure scientists and bridging scientists to evaluate the knowledge of potential firm partners 
(Brook, 1994). The presence of intellectual human capital also assists in absorbing, 
assimilating, and exploiting knowledge from alliance partners (Murray, 2004).  
 While the above arguments suggest that intellectual human capital enhances the 
contribution of firm alliances to technological performance, it is equally true that alliance 
partners enhance the contribution of intellectual human capital to technological 
performance by helping them learn new skills (Hitt, Bierman, Shimizu and Kochhar, 
2006). This leads to the fourth hypotheses: 
Hypothesis 4a: Pure scientists and firm alliances complement one another in explaining 
a firm’s technological performance. 
Hypothesis 4b: Bridging scientists and firm alliances complement one another in 
explaining a firm’s technological performance. 
Hypothesis 4c: Pure inventors and firm alliances complement one another in explaining 
a firm’s technological performance. 
 
 Table 4.1 provides the summary of hypothesized interaction effects.  
Table 4.1. Summary of Interaction Hypotheses 
 
Variables Firm Alliances University Alliances 
Pure Scientists            +                 - 
Bridging Scientists            +                     - 





To test the hypotheses, I collected data from the biotechnology industry. Biotechnology is 
recognized to be one of the most innovation-intensive industries (Sorenson and Stuart, 
2000). The biotechnology industry was an ideal context in testing the framework, because 
the industry is characterized by technological transformation, a growing number of inter-
organizational relationships, and the widely recognized importance of intellectual human 
capital.  
 The data is drawn from Plunkett's12 directory that is comprised of 437 public-
listed biotechnology firms. Biotechnology directories are one of the sources that prior 
research works have consulted in drawing their sample (Gulati and Singh, 1998; Stuart, 
Hoang, and Hybels, 1999). Generally, firms in the directory are based in the United 
States of America. However, the headquarters of 70 firms are located in other nations 
such as Canada, Japan, UK, India, Switzerland, etc. The directory has 3 firms from 
agriculture, 13 from infotech, 100 from chemical manufacturing and 321 from the health 
care areas of biotechnology. The directory comprises of firms such as EISAI Co. Ltd., 
DOW Agrosciences, BASF AG and TRIPOS Inc. that have attained the highest sales 
revenue in the year 2000 for the health care, agriculture, chemical manufacturing and 
infotech areas respectively. The directory includes very small firms (with respect to 
R&D, number of employees and sales) such as VIRAGEN and SPECTRAL 
DIAGNOSTICS, as well as large firms such as BAYER and NOVARTIS. With respect 
to age, there are old firms such as PFIZER, as well as new firms formed in late 90’s such 
as ATHEROGENICS and ARENA PHARMACEUTICAL. 
                                                 
12 Plunkett's Biotech and Genetics Industry Almanac 2005: the only comprehensive guide to biotechnology 
and genetic companies and trends/editor and publisher: Jack W. Plunkett. 
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 I used the publication, patenting, and alliances of these firms in testing the 
hypotheses. The patents issued to these firms between 1990-2000 were obtained from the 
NUS patent database13. The database comprises of patents issued to firms by the United 
States Patent and Trademark Office (USPTO). Publication information of firms between 
1980-2000 was obtained from Web of Science, ISI Science Citation Index (SCI). The SCI 
is an excellent source because it covers a broad range of basic and applied scientific 
journals (Lim, 2004). As the birth of the biotechnology industry is dated back to the late 
70’s and my patent data was restricted to 2000, I focused on publication during the period 
1980-2000.The Recombinant Capital (Recap) database that provides a comprehensive list 
of biotechnology companies worldwide along with their alliances, valuations and clinical 
trials information was used to cross-validate the list of biotechnology firms chosen from 
the directory and to obtain alliance-related information between 1990-2000. Compustat 
Global was used in collecting the financial data of these firms. 
 The US patent classification system comprises of over 100,000 patent subclasses 
aggregated to about 400 three-digit patent classes. I used the three-digit patent classes and 
only included those patents that fall within the U.S. patent classes listed in Table 4.2, 
which belong to the biotechnology industry. The classes were chosen with reference from 
the USPTO Technology Profile Reports and from prior research (Lim, 2004). Filtering 
those firms that did not have patent data in the specified classes between 1990-2000, the 
final sample size was 222 firms. The list of 222 firms is provided in Table A.2 of the 
Appendix. Of the listed firms, 215 (437-222) firms were dropped from the directory 
because they had zero patents. To ensure that the results were still generalizable, I carried 
out a preliminary assessment of firm level variables. As shown in Table A.3, the average 
                                                 
13 http://patents.nus.edu.sg/ 
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of firm R&D and firm size for 437 firms was not significantly different from the average 
of these variables in my final sample. However, I found that the average age of my final 
sample firms was higher than that of average age for 437 firms. This is possibly because 
younger firms in the directory might not have patents issued between 1990-2000. 
Nevertheless, I do believe that the results of my study hold true even for younger firms, 
because my sample does indeed include younger firms such as Atherogenics and Arena. 
 The total number of patents and publications under consideration was 10,646 and 
100,375. There is huge heterogeneity with respect to patent and publication data. Firms 
like Anika Therapeutics and Viragen received one patent each, while Abbott and Bayer 
had about 1000 patents. Patents issued to firms increased from 424 in 1990 to 1722 in 
2000. There were 19 firms in my sample with 0 publications, but also about 10 firms with 
at least a few thousand publications. The publications made by firms increased from 1826 
in 1980 to 8181 in 2000. The number of publications, patents and alliances of my sample 
firms between 1990-2000 is provided in Table A.4 of the Appendix. 
Table 4.2. U.S. Patent Classes 
 
Class Description 
424 Drug, bio-affecting and body treating compositions 
435 Chemistry: molecular biology and microbiology 
436 Chemistry: analytical and immunological testing 
514 Drug, bio-affecting and body treating compositions 
530 Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction 
products thereof 
536 Organic compounds 
800 Multicellular living organisms and unmodified parts thereof and related processes 
 
Measures 
Technological Performance (Forward Citation): The dependent variable is the 
cumulative forward citation frequencies accrued to an individual patent. I count all 
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forward citations received by each patent at the end of 2004. By law, each patent must 
cite prior patents that relate to its technology. Research demonstrates that the number of 
forward citations received by a patent correlates highly with its technological importance 
(Trajtenberg, 1990; Albert, Avery, Narin and McAllister, 1991). Prior studies have 
observed that the self-citation of a firm to its patents represents the extent to which the 
firm appropriates the returns from the patents. As a consequence, they find self-citation to 
reduce the probability of other firms citing the patent (Zhuang, Wong and Lim, 2006). 
However, in my sample I found the self-citations to be positively related to the overall 
forward citations, which indicates that overall citations represent the value of knowledge 
underlying the technology. Hence, instead of removing self-citations, I restricted my 
attention to overall citations accrued by a patent. 
 One way to measure technological performance would be to use the number of 
products introduced by a firm. However, I restricted my focus to a patent-based 
performance measure because of the following three reasons. First, obtaining data on the 
number of products introduced by my sample firms was difficult.  
 Second, the number of products introduced by a firm not only depends on the 
technological competency of the firm but also other factors such as U.S. Food and Drug 
Administration (FDA) authorization etc. In order to prevent the results from being 
confounded by factors that are not of interest to my research, I relied on patent-based 
performance measure.  
 Third, the biotechnology industry is characterized by open innovation in which 
the activities pertaining to the higher end of the value chain are performed by the firms 
competent in it, while FDA approval and commercialization are taken care of by other 
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firms. Hence, a firm introducing a product into the market may not necessarily be the one 
responsible for its basic technological development. As the focus of my study is to relate 
technological competency of a firm with its performance, I believe that a patent would be 
a more appropriate measure of a firm’s capability to generate valuable technologies.  
 Since patent to product conversion process in the biotechnology industry is time 
consuming, many of the results that hold true for a patent-based technological 
performance measure might not hold for a product-based measure. Hence, an interesting 
future research can be to test my research model with both patent-based and product- 
based performance measures and compare their results.  
 
Independent Variables 
Intellectual Human Capital (Pure scientists, Bridging Scientists and Pure Inventors): 
The greater the presence of the three types of intellectual human capital, the higher the 
availability of knowledge, experience, and skill for new knowledge search. Traditionally, 
studies capture the quality of human capital by measuring their qualifications, affiliations, 
etc. (Hitt, Bierman, Uhlenbruck, and Shimizu, 2001; Hitt et al., 2006). My study 
implicitly captures this by looking only at intellectual human capital that possesses high 
qualifications in order to engage in R&D activities.  
 I operationalize the three variables in the following manner. The pure scientist 
measure represents the percentage of scientists within firms whose names are exclusively 
listed in publications and not in patents. Then, the bridging scientist measure represents 
the percentage of patent inventors within a firm whose names are listed in both patents 
and scientific papers published by the firm. Finally, the pure inventor measure represents 
the proportion of inventors exclusively involved in patenting but not publishing. In order 
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to obtain these measures, I identified two overlapping sets of individuals for each firm. 
The first comprises of scientists whose names are listed on at least one publication made 
by the focal firm, and the second comprises of inventors whose names are listed on at 
least one patent issued to the focal firm. Based on these two lists, I found the percentage 
of individuals listed as inventors who are also listed as scientists for each firm. This 
percentage of scientists is termed as bridging scientists. The measure is borrowed from 
the work of Gittelman and Kogut (2003). Then, I identified the percentage of those 
scientists whose name appeared only in the publications and not in the patents. These 
scientists who are exclusively involved in scientific publishing are termed as pure 
scientists. Then, for each patent, I identified the number of inventors whose names do not 
appear on the list of scientists. These inventors exclusively involved in patenting are 
termed as pure inventors. On average, my sample firms had about 900 pure scientists, 34 
bridging scientists and 47 pure inventors. Firms such as Bayer and Merck had the highest 
number of pure scientists, bridging scientists and pure inventors. This shows that the 
measures are not a complement of each other, with the pure inventors measure being 
calculated at the patent level while scientist measures are at the firm level. 
  Apart from qualifications, there are other aspects of quality of intellectual human 
capital as measured by the extent to which they are active in producing high-quality 
work. This aspect of quality, as measured by the volume and citations of firms’ 
publications stocks of patents, are captured and controlled in this study. This helps to 
explore if firms endowed with greater proportion of each of the intellectual human capital 
dimensions (after controlling for quality) are better in their new knowledge search. 
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Alliances (University alliances, Firm alliances): This measure represents the number of 
partnerships that a firm engages in a year. I tracked each firm’s alliances with academic 
institutions and for-profit organizations, and had the count of academic alliance partners 
and firm alliance partners separately. I used the Recap database in obtaining this measure. 
The Recap database comprises of a list of alliances made by firms in a particular year 
along with other information such as the type of alliance (R&D, acquisition, 
manufacturing, joint venture, licensing, etc.), type of alliance partners (university/firm), 
and technology concentration of alliance. There are 26 types of alliances and 53 types of 
technology classifications available in the Recap database. The list of alliance types and 
technology classification is provided in Table A.5 and A.6 of the Appendix. Since the 
study is pertaining to the R&D activities of value chain, I concentrated on alliance 
pertaining to Research and Development. However, I concentrated on all types of 
technology classifications. The information pertaining to the type of alliance partner is 
used in counting the number of university and firm alliances separately. On average, my 
sample firms engaged in 40 alliances during the period of observation, of which 7 were 




Publication Volume: This measure is a count of the number of publications produced by 
the focal firm in the year of observation in which a patent was filed by the focal firm. I 
used the number of publications made by a firm as a proxy for its scientific capability. A 
number of scholars have used publication count to measure the scientific capability of 
firms (Lim, 2004; Gittelman and Kogut, 2003; Arora and Gambardella, 1994). A firm 
with a strong scientific capability is capable of identifying new applications in the 
technology domain that might give rise to more valuable patents. Prior researchers have 
also shown the significant relationship between publication count and patent 
performance. It is therefore imperative that I control for it.  
Non-patent Reference: Non-patent reference is the count of the number of times a patent 
issued to a firm references non-patented literature. Every patent is required to cite the 
prior art that it builds upon. This includes both the patent and non-patent references. It 
has been observed by Fleming and Sorenson (2004) that 69% of the non-patent 
references are from peer-reviewed scientific journals. Non-patent references cited by a 
patent are often used as an indicator of the science intensity of the invention that is found 
to be influencing the forward citation of patents (Gittelman and Kogut, 2003; Noyons, 
van Raan, Grupp and Schmoch, 1994). Hence, I controlled for it. The average number of 
non-patent references cited by the patents under study is about 18. 
Firm’s Average Cites to Publications: I use the citations received by the focal firm’s 
publications to represent the relative quality of the firm’s stock of scientific knowledge. 
To compute this measure I first identified all the publications produced by the focal firm 
between the years 1980-2000, and then obtained the number of citations received by 
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these publications. Based on the citations, I calculated the mean and standard deviation of 
the citations received by all articles of the sample firms in a publication year. Next, the 
raw citation counts for each publication of firms are normalized by the mean and standard 
deviation of the citations received by all articles in its publication year. Normalizing the 
raw citations by year allows the citations to be summed across years for each firm 
(Gittelman and Kogut, 2003). I then aggregated the normalized citation count of 
publications in a year and divided it by the total number of publications made by the firm. 
The normalized citation count is then aggregated up to the year the observed patent was 
filed in order to obtain a cumulated amount of publication quality. Because a firm’s 
competency in generating high-quality scientific papers has been observed to impact its 
capability to produce high-impact innovation, I controlled for it (Gittelman and Kogut, 
2003).  
Firm’s technological strength: Since a technologically strong firm is likely to receive 
more citations, there is a need to control for it. I used the number of patents granted to a 
firm to measure the technological strength of the firm. I take into account the year of the 
focal patent in calculating the number of patents granted to a firm. For example, if the 
patent under observation is a patent filed by a firm in year t, I count the number of patents 
issued to the firm in the year t, to account for its technological strength.  
Other Control Variables (Technology class dummy variable, Patent age, Year fixed 
effects, R&D expenditure, Firm size, and Firm age): Forward citations may accrue to 
patents for other reasons such as technology field characteristics, patent characteristics 
and firm characteristics. Therefore, I included the patent-level and firm-level control 
variables to account for heterogeneity among the firms and for age and field effects. 
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Patents belonging to certain technology classes may inherently be more cited than others. 
Similarly, patents with more years having elapsed since the patent was filed are capable 
of attaining higher citations. I used technology class dummy variables and patent age as 
patent-level control variables to control for these effects. I also used year fixed effects to 
capture the differences in citation probability across different years.  
 At the firm level, larger firms due to economies of scale and scope, younger firms 
because they represent the knowledge of younger vintage and firms that devote more 
resources for R&D are capable of being highly innovative. Hence, I included firm-level 
control variables such as R&D expenditure, size of the firm as measured by the number 
of employees and age of the firm as measured by the number of years since the firm was 
founded. I included the logarithmic value of the above variables as the control variables.  
  The summary of the dependent, independent, and control variables is presented in 
Table A.1 of the Appendix. The summary data for the dependent and independent 
variables and the correlation between the variables at the patent level are reported in 
Table 4.3. As the numbers show, the patents and publications exhibit a lot of variance. 
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Table 4.3. Descriptive Statistics and Correlations 
 
S.No Variables Mean Std. 
Dev 
Min Max 1 2 3 4 5 6 7 8 9 10 11 12 13 
1 Forward Citation 6.34 11.87 0 233 1             
2 Pure Scientists 0.77 0.32 0 0.99 0.02 1            
3 Bridging Scientists 0.25 0.15 0 0.83 -0.02 -0.69* 1           
4 Pure Inventors 0.65 1.11 0 17 -0.01 -0.34* 0.45* 1          
5 No. of University 
Alliances 
1.61 2.25 0 18 0.26* 0.02 0.09* 0.03* 1         
6 No. of Firm 
Alliances 
10.00 10.99 0 93 0.12* -0.05* 0.06* 0.05* 0.04* 1        
7 Publication Volume 136.39 222.74 0 1272 -0.06* 0.31* -0.18* -0.10* -0.01 0.08* 1       
8 Publication Citation 0.04 0.91 -6.73 9.65 -0.04* -0.28* 0.25* 0.08* 0.08* 0.03* -0.08* 1      
9 Patent Age 10.12 2.80 7 17 0.28* -0.09* 0.10* -0.02 0.08* -0.02 0.11* -0.01 1     
10 R&D 3.04 2.15 -0.55 12 0.17* 0.34* -0.37* -0.21* -0.02 -0.17* -0.30* 0.09* 0.06* 1    
11 Firm Size 6.82 2.32 0 11.69 -0.10* -0.63* 0.55* 0.30* 0.03* 0.11* 0.00 -0.04* 0.01 -0.69* 1   
12 Firm Age 3.37 1.21 0 5.01 -0.18* -0.47* 0.61* 0.28* 0.18* 0.17* 0.14* 0.29* 0.07* -0.57* 0.53* 1  
13 Tech. Strength 53.22 56.29 1 240 -0.16* -0.37* 0.32* 0.17* -0.02 0.14* 0.18* -0.12* -0.09* -0.65* 0.62* 0.46* 1 
14 Non Patent 
Reference 




Since the dependent variable is forward citation count, a count model was more 
appropriate for this research. The Poisson model is a frequently used count model. As 
patent citations exhibited over-dispersion, I used a negative binomial model that is best 
suited for estimating an over-dispersed parameter (Cameron and Trivedi, 1998). The 
results of negative binomial regression are presented in Table 4.4. All specifications 
include fixed effects for both technology class and application year of the patents. I used 
robust standard errors adjusted for clustering of firm to control for random firm effects.   
Effect of control variables 
 Model 1 of Table 4.4 presents the regression coefficients for the control variables. 
The publication volume has a significant negative effect (p<0.01) on the forward citation 
of patents. On the contrary, the non-patent reference has a significant positive influence 
on forward citations (p<0.01). The result pertaining to the negative role of publications 
on patent citation rate is contrary to the findings of Cockburn and Henderson (1998), 
Gambardella (1995) and Gittelman and Kogut (2003). These scholars observed 
publication volume to have either an insignificant or positive influence on patent 
citations. One possible explanation of my result is that when firms concentrate more on 
producing scientific publications their attention towards developing important 
technologies might deteriorate and result in fewer forward citations for their patents. This 
explanation is also consistent with the result pertaining to the publication citation. The 
quality of firms’ publications, as reflected by the average cites to publications, has a 
negative relationship with the forward citation of patents (p<0.10). This shows that when 
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firms engage in generating cutting-edge scientific research, their technological 
performance suffers.  
 As expected, firm age has a negative impact on the forward citation of patents 
(p<0.01). Firm size and R&D expenditure do not have a significant relationship with the 
forward citation of patents. A plausible explanation for R&D and firm size being 
insignificant is that increased R&D spending and economies of scale need not necessarily 
increase the quality of innovation, as measured by the forward citations. The 
technological strength of a firm, as measured by the number of patents generated, is 
negatively associated with the forward citation of patents (p<0.01). This shows that 
quality of patents is inversely proportional to the quantity generated. A plausible 
explanation is that for a given amount of R&D investment and firm size, firms producing 
more number of patents receive fewer citations for their patents. The significant (p<0.01) 
positive effect of patent age shows that older patents receive more citations. 
Main effect of intellectual human capital and alliances 
 The regression coefficients in testing the main effects of intellectual human 
capital and alliances are provided in Table 4.4. Models 2, 3 and 4 present the main effects 
of the three intellectual human capital variables. Both bridging scientists and pure 
inventors have a significant positive effect (p<0.05, p<0.01) on the forward citation of 
patents, supporting H1b and H1c. On the contrary, pure scientists have a significant 
negative effect on the forward citation of patents (p<0.01), thereby rejecting H1a. Models 
5 and 6 present the main effect of alliances. As hypothesized in H2a and H2b, both 
university and firm alliances have a significant positive effect on the forward citation of 
patents (p<0.01, p<0.01). 
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 Interaction effects: Complements and Substitutes 
 The interaction terms of the three intellectual human capital factors with 
university alliances are presented in Model 7. Model 8 presents the regression 
coefficients when all the interaction terms are included in the specifications. The results 
show that pure scientists and bridging scientists substitute university alliances. Hence, 
H3a and H3b are supported. 3D graphs illustrating this substitution effect are presented in 
Figure 4.1 and Figure 4.2. In Figure 4.1 the coordinate (L, L) represents low in pure 
scientists and low in university alliances, while (L, H) represents low in pure scientists 
and high in university alliances. Similarly, the coordinate (H, L) represents high in pure 
scientists and low in university alliances, while (H, H) represents high in pure scientists 
and high in university alliances. The negative slope from (L, L) to (H, L) and (L, H) to 
(H, H) clearly shows that pure scientists and university alliances are substitutes of each 
other. Figure 4.2 should be interpreted in the same way as Figure 4.1 in explaining the 
substitution effect between bridging scientists and university alliances. Though I did not 
hypothesize the interaction between pure inventors and university alliances, I included 
their interaction term to explore the relationship. The interaction term is insignificant, 
which neither supports the complementary or substitutive argument. A plausible 
explanation is that pure inventors are not connected to scientific networks to substitute 
for university alliances, nor are they are competent in the scientific domain to 
complement university partners.  
 With regard to firm alliances, the results show that all three intellectual human 
capital variables complement firm alliances. Thus, the results support H4a, H4b, and 
H4c. Figures 4.3, 4.4 and 4.5 that are 3D plots of complementarity can be interpreted in 
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the same way as that of Figure 4.1. The positive slopes in these figures illustrate the 
complementarity between pure scientists, bridging scientists, pure inventors and firm 
alliances.    
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Table 4.4. Negative Binomial Regression in Testing the Impact of Intellectual Human Capital, 
Alliances and Control Variables on the Forward Citation 




































































































       0.0031*** 
[0.0011] 









































































































Patent-Level Control Variables 


































Log Likelihood -20523.86 -20498.67 -20482.71 -20475.20 -20035.10 -19864.56 -19769.96 -19762.32 
No. of 
Observations 
7648 7648 7648 7648 7648 7648 7648 7648 
*p<0.1, **p<0.05, ***p<0.01. Standard error is provided in the parentheses. 
Technology class dummy variables and year fixed effect were included but not reported. 
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Figure 4.1. Interaction between Pure Scientists and University Alliances 
 
 















Figure 4.2. Interaction between Bridging Scientists and University Alliances 
 
 









Figure 4.3. Interaction between Pure Scientists and Firm Alliances 
 
 






Figure 4.4. Interaction between Bridging Scientists and Firm Alliances 
 
 







Figure 4.5. Interaction between Pure Inventors and Firm Alliances 
 
 







DISCUSSION AND CONCLUSION 
Following recent theoretical developments emphasizing that antecedent to technological 
performance can be found in factors at firm and network level (Eisenhardt and Martin, 
2000), this research extends the current understanding of interdependence between 
factors across these different levels. Intellectual human capital endowed with a firm is the 
firm level factor under study. Resources leveraged from external relationships such as 
alliances represent the network level factor under consideration. First, I examined the 
independent influence of these factors on the technological performance of firms. 
Second, I investigated if the factors across these two levels are complements or 
substitutes of each other. 
 The first hypothesis tested in this study confirms the importance of intellectual 
human capital for better technological performance. Human capital has been 
conceptualized in different ways, and recent studies on high-tech industries recognize the 
importance of intellectual human capital such as scientists (Zucker and Darby, 2001; 
Zucker, Darby and Brewer, 1998). In order to extend the current understanding of 
intellectual human capital’s contribution to technological performance, this research 
classifies them into three categories viz. pure scientists, bridging scientists and pure 
inventors. The results demonstrate that both pure inventors and bridging scientists have a 
positive impact on the technological performance of firms. On the contrary, pure 
scientists have a negative impact on technological performance. The positive effect of 
pure inventors is trivial because they are solely dedicated to applied research and to 
developing important innovations. However, it is interesting to note the contingent value 
of scientists, whose involvement in scientific research detracts them from technology 
development. Scientists have a positive influence on technological performance only if 
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they are bridging scientists, viz. they are capable of engaging themselves in scientific 
research as well as in technology development. Thus, I follow Gittelman and Kogut’s 
(2003) assertion that scientists who can play a dual role and successfully bridge the 
science and technology domains have a positive influence on technological performance. 
 The second hypothesis tests the importance of alliances for technological 
performance. I categorize alliances into university alliances and firm alliances, depending 
on the institutional characteristics of the partners. The results show that both university 
and firm alliances are helpful for technological performance, but with varied effect sizes. 
The contribution of university alliances to technological performance was considerably 
higher than that of firm alliances. This underlines the importance of firms to have 
partnerships with public research organizations in order to enhance their innovation 
performance (Powell et al., 1996).   
 The third and fourth hypotheses of this study examine the interdependency of 
intellectual human capital and alliance in enhancing a firm's technological performance. 
While prior studies have shown that intellectual human capital and alliances are either 
substitutes or complements of each other, my study supports both. Further, I show that 
the nature of interdependency is contingent on the characteristics of intellectual human 
capital and attributes of alliance partners. My results show that pure scientists and 
bridging scientists substitute university alliances, whereas pure scientists, bridging 
scientists and pure inventors complement firm alliances. Public research organizations, 
such as universities, tend to shy away from proprietary limitations on the use of their 
knowledge. Hence, pure scientists and bridging scientists, who are connected to the 
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academic community through their publications, facilitate free inflow of knowledge from 
the academic arena, thereby making partnerships with universities redundant.  
 However, firms are reluctant to share their knowledge through informal channels 
and require formal arrangements such as alliances in benefiting from them. Firms also 
exercise stringent legal mechanisms to limit spillover of knowledge to alliance partners. 
With regard to such close conduits of linkages, the presence of intellectual human capital 
facilitates the transfer and exploitation of knowledge from partners. Hence, intellectual 
human capital is observed to complement firm alliances. My results show that all three 
types of intellectual human capital complement firm alliances. The technology 
development experience of bridging scientists and pure inventors enhances the relative 
absorptive capacity of firms, thereby facilitating the transfer and exploitation of 
knowledge from firm alliance partners. Hence, their role in complementing firm alliances 
is stronger than that of pure scientists. Taken together, the results show that the role 
played by different intellectual human capital in complementing or substituting the 
alliance network differs depending on their expertise. In either case, bridging scientists 
turn out to be an important type of intellectual human capital, and contribute to 
technological performance in several ways.  
 While prior studies have widely explored various determinants of technological 
performance and investigated their interdependency, my findings demonstrate the 
importance of considering the features of the determinants. I show that the extent to 
which a focal firm benefits from collaborative strategies depends on the institutional 
demographics of collaborative partners as well as on the social connections of the 
intellectual resources of the focal firm. Thus, benefits from a formal partnership depend 
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on whether or not it is an extension of the social relationships of human capital residing 
within the firm. This explains why firms encourage their corporate scientists to be active 
in collaborating with star scientists from universities (Zucker, Darby and Armstrong, 
2002). This also explains why scholars suggest that informal relationships between 
individuals residing within a firm should span geographical and technological boundaries 
(Singh, 2005).  
 My study also helps in understanding how benefits derived from alliance partners 
depend on the characteristics of the partners and the kind of resources endowed within 
the firm. Prior studies have shown the importance of intellectual human capital within a 
firm for benefiting from alliance partners (Hitt et al., 2006). I go further in saying that the 
characteristics of intellectual human capital within a firm also help to determine if it is 
necessary to form partnerships with an entity or not.  
 This research is subject to a number of limitations, the first of which pertains to 
patent data. Restricting the scope to patent data has several limitations because not all 
companies have the same propensity to patent, firms can limit their patents to only the 
most successful innovations, and the like. In spite of the above limitations, patent data 
has been widely used in testing the factors contributing to innovation (Sorenson and 
Fleming, 2004; Gittelman and Kogut, 2003). 
 The second limitation is related to intellectual human capital measure. Currently it 
is operationalized as the proportion of intellectual human capital in 
science/technology/both domains. In reality, there exists huge heterogeneity even among 
individuals belonging to each of these categories. Hence, one of the fruitful research 
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extensions can be to develop an intellectual human capital measure capable of capturing 
an individual’s breadth and depth of knowledge.  
 A third limitation pertains to publications. Not all firms involved in scientific 
research have the inclination to disclose their findings through publishing. Even among 
publications, there are articles that can be classified as basic journals and applied journals 
(Lim, 2004). A fine-grained approach in categorizing publications can strengthen my 
implications. There are also publications made by firms through collaboration with other 
firms and universities. My study includes all publications that are affiliated with the 
sample firms, irrespective of whether the publication is associated with more than one 
organization or not. However, not considering the information on collaboration is not a 
major limitation of my study. This is because the publication is still a strong predictor of 
the knowledge captured by the firm and that the firm has acquired the tacit knowledge of 
individuals engaged in the research (Zucker, Darby and Armstrong, 2002). 
 Fourth, my study exploring the importance of intellectual human capital can only 
be generalized to those high-technology industries where intellectual human capital is 
considered a key input for technological innovation.  
 Despite the limitations, my research provides important insights about the 
interdependence of antecedents of innovation across two different levels, one at the firm 
and other at the network level. With several industries being dominated by an open 
innovation structure, my study draws the attention of scholars and managers into more 




DISCUSSION AND CONCLUSION 
CONCLUSION 
This dissertation comprises of three essays. The central theme underlying the three essays 
is in exploring the determinants of the technological performance of firms. Specifically, 
the essays attempt to study the interrelationships between intellectual human capital, 
strategic alliances and technological performance. 
 The first essay investigates the means through which intellectual human capital 
and strategic alliances contribute to technological performance. The findings show that 
new knowledge search is one process through which intellectual human capital and 
strategic alliances contribute to the technological performance of firms. Since intellectual 
human capital differ in their capabilities, I categorized them into pure scientists, pure 
inventors and bridging scientists, depending on their specialized domains. The results 
show that the relationship between bridging scientists, pure inventors and technological 
performance is mediated by technological and geographical searches. The new 
knowledge search does not mediate the relationship between pure scientists and 
technological performance. However, pure scientists are observed to help the 
technological and geographical searches conducted by bridging scientists, thereby 
contributing to new knowledge search indirectly.  
 With regard to alliances, the results demonstrate that firms have to rely on 
external resources, such as those leveraged from alliance partnerships, in order to 
enhance the value of their new knowledge search to technological performance. A 
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technologically and geographically diverse alliance portfolio is known to increase the 
contributions of technological and geographical searches to technological performance.  
The second essay is about mechanisms that help a firm in converting the 
competencies of its intellectual human capital, especially scientists, into better 
technological performance. The essay investigates the importance of two mechanisms for 
bridging science and technology domains, one at the individual level and the other at the 
firm level, that help a firm in translating the competencies of its scientists into better 
technologies. The results suggest that the individual-level mechanism of possessing 
bridging scientists, who are engaged in both scientific research and technology 
development, helps an organization to bridge its science and technology domains. 
Further, the results show that bridging science and technology domains within an 
organization cannot be achieved by merely engaging individuals in both of the domains. 
Instead, a firm should have an exploitation mechanism in place for exploiting the 
knowledge generated by in-house scientists in the technology domain.  
The third essay is about the inter-relationship between firm level factors, such as 
intellectual human capital, and network level factors, such as strategic alliances. The 
essay examines if intellectual human capital and strategic alliances are substitutes or 
complements of each other. The findings illustrate that, depending on the characteristics 
of intellectual human capital and attributes of alliance partners, the factors at these two 
levels can be either substitutes or complements. Similar to the first essay, three types of 
intellectual human capital are taken into consideration in testing the interdependency. 
With respect to alliances, the partners are classified into (1) university alliances and (2) 
firm alliances, depending on their institutional affiliation. Pure scientists and bridging 
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scientists residing within a firm are observed to be substitutes of university alliances. On 
the contrary, all of the three intellectual human capital variables are observed to 
complement firm alliances.   
 
CONTRIBUTIONS 
The dissertation contributes to theory and practice in several ways. The first contribution 
is to the research on knowledge search. This dissertation augments the existing studies 
that emphasize the importance of technological, geographical and science search for 
better technological performance (Ahuja and Katila, 2004; Phene et al., 2006; Rosenkopf 
and Nerkar, 2001). The curvilinear effects of geographical and science searches suggest 
that, beyond a point, search along these dimensions can result in diminishing returns. The 
curvilinear effect also highlights the value of identifying the optimum amount of search, 
suggested by scholars investigating the exploration/exploitation balance. Unlike 
searching across diverse geographic areas or scientific domains, technological search had 
a linear positive effect on technological performance. Prior studies have suggested the 
importance of scientific findings to technological search, and that technological search 
conducted beyond national boundaries is detrimental to innovation (Fleming and 
Sorenson, 2004; Phene et al., 2006). However, after controlling for the geographical and 
science searches, the linear positive effect of technological search suggests that searching 
a wide array of technologies is always beneficial to biotech innovations, which are 
characterized to be inter-disciplinary in nature.  
 A second implication of this dissertation is to the upcoming research on various 
mechanisms that help the new knowledge search process. Intellectual human capital and 
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strategic alliances are two important mechanisms identified to be helpful in new 
knowledge search and knowledge brokering (Rosenkopf and Amedia, 2003; Hsu and 
Lim, 2008). Borrowing insights from absorptive capacity, I show that intellectual human 
capital helps in searching for new knowledge and that strategic alliances help in 
translating the new knowledge search into better technological performance. 
Consequently, I add to the stream of research by distinguishing the value of these two 
mechanisms to new knowledge search.  
 Third, in recent times an increasing number of scholars are interested in 
examining the contributions of human capital, especially the contributions of intellectual 
human capital to knowledge related activities and technological performance (Zucker et 
al., 2001; Subramaniam and Venkaratraman, 2001; Rothaermel and Hess, 2006). The 
results from the first essay suggest that bridging scientists and pure inventors assist in 
technological and geographical searches. The essay also suggests that pure scientists help 
the technological and geographical searches conducted by bridging scientists. The results 
from the third essay suggest that pure scientists and bridging scientists also help in the 
free flow of knowledge from the open scientific network. Taken together, the results add 
to the above stream of research in suggesting the kind of knowledge that can be accessed 
through the different types of intellectual human capital (Rosenkopf and Nerkar, 2001). 
The findings contribute to the upcoming stream of research that attempts to relate a firm’s 
knowledge exploration process to the kind of employees that the firm hires (Perretti and 
Negro, 2006). They also support the notion that contributions of pure scientists to 
technological activities are indirect, by assisting the knowledge related activities of 
individuals who are directly involved in technological activities (Furukawa and Goto, 
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2006; Rothaermel and Hess, 2006). In addition, I contribute to the research on the 
intellectual human capital-technological performance link by showing that new 
knowledge search is one of the processes through which intellectual human capital 
contributes to technological performance.  
 The above findings may also help managers in deciding on the kind of intellectual 
human capital to hire, depending on their knowledge requirements. If an organization is 
interested in searching wide arrays of technologies and geographies, the firm should 
consider hiring bridging scientists and pure inventors. Further, the results show how 
important it is for organizations to hire bridging scientists. Apart from assisting in the 
new knowledge search and connecting science-technology domains, bridging scientists 
also bridge pure scientists and the new knowledge search process, thereby helping firms 
to indirectly benefit from their pure scientists. Pure scientists might not be of direct help 
in searching for new knowledge related to technology development. Nevertheless, this 
thesis identifies a distinct and important role played by pure scientists. Since pure 
scientists are known to be connected to the open scientific world through publishing, 
these scientists bring in knowledge and information benefits similar to those that 
university partners can bring in. As university-firm partnerships are compared to the 
merging of entities from Mars and Venus, a firm can avoid such difficult partnerships by 
employing pure scientists within their organization. 
 Fourth, the findings from the second essay add to the stream of research on 
science-technology relationship in suggesting that bridging science and technology 
domains within a firm is not a simple human capital story of having scientists do both. A 
firm should have an appropriate exploitation mechanism in place to achieve this. The 
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essay also contributes to the research on knowledge exploration/exploitation in the 
following ways. First, it not reasonable to expect the individuals/domains involved in 
exploration to be also involved in exploitation. Instead, the exploration/exploitation 
balance should be balanced across different level/domains (Levie and Rosenkopf, 2006). 
Second, firm level structures play a vital role in appropriating returns from organizational 
search (Argyres and Silverman, 2004; Siggelkow and Rivkin, 2006). I also developed a 
novel measure that uses the patent and publication data to capture the extent to which a 
firm exploits the scientific knowledge that it produces in its technology development 
activities. In computing this measure, I first identified all publications produced by the 
focal firm and then all the patents citing those publications. Based on the assignee name 
of the patents, I calculated the proportion of the focal firm’s patents over all patents citing 
the focal firm’s scientific publications. The measure that lies between 0 and 1 helps in 
estimating the extent to which the scientific publications produced by a firm are being 
exploited in its patents. This measure can be used by scholars investigating the science-
technology relationship and the exploration/exploitation balance issues.  
 The above findings have important implications for practice. Managers cannot 
simply recruit intellectuals such as scientists and expect to see returns. The results 
suggest the importance of firm-level mechanisms for benefiting from intellectual human 
capital. I conducted interviews with the CEOs of two biotech firms in order to identify 
firm-level factors that they think are important for benefiting from intellectual human 
capital like scientists. Five factors emerged from the interviews. They are (1) frequent 
inter-departmental meetings that encourage exchange of ideas, (2) deliberate personal 
meetings with introverted scientists, who are generally silent during meetings, (3) a good 
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project manager- a person with good interpersonal skills, who need not necessarily be a 
scientist, but is capable of understanding what each scientist in a team is saying at a 
broader level and attempts to unify the scientists with a single project identity, (4) 
centralized R&D structure and (5) having at least one star scientist within the firm, or 
inviting a star scientist from outside onto the firm’s advisory board  
 The fifth implication is to the research on strategic alliances. The importance of 
strategic alliance to technological performance has been well established in the literature 
(Powell et al., 1996). Subsequently, scholars have started concentrating on the attributes 
of alliance partners in order to evaluate their significance (Stuart, 2000). This dissertation 
proposes that a holistic understanding of the strategic advantage derived from alliance 
partners warrants a careful examination of the alliance partners’ attributes and their 
interaction with the focal firm’s characteristics. A few scholars have started to unravel 
this effect by studying the technological overlap between alliance partners in 
investigating the relative benefits (Mowery, Oxley and Silverman, 1998). My first essay 
contributes to this stream of research in identifying the kind of alliance portfolio that best 
fits with the different types of searches conducted by the focal firm. Similarly, the finding 
from the third essay that pure scientists and bridging scientists substitute university 
partners suggests that the benefits from a formal partnership depend on whether or not it 
is an extension of the social relationships of human capital residing within the firm. The 
substitutive/complementary findings from the third essay underline that knowledge 
spillover from network entities is a function of their institutional commitments and 
practices of members of the network (Owen-Smith and Powell, 2004). The above result 
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also encourages multi-level scholars who investigate the inter-dependency of factors 
across different levels to give due attention to the characteristics of factors under study.  
  In deciding on the alliance strategy, management is required to choose a 
particular partner from a set of possible choices, often with the objective of minimizing 
the risk of making the wrong choice. The above findings provide important directions to 
managers in deciding if a firm will benefit from choosing an entity as an alliance partner 
or not, in conjunction with the firm’s internal requirements and competencies. The 
findings suggest that if a firm is interested in searching for new knowledge from a wide 
array of technologies and geographies, it is vital that the firm deliberately chooses a 
technologically and geographically diverse alliance portfolio. Nevertheless, it should be 
acknowledged that absorbing knowledge from such a diverse portfolio is not an easy task. 
The results supporting the argument that intellectual human capital and firm partners are 
complements proposes a solution to this absorptive issue. The findings advocate that a 
firm should have the necessary diversity in their internal expertise in order to ensure that 
they can absorb the knowledge from a diverse alliance portfolio. 
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LIMITATIONS AND FUTURE DIRECTIONS 
 
There are number of limitations acknowledged in each of the essays. A few important 
ones to mention are as follows. The first limitation is pertaining to patent and publication 
data. Restricting the scope to patent data has several limitations because not all 
companies have the same propensity to patent and publish. In collecting the patent data, I 
restricted my attention to 7 technology classes (US 3-digit classification) that represent 
the biotechnology industry. However, I take into consideration all the publications made 
by the sample firms rather than restricting my attention to those that concentrate on 
biotechnology areas. It is possible that a few diversified firms such as Johnson and 
Johnson and BASF have publications on areas that are beyond the focus of the patent 
portfolio under consideration. Consequently, an important limitation of my three essays is 
that the estimates pertaining to publications and scientists can be biased upwards for a 
few firms.   
 Second, it is noted that 40% of the citations in patents are added by patent 
examiners (Alacer and Gittelman, 2006). I take into account all the forward and 
backward citations of patents in calculating the measures, which is a notable limitation of 
this dissertation. However, as explained in the first essay, this limitation is mitigated by 
the way citations are used in my dissertation. 
 The third limitation is related to the operationalization of measures, such as new 
knowledge search and exploitation mechanism. Currently, these variables are restricted to 
inferences from patent and publication documents which represent successful searches 
and exploitation that eventually were transformed into patentable and publishable 
innovations. However, not all searches and knowledge exploitation eventually get 
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translated into successful patents and publications. A measure using primary data that 
completely incorporates the finer aspects of the above variables will improve my findings 
and implications. Further, in accounting for the geographical search and exploitation 
mechanism, I consider only the first inventor and first assignee of the patents. A more 
comprehensive measure encompassing the list of inventors and assignees of patents 
would make the results and implication robust.  
 Last but not least, my study exploring the importance of intellectual human 
capital can only be generalized to high-technology industries where intellectual human 
capital is considered to be a key input for technological innovation. Further, my sample 
focuses only on those firms that have patents issued under their name. Hence, the results 
are applicable only to those firms that have the inclination and competency to apply for 
patents and get them issued.  
 There are several avenues of future research. First, I am interested in identifying 
other factors that might mediate the relationship between intellectual human capital and 
technological performance. A second opportunity for research is in understanding how 
intellectual human capital and alliances help firms in a new knowledge search that is both 
technologically and geographically distant (i.e. interaction of technological and 
geographical search). Third, I am conducting interviews with biotech firms in order to 
unravel some of the firm-level factors that facilitate the exploitation of knowledge within 
organizations. Fourth, while this dissertation uses performance of patents as the 
dependent variable, a worthwhile area of research is to identify outputs (that are capable 
of generating economic rents) at different stages of the biotech value chain. This will help 
in precisely evaluating the contributions of factors that lie across different stages of the 
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value chain. A fifth possibility for research is to identify a method capable of measuring 
the contributions of alliance partners individually, by looking at the intellectual property 
rights emerging from each partnership.  
 To conclude, I believe that the findings from my dissertation will stimulate 
scholars and practitioners to have a systemic view of managing intellectual human capital 
and strategic alliances for better technological performance. Scholars and managers 
should be motivated to delve into the characteristics of intellectual human capital and 
attributes of alliance partners while they investigate the benefits derived from these 
factors. In exploring the contribution of intellectual human capital to technological 
performance, it is equally important that scholars and practitioners give due attention to 
the organizational structure, as this is what ensures a smooth translation of the 
competencies of intellectual human capital into better technologies. 
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APPENDIX 
Table A.1. Summary of Dependent, Independent and Control Variables 













One minus the Herfindahl concentration index of the technology 





One minus the Herfindahl concentration index of the geographical 
origin of backward cited patents  
Science search Patent-Year 
Level 
Number of times a patent refers to non-patented literature 
Pure scientists Firm   Level Proportion scientists within firms whose names are exclusively 
listed in publications and not in patents  
Bridging scientist Firm Level Proportion of patent inventors within a firm whose names are also 
listed in scientific papers published by the firm 
Pure inventors Patent-Year 
Level 
Number of patent inventors for each patent who names are 
exclusively listed in patents  
Technological 




One minus the Herfindahl concentration index of the 
technological classification of alliance portfolio (Alliance 
portfolio comprises of all the entities with whom the focal firm 
had formed alliance in the year of observation in which a patent 
was filed by the focal firm)  
Geographical 




One minus the Herfindahl concentration index of the geographical 
location of alliance portfolio (Alliance portfolio comprises of all 
the entities with whom the focal firm had formed alliance in the 
year of observation in which a patent was filed by the focal firm) 
No of university 




Number of alliance partners from academic institutions in the year 







Proportion of focal firm’s patents over all patents citing the focal 
firm’s scientific publications  
University alliances Firm-Year 
Level 
Number of university partners with whom the focal firm had 
formed alliance in the year of observation  
Firm alliances Firm-Year 
Level 
Number of firm partners with whom the focal firm had formed 
alliance in the year of observation  
Control Variables 
Publication volume Firm-Year 
Level 
Cumulated count of the number of publications produced by the 
focal firm in the year of observation in which a patent was filed by 
the focal firm 
Publication citation Firm-Year 
Level 





Number of patents granted to a firm in the year of observation in 
which a patent was filed by the focal firm  
R&D expenditure Firm-Year 
Level 
R&D expenditure made in the year of observation in which a 
patent was filed by the focal firm 
Firm size Firm-Year 
Level 
Number of employees in the year of observation in which a patent 
was filed by the focal firm 
Firm age Firm-Year 
Level 
Number of years since the firm was founded 
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Patent age Patent-Year 
Level 





Dummy variable for the technology class of the focal patent 
Year fixed effects Patent-Year 
Level 
Dummy variable for the year in which the focal patent is filed 
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Table A.2. List of Sample Firms 
 
AASTROM BIOSCIENCES INC IMMUNOGEN INC 
ABAXIS INC IMMUNOMEDICS INC 
ABBOTT LABORATORIES INSITE VISION INC 
ABGENIX INC INSPIRE PHARMACEUTICALS INC 
ACCESS PHARMACEUTICALS INTRABIOTICS PHARMACEUTICALS 
ACLARA BIOSCIENCES INC ISIS PHARMACEUTICALS INC 
ADOLOR CORP JOHNSON & JOHNSON 
ADVANCED BIONICS CORPORATION KING PHARMACEUTICALS INC 
AFFYMETRIX INC KOS PHARMACEUTICALS INC 
AKZO NOBEL NV KOSAN BIOSCIENCES INC 
ALBANY MOLECULAR RESEARCH LA JOLLA PHARMACEUTICAL 
ALCON INC LARGE SCALE BIOLOGY CORP 
ALEXION PHARMACEUTICALS LEXICON GENETICS INC 
ALIZYME PLC LIFECORE BIOMEDICAL INC 
ALKERMES INC LIGAND PHARMACEUTICALS INC 
ALLERGAN INC LYNX THERAPEUTICS INC 
ALLIANCE PHARMACEUTICAL CORP MARTEK BIOSCIENCES CORP 
ALLOS THERAPEUTICS INC MATRITECH INC 
ALPHARMA INC MAXIM PHARMACEUTICALS 
ALTEON INC MAXYGEN INC 
ALZA CORP MDS INC 
AMARILLO BIOSCIENCES INC MEDAREX INC 
AMGEN INC MEDICIS PHARMACEUTICAL CORP 
AMYLIN PHARMACEUTICALS INC MEDIMMUNE INC 
ANDRX CORP MERCK & CO INC 
ANGIOTECH PHARMACEUTICALS MILLIPORE CORP 
ANIKA THERAPEUTICS INC MOLECULAR DEVICES CORP 
APHTON CORP MONSANTO CO 
ARENA PHARMACEUTICALS INC MYRIAD GENETICS INC 
ARIAD PHARMACEUTICALS NANOGEN INC 
ARQULE INC NASTECH PHARMACEUTICAL CO INC 
ASTRAZENECA PLC NEOPHARM INC 
ATHEROGENICS INC NEOSE TECHNOLOGIES INC 
ATRIX LABORATORIES INC NEUROBIOLOGICAL TECHNOLOGIES INC 
AUTOIMMUNE INC NEUROCRINE BIOSCIENCES INC 
AVANIR PHARMACEUTICALS NEUROGEN CORP 
AVANT IMMUNOTHERAPEUTICS NEXIA BIOTECHNOLOGIES INC 
AVI BIOPHARMA INC NEXMED INC 
AVIGEN INC NORTHFIELD LABORATORIES 
BARR LABORATORIES INC NOVARTIS AG 
BASF AG NOVAVAX INC 
BAUSCH & LOMB INC NOVEN PHARMACEUTICALS 
BAXTER INTERNATIONAL INC NPS PHARMACEUTICALS INC 
BAYER CORP NUTRITION 21 INC 
BIOCRYST PHARMACEUTICALS ONYX PHARMACEUTICALS INC 
BIOMET INC ORCHID BIOSCIENCES INC 
BIOMIRA INC ORGANOGENESIS INC 
BIOSITE INC ORPHAN MEDICAL INC 
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Table A.2. List of Sample Firms (Contd.) 
 
BIOTECH HOLDINGS LTD OSI PHARMACEUTICALS INC 
BIOTIME INC OXIGENE INC 
BONE CARE INTERNATIONAL OXIS INTERNATIONAL INC 
BOSTON BIOMEDICA INC PEREGRINE PHARMACEUTICALS INC 
BRADLEY PHARMACEUTICALS PFIZER INC 
BRISTOL MYERS SQUIBB CO PHARMACOPEIA INC 
CANGENE CORP PHARMACYCLICS INC 
CARRINGTON LABORATORIES INC POLYDEX PHARMACEUTICALS 
CELGENE CORP POZEN INC 
CELL GENESYS INC PRAECIS PHARMACEUTICALS 
CELL GENESYS INC PROGENICS PHARMACEUTICALS 
CELLEGY PHARMACEUTICALS PROMEGA CORP 
CELSIS INTERNATIONAL PLC PROTEIN DESIGN LABS INC 
CEPHALON INC PROTEIN DESIGN LABS INC 
CHATTEM INC QLT INC 
CHIRON CORP REGENERON PHARMACEUTICALS INC 
CIMA LABS INC RIGEL PHARMACEUTICALS INC 
CIPHERGEN BIOSYSTEMS INC SALIX PHARMACEUTICALS 
COLLAGENEX PHARMACEUTICAL SANOFI-SYNTHELABO 
COLUMBIA LABORATORIES SCHERING AG 
COMMONWEALTH BIOTECHNOLOGIES INC SCHERING-PLOUGH CORP 
CONNETICS CORP SCICLONE PHARMACEUTICALS 
CORTEX PHARMACEUTICALS SCIOS INC 
CSL LIMITED SENETEK PLC 
CUBIST PHARMACEUTICALS SEPRACOR INC 
CV THERAPEUTICS INC SEQUENOM INC 
DEPOMED INC SICOR INC 
DISCOVERY LABORATORIES SKYEPHARMA PLC 
DOW AGROSCIENCES LLC SONUS PHARMACEUTICALS 
DRAXIS HEALTH INC SPECIALTY LABORATORIES INC 
DUSA PHARMACEUTICALS INC SPECTRAL DIAGNOSTICS INC 
DYAX CORP STRATAGENE CORP 
EISAI CO LTD SUPERGEN INC 
ELAN CORP PLC SYNAPTIC PHARMACEUTICAL 
ELI LILLY & CO SYNBIOTICS CORP 
EMBREX INC TANOX INC 
EMISPHERE TECHNOLOGIES TARGETED GENETICS CORP 
ENTREMED INC TARO PHARMACEUTICAL INDUSTRIES 
ENZO BIOCHEM INC TECHNE CORP 
EPIMMUNE INC TELIK INC 
E-Z-EM INC TEVA PHARMACEUTICAL INDUSTRIES 
FORBES MEDI-TECH INC THIRD WAVE TECHNOLOGIES INC 
FOREST LABORATORIES INC TRANSKARYOTIC THERAPIES 
FUJISAWA PHARMACEUTICALS COMPANY 
LTD TRIMERIS INC 
GENE LOGIC INC TRIPOS INC 
GENELABS TECHNOLOGIES INC TULARIK INC 
GENENCOR INTERNATIONAL INC UNIGENE LABORATORIES 
GENENTECH INC V.I. TECHNOLOGIES INC 
GEN-PROBE INC VALENTIS INC 
GENTA INC VASOGEN INC 
174 
Table A.2. List of Sample Firms (Contd.) 
 
GENVEC INC VERTEX PHARMACEUTICALS INC 
GENZYME BIOSURGERY VICAL INC 
GILEAD SCIENCES INC VION PHARMACEUTICALS INC 
GUILFORD PHARMACEUTICALS INC VIRAGEN INC 
HAUSER INC VIROLOGIC INC 
HEMISPHERX BIOPHARMA INC VIROPHARMA INC 
HESKA CORP VYSIS INC 
HUMAN GENOME SCIENCES INC WATSON PHARMACEUTICALS INC 
HYBRIDON INC WYETH 
HYCOR BIOMEDICAL INC XECHEM INTERNATIONAL 
IDEXX LABORATORIES INC XOMA LTD 
IMCLONE SYSTEMS INC ZILA INC 





Table A.3. Comparison of Descriptive Statistics across 437 and 222 firms 
 
Descriptive Statistics for 437 firms 
Variables Average Standard 
Deviation 
Max Min 
Firm R&D  9.97 15.6 162754.7 0.5 
Firm Age  29.6 2.74 149.9 1 
Firm Size 8.9 200.3 119372.0 0.1 
Descriptive Statistics for 222 firms 
Variables Average Standard 
Deviation 
Max Min 
Firm R&D 20.9 8.6 162754.7 0.5 
Firm Age 29.1 3.35 149.9 1 






Table A.4. General Description of 222 Sample Firms between 1990-2000 
 






1990 424 3863 298
1991 489 3436 455
1992 540 3995 577
1993 584 4573 468
1994 538 4857 643
1995 548 5349 545
1996 901 5297 805
1997 1394 6984 863
1998 1778 7095 847
1999 1728 7943 829







Table A.5. Types of Recap Alliances 
 
1 Acquisition 14 License 
2 Asset Purchase 15 Loan 
3 Assignment 16 Manufacturing 
4 Co-Development 17 Marketing 
5 Co-Market 18 Merger 
6 Collaboration 19 Option 
7 Co-Promotion 20 Research 
8 Cross-License 21 Security 
9 Development 22 Settlement 
10 Distribution 23 Sublicense 
11 Equity 24 Supply 
12 Joint Venture 25 Termination 




Table A.6. Technology Classification of Recap Alliances 
 
1 Adjuvant 28 Monoclonals - Conjugates 
2 Attenuated Virus Production 29 Monoclonals - Humanized Abs 
3 Bioinformatics 30 Monoclonals - Transgenic mice 
4 Carbohydrates 31 Natural Product 
5 Cell Therapy - Stem Cells/Factors 32 Oligonucleotide ligands 
6 Collagen matrix 33 Oligonucleotides - Antisense/Triple 
helix 
7 Combinatorial 34 Oligonucleotides - Gene Therapy 
8 Device 35 Oligonucleotides - Ribozymes 
9 DNA Probes 36 Peptides 
10 Drug Delivery - Liposomes 37 PFOB Emulsions 
11 Drug Delivery - Oral 38 Pharmacogenomics 
12 Drug Delivery - Other 39 Phototherapy 
13 Drug Delivery - Sustained Release 40 Polyclonal Antibodies 
14 Drug Delivery - Transdermal 41 Polyethylene glycol (PEG) products 
15 Gene Expression 42 Proteomics 
16 Gene Sequencing 43 Purines & Pyrimidines 
17 Generics 44 Rational Drug Design - Computational 
18 Hyaluronic acid 45 Rational Drug Design - Synthetics 
19 Immunoassay 46 Recombinant DNA 
20 Immunoglobulin 47 Resin Polymers 
21 Implantable Devices 48 Screening 
22 In-licensed Products 49 Separations 
23 Microarrays 50 Service Laboratory 
24 Micropropagation 51 Synthetics 
25 Microspheres 52 Transcription Factors 
26 Monoclonals 53 Transgenics 
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